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Abstract 	
The purpose of this thesis was to investigate brain anatomy and 
physiology of subjects with impaired glucose tolerance (IGT – 12 subjects), 
type-2 diabetes (T2DM - 17 subjects) and normoglycemia (16 subjects) using 
multi-modal magnetic resonance imaging (MRI) at 3T.  
Perfusion imaging using quantitative STAR labeling of arterial regions 
(QUASAR) arterial spin labeling (ASL) was the core dataset. Optimization of the 
post-processing methodology for this sequence was performed and the 
outcome was used for hemodynamic analysis of the cohort. Typical perfusion-
related parameters, along with novel hemodynamic features were quantified. 
High-resolution structural, angiographic and carotid flow scans were also 
acquired and processed. Functional acquisitions were repeated following a 
vasodilating stimulus. Differences between the groups were examined using 
statistical analysis and a machine-learning framework. 
Hemodynamic parameters differing between the groups emerged from 
both baseline and post-stimulus scans for T2DM and mainly from the post-
stimulus scan for IGT. It was demonstrated that quantification of not-typically 
determined hemodynamic features could lead to optimal group-separation. 
Such features captured the pattern of delayed delivery of the blood to the 
arterial and tissue compartments of the hyperglycemic groups. Alterations in 
gray and white matter, cerebral vasculature and carotid blood flow were 
detected for the T2DM group. The IGT cohort was structurally similar to the 
healthy cohort but demonstrated functional similarities to T2DM. When 
combining all extracted MRI metrics, features driving optimal separation 
between different glycemic conditions emerged mainly from the QUASAR scan. 
The only highly discriminant non-QUASAR feature, when comparing T2DM to 
healthy subjects, emerged from the cerebral angiogram. 
In this thesis, it was demonstrated that MRI-derived features could lead 
to potentially optimal differentiation between normoglycemia and 
hyperglycemia. More importantly, it was shown that an impaired cerebral 
hemodynamic pattern exists in both IGT and T2DM and that the IGT group 
exhibits functional alterations similar to the T2DM group. 
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Introduction 
 
 Whether to gain insight into the underlying structure and function of body 
organs by means of dissection has been a matter of debate for centuries. In 
antiquity and medieval times, the human body was considered sacred and 
dissection was either limited or totally prohibited. It was in Alexandria in the 4th 
century BC where for the first time, physicians reported their observations 
based on cadaver dissection. However, the practice of dissection was 
abandoned and subsequently prohibited mainly due to religious reasons (1). It 
was not until the 14th century that anatomy was reinstated in Italy. At first, 
dissection was used for autopsy but as the years passed, it became clear that 
both the scientific community and society could have a lot to gain if they 
invested in it (2). From being considered an unethical practice for a period of 
more than 1500 years, in the 15th century, dissection became extremely popular 
and in the 16th century anatomy theaters were built around Italy and the rest of 
Europe. Such was its impact in society that even renowned painters such as 
Leonardo da Vinci and Rembrandt were inspired by it to create some of their 
masterpieces (figure 1).  
 
Figure 1: Rembrandt, The Anatomy Lesson of Dr. Nicolaes Tulp, signed and dated 
‘Rembrandt ft. 1632’. Canvas, 169,5 x 216,5 cm, The Hague, Mauritshuis 
 
It was in the 16th century, in Italian cities and universities, where it 
became clear that empirical observations and dissection of animals was a 
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limiting factor in understanding the human body and disease. A proper 
understanding would require a window into the living human body and at that 
time, the only window available was human cadaver dissection. 
In 1895 the emergence of X-ray imaging, discovered by Wilhelm 
Rontgen, gave for the first time the opportunity to study body organs in living 
humans. In the 1980s another breakthrough would change the way the human 
body was imaged. The emergence of Magnetic Resonance Imaging (MRI), 
attributed to Paul Lauterbur, Peter Mansfield and Raymond Damadian, allowed 
for non-ionizing imaging of the 3-dimensional structure of the body (3, 4).  
Within a few centuries, humanity has progressed from ignorance of what 
is happening inside the body, to the acceptance that understanding of a disease 
requires an insight inside the body that only dissection could provide, and finally 
to medical imaging approaches based on manipulation of atomic, chemical and 
physical properties of tissues. In general, progression in these approaches 
moves from ionizing and invasive techniques to being totally non-ionizing and 
non-invasive. MRI is one of the core bio-imaging modalities used nowadays and 
along with ultrasound is the safest modality for anatomical imaging. Ultrasound 
imaging, however, is limited in its ability to provide an image of the brains 
interior since the skull shields it from acoustic waves (except in newborns). 
Hence, MRI is currently the only imaging modality with the ability to provide high 
quality brain images using a non-ionizing approach. 
Although initially able to extract only structural information, nowadays 
MRI can also be used for functional assessment. MR images can be acquired 
from a wide range of body organs using a variety of specific MRI protocols.  
Medical imaging techniques, in particular MRI, are increasingly used for 
understanding, diagnosis and assessment of a disease’s severity. Another 
more recent field of interest is the identification of imaging biomarkers for 
disease prognosis. This requires that large longitudinal datasets and powerful 
processing methods are available in order for reliable predictions to be made. A 
great example is the BioBank initiative where numerous MRI scans and 
biometric factors are being collected from 500.000 individuals (5). The evolution 
of medical imaging continues, with research ongoing aimed at improving 
several aspects, ranging from the hardware and acquisition techniques to the 
highly specialized post-processing approaches. This thesis aims to be a part of 
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this effort, by being at the intersection of image processing and clinical 
research. 
The purpose of this thesis is to gain a deep insight into the brain of 
subjects with impaired glucose tolerance (IGT – pre-diabetes) and type-2 
diabetes mellitus (T2DM) patients. Diabetes currently affects 415 million people 
globally and 4 million in the UK (6). The prevalence of the disease and the fact 
that it is a risk factor for conditions such as stroke and Alzheimer’s disease 
renders its early diagnosis or even prognosis a necessity. It has previously 
been reported that the brain, amongst other organs, shows alterations of a 
structural and functional nature in individuals with diabetes. Uncovering the 
underlying brain changes could provide useful diagnostic and prognostic 
biomarkers for the disease.  
 In this study, several MRI techniques were used to evaluate cerebral 
structural and functional characteristics in a cohort comprised of healthy 
volunteers, subjects with IGT, and T2DM. Software tools were built for 
processing MRI images and new image analysis approaches were introduced. 
The developed processing pipelines have been made publically available in 
Matlab’s file exchange to promote reproducibility and dissemination. 
 The core imaging technique used in this study was arterial spin labeling 
(ASL) MRI, a technique used for blood perfusion assessment. In addition, high-
resolution structural scans were used to shed light on anatomical changes, 
diffusion weighted imaging was used to evaluate the microscopic water mobility 
within brain tissues and angiographic scans provided information about the 
cerebral vasculature. Flow inside the internal carotid artery was also evaluated, 
providing a window into the input the brain gets from the wider cardiovascular 
system. 
 
This thesis is organised as follows: 
In Chapter 1, relevant background material is presented. A brief 
overview is given of basic brain anatomy, diabetes and known changes 
occurring in the diabetic brain.  
In Chapter 2, an overview of MRI theory is provided. In the second part, 
techniques relevant to the work performed in this thesis are discussed, mainly 
focused on the core modality of this project, ASL.  
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In Chapter 3, brain image processing techniques and machine learning 
approaches utilised for data analysis are presented.   
In Chapter 4, the available cohort, acquired imaging modalities and 
utilised software tools are summarised. 
In Chapter 5, the methodology developed for processing multi inversion 
time-point ASL data is described, evaluated and discussed. 
In Chapter 6, the developed ASL processing pipeline is applied to the 
available cohort and the resulting hemodynamic data are analysed in a novel 
way. Machine learning is used to extract the most significant hemodynamic 
feature combinations. 
In Chapter 7, structural, diffusion-weighted and angiographic MR images 
are analysed and optimal processing approaches are discussed.  
In Chapter 8, all the results from the individual MRI modalities are 
brought together in a single model to unravel potential disease biomarkers. The 
general study conclusions along with future directions are presented. 
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Chapter 1: 
Diabetes and the brain 	
1.1 The brain  
1.1.1 Essential brain anatomy 
The brain is separated into three main structures: the cerebral cortex, the 
cerebellum and the brainstem. Nerve fibers forming the spinal cord conduct 
signals to and from the brain, and in their posterior location they form a 
structure known as the brainstem. This structure is associated with functions 
such as breathing, body temperature and blood pressure control. At the top of 
the brainstem lies the cerebellum, which is associated with movement 
coordination. 
The cerebral cortex can be separated into two hemispheres and 
comprises four main lobes: the frontal, temporal, parietal and occipital lobe. 
Although these lobes are associated with distinct functions, they are highly 
interconnected and are interacting constantly with each other. The occipital 
lobes are specialized for visual information processing. Information processing 
for input coming from the muscles, joints, and skin is combined with information 
from visual and acoustic inputs within the parietal lobes. The temporal lobes are 
associated with higher perceptual functions such as face recognition and 
meaning comprehension. They accommodate areas that are unique to the 
human brain such as Wernicke’s area, associated with speaking and 
comprehension. The frontal lobes accommodate the motor cortex and they are 
associated with ‘executive functions’ such as planning (7). 
The brain contains billions of neurons, the essential constituents of the 
central nervous system. Every neuron is directly connected with around 1000-
10,000 other neurons via synapses. A neuron consists of its dendrites, its soma 
and its axon. The bundles of axons form what is called white matter (WM) and 
the gray matter (GM) is formed by the soma, dendrites and axon terminals. 
Cerebrospinal fluid (CSF) is a fluid circulating within and around the brain, 
stemming from the ventricles to the subarachnoid space where it forms a 
protective layer surrounding the brain and the spinal cord. Other key cellular 
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and microstructural elements found inside the mammalian brain are glial cells, 
blood vessels and neural stem cells. 
The brain is a highly protected organ. The principal external protection 
comes from the skull. On the inside, CSF provides protection since one of its 
functions is the absorption of vibrations. There is an additional level of 
protection called the blood brain barrier (BBB), which protects the brain from 
potential physiological threats coming via the bloodstream (figure 1.1).  The 
BBB in a healthy individual prohibits potential pathogens from entering brain 
tissue from the blood stream. Tight junctions between the endothelial cells of 
brain capillaries form the BBB. This membrane is semi-permeable allowing 
substances such as oxygen, glucose, water and several molecules to cross. 
The BBB can be disrupted in diseases such as Alzheimer’s, brain tumors, 
multiple sclerosis (8, 9) and type-2 diabetes (10). 
 
Figure 1.1: The blood brain barrier illustration.  
 
 
1.1.2 Neurovascular coupling 
The neurovascular unit comprises a collection of structures and cells 
working together to ensure that the vascular tone is adequately adapted to meet 
changing energy demands from activated neurons (11). This functional complex 
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is responsible for the maintenance of an appropriate regional blood supply in 
the brain.  
The neurovascular unit comprises mainly three distinct levels: neurones, 
glial cells (astrocytes, microglia and oligodendroglia) and vascular cells 
(endothelial cells, pericytes and vascular smooth muscle) (12). The interface 
between the neuronal and vascular components is considered to be the 
astrocyte, which via ‘endfeet’ is in contact with pericytes and vascular smooth 
muscle. Additionally, it is in close communication with neuronal activity, playing 
a role in the manufacture and exchange of neurotransmitters and 
neuromodulators and with receptors for a range of neurotransmitter substances. 
Endothelial cells have the ability to produce and secrete substances regulating 
vascular tone such as nitric oxide (causing dilation), endothelin and 
thromboxane (constriction) (13).  
Neurovascular coupling refers to the close interplay between the 
vasculature and the neurons for the maintainance of the vascular tone and its 
adjustment of local cerebral blood flow (CBF) when necessary. It is mediated by 
the neurovascular unit which enables the appropriate adjustment of cerebral 
blood flow to meet energy demands in metabolically activated areas. 
Neurovascular uncoupling is a common finding in diseases such as 
Alzheimer’s, hypertension and stroke (14), whereby the local regulation of CBF 
becomes ‘uncoupled’ to changes in neuronal or metabolic activity. Early 
neurovascular uncoupling has also been reported in T2DM (15). In this T2DM 
study, functional MRI was used to evaluate the shape of the hemodynamic 
response function (HRF) to a visual stimulus. The examined subjects were 
cognitively assymptomatic and had no apparent lesions. The HRF differed in 
both the amplitude and the time-couse between healthy controls and T2DM 
patients.  
The neurovascular coupling concept suggests that increases in neuronal 
activation lead to increases in local blood flow. There exists also the vasculo-
neural or hemo-neural hypothesis according to which the neuronal activation is 
adjusted based on the changes in blood flow, having glial cells and mainly 
astrocytes as a mediator of the process (16). Both concepts describe a two-way 
communication between neurons and the vasculature via glial cells (mainly 
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astrocytes), the endpoint being blood flow adjustment for the maintainance of 
homeostasis. 
 
1.1.3 Brain arterial supply. 
The brain is a greedy organ since it accounts for 2% of the total body 
mass but consumes 20% of the utilised oxygen and 25% of the consumed 
glucose (12). The needs for nutrient and oxygen supply are constant and even 
a short interruption in supply (ischemia) can cause significant damage to brain 
tissue. Long-term interruptions in blood supply have been connected with 
cognitive decline and vascular dementia (17). The internal carotid arteries and 
the vertebral arteries are the brain’s main vascular supply. Inside the cranium 
the aforementioned arteries form a circular structure, the Circle of Willis. The 
carotids supply the anterior part of the brain, whereas the basilar/vertebral 
arteries supply the posterior part and structures such as the brain stem (18).  
Cerebral anatomy in relation to the brain’s blood supply and 
cerebrovascular disease has been recently reviewed by Chandra et al. (19). 
The internal carotids arise from the common carotid arteries. The right common 
carotid emerges from a bifurcation of the brachiocephalic truck. The left 
common carotid emerges directly from the aorta. The common carotids split to 
internal and external at the level of the neck. The external carotids supply the 
facial skin. The vertebral arteries emerge from the subclavian arteries. At the 
level of the pons they come together to form the basilar artery. The frontal lobes 
are supplied by the anterior cerebral artery (ACA), the middle cerebral artery 
(MCA) supplies part of the frontal, temporal and parietal lobes (figure 1.2). The 
posterior cerebral circulation supplies the temporal and occipital lobes and is 
responsible for about 1/3 of perfusion. The ACA, MCA and the anterior 
choroidal artery (AChA) are responsible for 72% of total CBF. 
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Figure 1.2: Coronal and axial maximum intensity projections of an MR angiogram 
demonstrating the brain vasculature. 
 
 
1.1.4 Oxygen and glucose path to the brain 
Oxygen and glucose are necessary for catabolic reactions taking place in 
the organism. The products of glucose breakdown are used for the generation 
of adenosine triphosphate and neurotransmitters.  
Oxygen is attached to hemoglobin molecules within erythrocytes (red 
blood cells), forming oxyhemoglobin. Every hemoglobin molecule has four 
heme groups with the potential to transfer up to one oxygen molecule each, so 
four oxygen molecules are transported by one hemoglobin molecule. When red 
blood cells pass through the lungs, oxygen molecules are attached and 
subsequently travel through the bloodstream (20). From the arteries, they 
progress to the arterioles and from there they enter the capillary bed. Inside, the 
microvasculature oxygen and nutrient exchange occurs, with oxygen being 
transferred from the hemoglobin molecules into the extravascular local tissue. 
Oxygen has the ability to diffuse freely across the BBB (21). 
Glucose is retained following a meal, it can also be stored in the body for 
use when required in the form of glucogen. When in the bloodstream, it travels 
around the body, in order to be taken up by the cells and used for energetic 
purposes. The brain’s glucose uptake is mediated by insulin and glutamate 
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transporters (GLUT-1, GLUT-3) (Mergenthaler et al 2013). Glucose in the brain 
is used by both neurons and glial cells. 
Transportation of both oxygen and glucose is based on the existence of 
a concentration gradient between the intravascular and extravascular 
compartments with the intravascular concentration being higher in both cases. 
 
1.2 Type-2 diabetes mellitus 
1.2.1 T2DM background  
Diabetes mellitus is a metabolic syndrome that has two dominant forms: 
Diabetes mellitus type-1 (T1DM) and diabetes mellitus type-2 (T2DM). T1DM is 
more common in people under the age of 40 years and the most common type 
in childhood accounting for 10% of diabetic patients. T2DM is the most 
prevalent form of diabetes mellitus after the age of 40 years and it accounts for 
90% of diabetic patients. T1DM, is attributed to insulin deficiency, whereas 
T2DM occurs due to insulin resistance (6). The main risk factors for developing 
T2DM are: eating habits; sedentary lifestyle; age; and family history (22). 
Insulin, a hormone produced in the pancreas is responsible for the 
stimulation of glucose uptake by the cells. Glucose is the end product of food 
breakdown in the stomach, it is the basic ‘fuel’ of the organism and its uptake is 
crucial for the maintenance of homeostasis. In T2DM cells develop insulin 
resistance. The first response of the organism to this condition is the production 
of higher levels of insulin by the pancreas to compensate for the reduced insulin 
uptake (hyper-insulinemia). Insulin resistance results in reduced glucose uptake 
and glucose remains in the bloodstream resulting in hyperglycemia (23). The 
organism after a certain point becomes dysregulated, as the amount of energy 
needed by the cells in order to function properly is not met. Impaired glucose 
tolerance (IGT) and impaired fasting glucose are considered to be pre-diabetic 
conditions, whereby insulin production and glucose uptake are impaired. 
However, the subjects do not fulfil the clinical criteria to be categorised as 
diabetic. IGT is considered to be reversible with lifestyle changes (24) and anti-
diabetic drug usage (25), but it has a high rate (70%) of progression to T2DM 
(26). 
Diabetes can affect several organs such as: the eyes (retinopathy), being 
one of the main causes of blindness in adulthood (27); kidneys (nephropathy) 
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affecting 20-40% of patients with diabetes who develop diabetic nephropathy 
(28); and nerves (neuropathy) affecting 15-26% of individuals suffering from 
diabetes (29). Furthermore, it is one of the main risk factors for developing 
cardiovascular disease, which accounts for 52% of deaths in type-2 diabetics 
(30). 
Usually diabetes is diagnosed following the onset of diabetic symptoms 
such as excessive urination, or by performing tests targeted to detect high 
glucose in urine or in the blood. A factor typically used to evaluate the diabetic 
status is the amount of circulating glycated hemoglobin (HbA1c) with a 
physiological level being below 6% (31). HbA1c reflects directly the amount of 
glucose inside the bloodstream. As described earlier, oxygen binds to 
hemoglobin molecules, circulates via the bloodstream and is delivered to 
tissues to participate in metabolic reactions. When the amount of glucose is 
excessive in the organism, glucose binds to hemoglobin molecules. This 
renders hemoglobin molecules dysfunctional in terms of O2 delivery to tissues, 
since its affinity for it is increased leading to a shift in its oxygen dissociation 
curve (32). 
 
1.2.2 Brain imaging findings in T2DM 
The brain is not typically considered one of the organs affected by 
T2DM. The main reason for that is that the impact of T2DM can be detrimental 
for multiple organs (eyes, kidneys, nerves) creating conditions that need to me 
managed and closely monitored. Its effect on the brain might become prominent 
in the long-term and usually emerges with other complications, for example 
stroke and dementia.  
Neuroimaging studies focused on T2DM report findings suggestive of 
functional and anatomical brain alterations (33, 34). Some of the most common 
structural abnormalities involve: Cortical and subcortical atrophies (35-38), WM 
hyper-intensities (35, 37, 39), hippocampal atrophy (40) and increase in CSF 
volume (36). A 6-year longitudinal study by Umemura, Kawamura (41) has 
shown that there is an association between the number of silent brain 
infarctions, WM lesion progression and endothelial dysfunction in T2DM.  
 In terms of functional abnormalities, impaired cognition has been 
reported in T2DM patients (35, 39). The affected cognitive skills involve 
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processing speed, memory and learning. Studies focused on the ‘default mode 
network’ have shown alterations in connectivity. Findings regarding cerebral 
perfusion have been inconsistent. Some studies report hypo-perfusion (36, 42, 
43), whereas others have concluded that there is no difference between T2DM 
patients and healthy subjects (44, 45). A few studies (46, 47) have reported 
increased perfusion in T2DM. These inconsistencies are highly likely to reflect 
differences in the utilised perfusion imaging techniques rather than actual 
pathophysiological alterations. Imaging of the brain hemodynamic pattern can 
be conducted using a wealth of imaging techniques, each one measuring a 
slightly different property trying to capture the underlying perfusion pattern. 
Some techniques are focused on the blood velocity pattern at the level of the 
carotids (phase contrast- magnetic resonance angiography), whereas other try 
to image directly the delivery of water molecules to the brain tissue (ASL).  
 The ability of the cerebrovascular network to deliver the appropriate 
amount of nutrients and oxygen to the targeted tissues via the bloodstream can 
be disturbed in diabetes, rendering the brain sensitive to ischemia. This 
reduced perfusion is often attributed to impaired function of the endothelial cells 
and alteration in permeability of the BBB (36, 48) and has been found in both 
hyper- and hypo-glycemic conditions (10). Especially in T2DM, impaired 
endothelial function is found in nearly all cases and is closely connected to 
insulin resistance and small-vessel disease caused by prolonged exposure to 
hyperglycemic conditions (49-51). Hyperglycemia and insulin resistance initially 
cause inflammation and oxidative stress, triggering structural or functional 
alterations in the microvasculature, resulting in impaired endothelial function 
(52).  One of the main functions of the endothelial cells, that becomes impaired 
in T2DM, is their ability to trigger vessel dilation in response to a stimulus in 
order to meet the increased need for blood. This property is described as 
Cerebrovascular Reactivity (CVR). 
Findings regarding CVR, normally quantified as the % increase in blood 
flow following a vasodilating stimulus, have been more consistent with a lower 
CVR observed in T2DM patients (36, 42, 44, 53). The study by Selvarajah et al. 
(53) has reported a decrease in flow in both T2DM and IGT. CVR 
measurements are thought to capture changes in neurovascular coupling. 
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The consistency of the reported structural brain imaging findings might 
be linked to the fact that the utilised techniques are well-established, acquired 
with relatively high resolution and are reasonably well standardized. By 
contrast, perfusion imaging techniques are less well established with many 
different techniques in development, each one having its own advantages and 
disadvantages. This lack of standardization, along with the small disease effect 
relative to acquisition noise and limited study populations performed to date are 
some of the key contributors to the contradictory findings that have been 
obtained when perfusion imaging methodologies have been applied to T2DM 
patients. Another confounding factor to the inconsistent findings could be that 
some diabetic subjects might have developed a multitude of conditions such as 
hypertension (54) or peripheral neuropathy (55) which are connected with 
impaired perfusion.  
Consequently, for diseases such as T2DM where the perfusion deficits 
are not prominent especially in the absence of cognitive impairment, no clear 
answer has emerged as to whether and how perfusion in the brain is altered. 
Hence, when evaluating the results of a study, one needs to examine 
thoroughly the characteristics of the cohort, the utilised perfusion imaging 
technique, its limitations, which property coupled to the underlying perfusion is 
measured and in which anatomical location it is measured.  
 
1.2.3 Potential mechanism driving changes in the diabetic brain 
One of the macrovascular complications of T2DM is atherosclerotic 
plaque formation inside major vessels (56). Additionally, hyperglycemia is 
connected with high blood viscosity. These effects could lead to flow alterations 
with reduced oxygen and nutrients reaching the tissue within a certain time-
frame. 
Excessive amounts of circulating glucose have a deleterious effect and 
are considered to affect the production and secretion of neurotransmitters such 
as nitric oxide, which is a vasodilatory neurotransmitter. This could lead to 
reduced CVR compared to healthy population.  
The disruption of homeostasis due to the alterations in insulin production, 
increased circulating glucose and reduced glucose uptake, affects the function 
of the endothelial cells (57) and mainly their ability to initiate dilation or 
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constriction of the blood vessels (58, 59). Potential disruption of the BBB could 
lead to altered tissue CVR and perfusion. Under-expression of the glucose 
transporter GLUT-1 found in several animal studies could also drive changes in 
the diabetic brain (10).  
Finally the amount of HbA1c circulating in the bloodstream of T2DM 
patients is high, suggesting that the appropriate amount of O2 needed by the 
cells to function properly might not be met, since glycated hemoglobin does not 
deliver oxygen as efficiently as non-glycated (32). The implications of these 
effects can be multiple, ranging from structural to functional alterations due to 
changes occurring in the vasculature and the vascular supply. 
 
Study hypothesis 
Our study hypotheses were formulated based on existing findings and 
well-established pathophysiological mechanisms associated with diabetes. We 
hypothesise that cerebral hemodynamics are impaired in T2DM and in its 
prodromal syndrome, IGT. To examine this hypothesis we scanned a cohort 
comprised cognitively and neurologically asymptomatic IGT and T2DM patients 
and healthy volunteers. We also hypothesise that IGT and T2DM subjects 
present structural abnormalities in their GM and cerebral vasculature. Finally, 
we hypothesise that the patient cohort has an impaired carotid velocity and 
mean diffusivity pattern. 
The described hypotheses were investigated using MR imaging 
modalities as the means to gain an insight into the brain of pre-diabetic and 
diabetic subjects. Our ultimate goal was to determine MR image-extracted 
metrics to be used in the future as disease biomarkers.  
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Chapter 2: 
Magnetic Resonance Imaging theory and 
modalities 
 
This thesis examines structural, functional and physiological changes in 
the brain of T2DM patients and subjects with IGT using a multitude of MRI 
techniques. The core modality investigated in this work is perfusion MR imaging 
using multi-time-point ASL. In the first part of this chapter, basic MRI theory is 
presented. In the second part, the focus is transferred to perfusion MRI and 
more specifically to ASL. In the final part of this chapter structural, diffusion 
weighted, fluid attenuation recovery (FLAIR) MRI and time-of-flight (TOF) and 
phase contrast (PC) magnetic resonance angiography (MRA) which were also 
used in this project are presented. 
 
2.1 Nuclear magnetic resonance 
Numerous imaging modalities have been developed over the last few 
decades for brain imaging (neuroimaging), with a view to extracting structural 
and functional information from acquired medical images. Structural 
neuroimaging can be used for identification of anatomical biomarkers, whilst 
functional neuroimaging enables assessment of changes occurring in the 
brain’s physiological processes, such as alterations in hemodynamic or 
metabolic parameters. The three imaging modalities mainly used for cross-
sectional brain imaging are: Positron Emission Tomography (PET) (60), 
Computed Tomography (CT) (61), and MRI. From these three modalities only 
MRI is completely non-ionising, making it the preferred choice when repeated 
scans need to be performed. The remainder of this Chapter describes basic 
Nuclear Magnetic Resonance theory relevant to the work presented in this 
thesis. PET and CT theory are not discussed, since they are out of the context 
of this thesis. The subsequently discussed MRI theory is based mainly on (62-
65). 
MRI is completely non-ionizing and does not require the introduction of a 
radioactive tracer, neither to acquire the signal of interest, nor to provide 
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contrast, thus making it a safe scanning technique. At the core of conventional 
MRI is the hydrogen nuclei, which consists of a single proton. Hydrogen atoms 
are by far the most abundant chemical species in the human organism. Protons 
are positively charged and spin round their symmetry axis, acting thus as a 
small magnet, giving rise to a magnetic moment. MRI measures the 
magnetization of a collection of atoms situated in a volume unit (voxel). The 
magnetization vector can be analysed as two constituent components: a 
longitudinal and a transverse vector. 
When there is no external magnetic field applied, the magnetic moments 
of the protons are randomly oriented. When a magnetic field is applied, 
magnetic moments align either parallel (low energy state) or antiparallel (high 
energy state) to the applied field and precess around their axis with a 
characteristic frequency termed the Larmor frequency. There is a slight excess 
in the number of nuclear magnetic moments that align parallel to the applied 
magnetic field which is the low energy state (figure 2.1). This number can be 
determined by a Boltzmann distribution as in equations 2.1-2.3. The energy 
difference between the distinct spin states can be determined using the 
Zeeman equation (ΔΕ = hγBz). 𝑁↑𝑁↓ = 𝑒& ∆()*+ = 𝑒&ℏ-./)*+ 		[2.1]				𝑁↑𝑁↓ ≈ 1 − ℏ𝛾𝐵:𝑘.𝑇 	[2.2]						𝑛 ≈ 𝑁ℏ𝛾𝐵:2𝑘.𝑇 	[2.3]						 
 
Where kB is the Boltzmann constant, T is the system’s temperature, ΔΕ 
is the energy difference between the distinct energy levels. 
Magnetic moments precess with the same frequency, however their 
phase, remains random. Phase alignment can be induced using a radio 
frequency (RF) pulse of a certain duration and amplitude. The characteristics of 
the RF pulse are modulated so that the longitudinal magnetization is tipped 
towards the transverse plane by a factor α, which is called the ‘flip angle’.  
The applied RF pulse needs to have the same frequency as the Larmor 
frequency in order for the resonance condition to be fulfilled. Only then will the 
magnetization vector be effectively tipped by the flip angle. In order to create a 
delta-shaped function, which is an infinitely small rectangular-shaped pulse we 
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would require to apply in the time-domain an infinitely long sinc function. Hence, 
the RF pulse is not a delta-shaped function at the required Larmor frequency, 
but a narrow bandwidth pulse centered on the Larmor frequency (equation 2.4) 
created using a sinc pulse in the time-domain, thus exciting protons precessing 
within a certain frequency range. 𝜔 = 𝛾 ∗ 𝛣B							[2.4] 
Here, ω is the precessional frequency, γ is the gyromagnetic ratio (atom-
specific) and B0 is the applied constant external magnetic field. The value of M0, 
which determines the NMR signal, is described by equation 2.5.  𝑀B = 𝛾EℎE𝑁G𝐵B4𝑘𝑇 		[2.5] 
Where Ns is the number of spins. From this equation it follows that the 
NMR signal can be increased by either increasing the B0 field strength or 
decreasing the temperature of the system. 
Following application of the RF pulse, two phenomena take place in 
order for the system to return in equilibrium: recovery of longitudinal 
magnetization characterised by the T1 time-constant, a procedure involving 
energy transfer from the spin to the lattice; and loss of transverse magnetization 
governed by T2 time-constant, resulting from spin-spin interactions and loss of 
phase coherence in the transverse plane. This is the philosophy of the simplest 
MRI experiment that can be performed, which gives rise to a signal that can be 
measured with a coil. This resulting signal is termed the free induction decay 
(FID).  
Regaining of the longitudinal magnetization results from re-emitting the 
absorbed energy back to the lattice in a process achieving thermodynamic 
equilibrium. The T1 relaxation time depends on two factors, the molecular 
tumbling rate and correlation time. The excited spins are subject to molecular 
motion, described as molecular tumbling, which involves vibration, rotation and 
translation. Free water molecules have a high tumbling rate since they move 
freely, whereas bound molecules have a lower tumbling rate. The second factor 
to be considered, correlation time (τc), describes the duration of the interaction 
of water molecules with macromolecules. Prolonged contact between the 
excited molecules and macromolecules will result in faster loss of the absorbed 
energy due to molecular interactions. Hence, water molecules have a high 
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tumbling rate but short correlation time, giving rise to a long T1. Molecules 
within soft tissues have a slower tumbling rate close to the Larmor frequency 
and a larger correlation time, hence T1 will he shorter. Molecules within solids 
have reduced tumbling rate but high correlation time, hence a long T1.  
 The loss of transverse magnetization can be attributed to the combined 
influence of two effects, one attributed to the random interactions between spins 
and one attributed to field inhomogeneities. The relaxation time incorporating 
the effects of field inhomogeneities, termed T2*, is shorter than the intrinsic T2 
relaxation time. The part attributed to field inhomogeneities can be regained by 
applying a 180o refocusing pulse, giving rise to spin-echo techniques, where the 
resultant echo signal depends on T2, rather than T2*. T1 and T2 relaxation 
times form the basis for numerous imaging sequence designs, with T1-weighted 
sequences generally preferred for examination of structural information and T2-
weighted sequences preferred for demonstration of pathology. 
T1 and T2 relaxation times are tissue specific and are influenced by the 
chemical environment in which the hydrogen protons are situated (figure 2.2). 
The 1H protons contributing to the NMR signal are mainly found in water 
molecules. Water is 50-70% of the human body and its movement can be 
relatively free or more restricted. Generally, more restricted or solid structures 
tend to have shorter relaxation times. These differences between T1 and T2 
relaxation times between different tissues are the reason for the excellent soft 
tissue contrast in MRI.  
When MRI sequences are designed, there are typically two key 
acquisition parameters that define the sensitivity of the sequence to T1 and T2 
effects: the time between two excitations (repetition time - TR) and the time 
between one excitation and the readout (echo time - TE). In spin-echo imaging 
a 180o refocusing RF pulse is applied, refocusing spins that were initially 
defocused after the initial applied pulse. As the spins refocus following 
application of the 180o pulse, the signal measured in the transverse plane 
increases to a peak and then decreases again.  This rise and fall in signal is 
known as a spin-echo. In gradient-echo sequences a defocusing gradient is 
applied during the FID. Subsequently a refocusing gradient of the same 
magnitude and opposite polarity refocuses the defocused spins generating an 
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echo. For example, in a spin-echo sequence, the measured signal S is 
associated with the following equation (2.6) 𝑆 = 𝑘 ∗ 𝑃𝐷 L1 − 𝑒&+M+NO 𝑒&+(+E							[2.6] 
In equation 2.2, k represents an instrumental scaling factor and PD is the 
proton density. The term inside the brackets determines the T1-weighting and 
the exponential outside the brackets the T2-weighting. Hence, for a T1-
weighted experiment the effect of term inside the brackets needs to be 
maximum, so a short TR is required, and the effect of the exponential outside 
the brackets needs to be a minimum, so a short TE is required. For a T2-
weighted experiment, TR and TE need to be long. When TE is short and TR is 
long, the contributions from the T1 and T2 terms are minimised and that leaves 
us with a proton density image. The combination of short TR and prolonged TE 
is not generally used. 
 
Figure 2.1: Magnetic moment orientation with and without the application of an external 
magnetic field. On the left, magnetic moments are randomly oriented when no field is applied. 
After the application of an external magnetic field B0 (green arrow), a slight excess of magnetic 
moments tend to align parallel to the field (blue arrows). 
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Figure 2.2: MRI principle for the main 3 tissue types in the brain. When a magnetic field is 
applied protons align with the field and precess with the Larmor frequency. An RF pulse is 
applied which causes a phase shift and aligns the phases, eliminating longitudinal 
magnetization (Mz), and creating a transverse magnetisation (Mxy). When the pulse is removed 
two phenomena take place: regaining of longitudinal magnetization governed by time T1 (the 
convention is that this time describes the recovery of Mz to 63% of its peak value) and loss of 
transverse magnetization in time T2 (which describes the time at which Mxy decays to 37% of its 
peak value).  
 
The spin-echo sequence can be modified so that an initial RF pulse of 
180o is applied prior to the 90o pulse.  This leads to the definition of another 
commonly encountered acquisition parameter, the inversion time (TI), which is 
defined as the time between the initial 180o pulse and the following 90o pulse. In 
such a case, the opportunity is given to null signals from certain tissue types if 
the 90o pulse is applied at the zero-crossing time for that particular tissue type.  
This method is commonly used to null the signal from either CSF in the FLAIR 
sequence or from fat (short TI inversion recovery (STIR) sequence), but can 
also be used to introduce additional contrast between certain tissues. 
 
2.2 MR image formation 
In order for an image to be reconstructed from the MR signal, the 
information needs to be encoded spatially. This is feasible by using magnetic 
field gradients, which cause the magnetic field to vary with position.  The 
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precessional frequency at each position will be dependent on the magnetic field 
strength at that position, as determined by the Larmor Equation.  Hence, the 
signal strength at every image position along the gradient direction can be 
inferred by the strength of the signal at every frequency. The higher the applied 
magnetic field gradient, the greater the frequency separation is between 
adjacent points. At the time of writing this thesis, typical maximum gradient 
strengths on 1.5T and 3T clinical scanners range between 30 and 45 mT/m. 
The rising time of the gradients are typically in the vicinity of 0.1 - 0.3 ms and 
considered along with the gradient strength they give rise to the slew rate 
(gradient strength / rising time). Thus, typical slew rates are in the range of 150 
- 200 mT/m/ms. The applied RF pulses have a typical maximum amplitude of 10 
– 50 μΤ and duration between 2 – 10 ms (66). 
 
Slice selection 
A linear gradient is typically used along the head-foot axis, so that the 
Larmor frequencies along this axis vary according to the position. Based on the 
desired slice thickness, the RF pulse bandwidth is modulated accordingly to 
excite only the limited range of frequencies corresponding to the spatial position 
of the slice. This gradient is termed the slice selective gradient (Gz). 
 
In plane localization 
Once the slice has been excited using the slice selective gradient and 
frequency selective RF pulse, the spatial position in the x-y plane needs to be 
encoded. This can be done by turning on and off the phase (Gy) and frequency 
(Gx) encoding gradients in order to induce position-specific changes in the 
precessional frequency and phase of the spins, which will be interpreted as 
spatial differences from the Fourier transform. The phase encoding gradient is 
briefly switched on along one axis (conventionally denoted y) following the slice 
selective gradient. This results in a position-dependent phase difference 
encoded in the magnetization across the axis on which the Gy gradient is 
applied. Subsequently, a frequency encoding gradient GX is applied along the x-
axis during readout of the echo signal inducing frequency differences in the 
spins along the axis of implementation (figure 2.3).  
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Figure 2.3: Phase and frequency encoding in 2D depiction. 
 
In order to record multiple slices, the Gz gradient is applied for each slice 
location, with the central frequency of the slice selective RF pulse shifted to 
correspond to the desired slice position and the 2D localization procedure 
repeated, as described above, once the slice has been excited. The magnetic 
field gradients can be depicted in a pulse sequence diagram (figure 2.4) that 
shows the timing of the gradients relative to the applied RF pulses and signal 
readout.  These diagrams can be particularly useful to provide a visual 
representation that helps to understand the intricacies of complicated pulse 
sequence designs. 
 
Figure 2.4: Example pulse sequence diagram. RF is the radiofraquency pulse applied to tip 
the magnetic moments by 90o in this case. The gradient pulse in Gz is the slice selective pulse, 
RF	
90o	
Gz	
Gy	
Gx	
signal	
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exciting a certain slice, Gy is the phase encoding gradient and Gx is the frequency encoding. In 
Gx two equal and opposite pulses can be seen, this gradient reversal forms a gradient echo 
from which the signal (echo) is measured. 
 
k-space 
An RF coil records the generated MR signals, which are digitised and 
stored in a format organized to accommodate the recorded signals according to 
their spatial frequency termed the k-space. The number of samples forming k-
space and its size depend on the acquisition’s field-of-view (FOV) and voxel 
size (Δx). In particular, the distance between two k-space samples (Δk) is equal 
to 1 / FOV and the dimension of k-space (2*kmax) is 1 / Δx. The horizontal axis 
in k-space is termed the ‘frequency-encoding’ axis (kx) and the vertical axis is 
termed the ‘phase-encoding’ axis (ky). An interesting parallel between lenses 
and k-space was drawn by R. Mezrich (67). In his paper, he explained how k-
space can actually be described as an equivalent to a lens, which is the 
intermediate Fourier space between an image and its idol; an explanation 
facilitating understanding of the complex nature of k-space. 
Every line of k-space corresponds to a certain value of the phase 
encoding gradient. The peak of the echo is centered along the vertical ky axis of 
k-space. The higher frequency components reside in the periphery and are 
associated with more fine details, whereas, the low frequency components are 
at the centre of k-space and are associated with properties such as contrast. 
The sampling rate of the acquired signals determines the resulting image 
resolution.  
In conventional imaging (gradient-echo, spin-echo imaging) the phase-
encoding gradient is pulsed every TR and hence one line of k-space is filled 
every TR. In echo-planar imaging (EPI) the whole k-space is filled in time TR 
(68). Full 3-D encoding in k-space utilises the addition of a secondary phase-
encoding gradient in the 3rd spatial dimension (69) instead of a slice-selective 
gradient. Important variants of the conventional approaches are fast gradient-
echo or fast spin-echo acquisitions (70, 71) which are used extensively and 
provide multiple phase-encodes per TR but not in a blipped fashion as in EPI.  
The conventional way to fill k-space is a line-by-line ‘Cartesian’ way, as 
illustrated in figure 2.5. The main alternative k-space trajectories include spiral, 
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zig-zag (utilised in EPI) and radial; each one with its own advantages and 
disadvantages (72, 73). Radial and spiral sampling’s competitive advantage is 
that they are less sensitive to motion artifacts, an attribute leading to their 
increasing utilisation.  
Conversion between k-space and the image space, is performed by 
using the discrete Fourier transform. 
 
Figure 2.5: Representation of k- space trajectory for conventional and 2D single shot EPI 
readouts. With the green line, the EPI readout philosophy is represented. Every line is read in 
the frequency encoding direction, subsequently the readout is blipped and a line is read at the 
opposite direction. The whole of k-space is read in time TR. In conventional imaging (blue line) 
the phase gradient is pulsed every TR localizing the readout in a particular line in the phase 
encoding direction starting every time from the centre of k-space. This particular line of k-space 
is read in time TR. 	
 
2.3 EPI imaging and artifacts 
In single-shot EPI all information needed for image reconstruction can be 
acquired in a “single-shot”, hence it is commonly used for rapid imaging. The 
pulse sequence diagram for an EPI acquisition can be found in figure 2.6. 
Following a slice-selective RF excitation pulse, a train of gradient pulses is 
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applied in the frequency encoding direction. Every echo can be encoded in the 
vertical (phase encoding) axis.  
	
Figure 2.6: EPI pulse sequence diagram. Adaptation based on Haacke et al. 1999 [64]. 
The fast readout combined with the fact that every line in k-space is read 
in alternate directions, introduces a multitude of artifacts which might be present 
in the final image, distorting the result (69). One of the artifacts commonly found 
in a single-shot EPI acquisition, is termed “water-fat shift” or “chemical shift” 
artifact. It is attributed to the different resonance frequencies of the water and 
the fat and may result in distortions of the image, with a ‘ghost’ image of the fat 
appearing in the region of interest (figure 2.7). This effect is caused due to 
interpretation of different frequencies by the inverse Fourier transform as 
different spatial locations. As a result the fat signal might end up displaced by 
numerous voxels in the phase encoding direction. The higher the field applied 
for imaging, the higher is the frequency separation of fat and water and thus the 
distance between them increases (74). Techniques for the mitigation of this 
artifact have been developed (for example fat suppression pulses), however all 
of them deal with its presence at the level of the acquisition of the image (75).  
Another common artifact in EPI acquisitions is the “ghost” (N/2 Nyquist) 
artifact, which appears as a ghost image in half the field of view (figure 2.7). 
This artifact occurs due to the very fast k-space scanning in the frequency 
encoding direction in alternate directions. As a result the odd and even echoes 
might be misaligned (76). A magnetic susceptibility artifact (figure 2.7) might be 
RF
90o
Gz
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present in the final image attributed to field inhomogeneities caused by the 
magnet or from the patient (69).  
 
Figure 2.7: Example EPI artifacts. left: Example of a N/2 ghost present at half the field of view. 
Centre: example of the chemical artifact, right: example of one form that the susceptibility 
artifact can acquire. 
 
2.4 Perfusion and CVR imaging 
 One of the functional characteristics that can be evaluated with MRI is 
perfusion, which is indicative of nutrients and oxygen delivery in tissues via the 
blood flowing in the vasculature and is connected to a tissue’s viability (77). The 
gold standard for perfusion quantification is considered to be 15O H2O- PET 
(78). Other techniques used are single-photon emission computed tomography 
(SPECT) (79), transcranial Doppler ultrasound (TCD) (80) and MRI-based 
techniques. 
Exogenous or endogenous contrast agents aside, the rationale behind 
perfusion imaging is common. A tracer is followed through the vasculature and 
the concentration in the tissue at a given time affects the measured MRI signal. 
The contrast agent when the BBB is intact in the case of dynamic susceptibility 
contrast (DSC)-MRI remains intravascular, hence the induced susceptibility 
effect is monitored. In ASL, since the hydrogen protons are monitored, the 
actual tissue delivery can be detected. 
A vibrant area of research in the MRI field is physiological and functional 
imaging. As part of this effort, a multitude of MRI methods for brain perfusion 
imaging have been developed, namely: DSC-MRI (81), ASL-MRI (82), 
intravascular incoherent motion (IVIM) (83), phase contrast magnetic resonance 
angiography (PC-MRA) and vascular space occupancy (VASO) (84). A more 
Suscep'bility	N/2	ghost	 Water-fat	shi9	
ar'fact	
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ar'fact	 ar'fact	
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recent development, which is still at an experimental state, is the use of 
hyperpolarised Xenon as a contrast agent (85). Functional blood oxygen level 
dependent (BOLD) functional MRI (fMRI) can also be used for CVR 
quantification (86) but it cannot provide quantitative perfusion measurements. 
All these techniques capture slightly different aspects of perfusion, such as 
water delivery to the tissue, blood velocity and changes in arterial blood volume. 
DSC-MRI is a popular perfusion imaging modality owing to its simple 
implementation and good contrast. ASL is also a popular technique with an 
undisputable momentum at the moment due to: concerns about gadolinium 
toxicity (Gd is the main contrast mechanism in DSC-MRI), widespread 
introduction of 3T systems into clinical settings, commercial availability of ASL 
by all major scanner manufacturers and due to the numerous developments in 
the ASL acquisition strategies. VASO and IVIM have been occasionally 
implemented in clinical studies; however they are not as popular. PC-MRA does 
not explicitly measure perfusion, it bares similarities with TCD since both 
techniques measure blood velocity.  
 While there are several metrics of interest related to perfusion, including 
CBF, cerebral blood volume, arterial transit time (ATT) and oxygen extraction 
fraction, the physiological metric that is most commonly studied in perfusion 
imaging is CBF. Evaluation of CBF has been routinely used in dementia 
(including Alzheimer’s disease) (87), brain tumours (88) and cerebrovascular 
disease (89) in order to account for perfusion patterns (mainly regional hyper-
perfusion or hypo-perfusion) which could be associated with the condition under 
examination.  
The ability of the brain to increase perfusion as a response to a 
vasodilating stimulus is indicative of the existing cerebrovascular reserve. 
Decreased CVR has been found in Alzheimer’s (90) and has been connected 
with cognitive changes in T2DM (91). CVR quantification requires a vasodilating 
trigger, to allow for measurement of relative CBF changes compared to 
baseline. Typical stimuli used include: pharmacological challenge; hypercapnia; 
reduction of blood pressure and carotid stent placement (92, 93).  
A pharmacological stress test is usually performed by injecting a potent 
vasodilator, such as acetazolamide (ACZ), intended to increase vasodilation, by 
means of vascular smooth muscle relaxation (93). The response to the 
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implemented stimulus is different between healthy individuals and individuals 
with reduced cerebral vasodilative capacity (94, 95).  The response of healthy 
individuals to the stimulus is an increase in local perfusion of about 20-40% in 
all vascular territories (96). On the contrary, in individuals with impaired 
perfusion the response can vary between mild, no response, or even a 
reduction in perfusion (97). This might imply that their system has reached the 
maximum vasodilatory capacity previously during normal function (98, 99).  
 Okazawa, Yamauchi et al. (98) have questioned whether a reduction, or 
an increase lower than expected, in regional CBF after ACZ challenge in 
patients with cerebrovascular disease, is indicative of reduced ability to 
vasodilate.  Instead, they have suggested that this phenomenon could also be 
explained by the fact that blood volume is not increased. Demolis et al.  (100) 
have questioned whether ACZ can accurately cause the same effect as 
autoregulatory vasodilation. 
Three methods have been used in the past for hypercapnia challenge: 
breath-hold, re-breath and gas mixture administration containing an elevated 
concentration of carbon dioxide (101). It has been shown in vivo that increased 
concentration of CO2 results in vascular smooth muscle relaxation via a 
mechanism involving alteration of extracellular pH, activation of potassium 
channels, membrane hyperpolarization and reduction of calcium concentration 
inside the cells (102). 
 
2.4.1 Arterial spin labeling 
ASL is a perfusion imaging technique that doesn’t require the injection or 
inhalation of contrast agents, as it uses water molecules as a freely diffusible 
tracer (82). Being an MRI technique, ASL is also completely non-ionising. Using 
water as the tracer has the inherent advantage of having a short half-life so it 
can be used multiple times (103). ASL allows multiple measurements to be 
made on the same person, with the only considerations being the duration of 
the scanning session and the comfort of the scanned individual who might 
move, giving rise to motion artifacts. 
The rationale behind ASL is that the subtraction of images acquired with 
(labeled) and without (control) magnetically labeled hydrogen protons gives rise 
to perfusion weighed images (figure 2.8). After labeling, a short time-gap (inflow 
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time) is allowed for the protons to reach the tissue of interest and exchange 
water. The labelled protons at the time of imaging have not fully recovered; this 
gives rise to subtle differences between control and labelled images (104, 105). 
Subtraction renders this technique sensitive to motion artifacts (106).  
Induction of differences in the magnetization vector between control and 
labelled acquisitions is common in all ASL techniques. However, the control 
image is not always one with non-inverted spins. For example, in some 
techniques the difference between the control and the labelled experiments is 
achieved with global inversion (control) followed by local inversion (labeled). 
 
 
Figure 2.8: Philosophy of ASL MRI. Pairs of control and labeled images are acquired. Their 
subtraction yields information about perfusion.  
 
Major disadvantages of ASL are its low signal-to-noise ratio (SNR) and 
low spatial and temporal resolution. In order to account for low SNR, averaging 
of multiple acquisitions is utilised, whereby pairs of images are acquired 
approximately every 4 seconds. Typical acquisition times are on the order of 5-
10 minutes. Other means to increase SNR include using increased magnetic 
field strength or by using a phased array receiver (107). This inherently low 
180	inversion	pulse	Control	image	 Labeled	image	
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SNR is attributed to the fact that only 1% of tissue water is replaced every 
second by perfusion in GM (108). For a bolus duration of 1 - 2 seconds, the 
captured signal difference is at the level of 1 – 2 %, since the introduced delay 
between labeling and acquisition further reduces the signal due to 
magnetization relaxation. 
In ASL, spiral or EPI sequences are typically used to ensure rapid 
imaging (109). Other utilised read-out schemes include: Rapid Acquisition with 
Relaxation Enhancement (RARE) (70), Gradient and Spin Echo (GRASE) (110) 
and balanced Steady-State Free Precession (bSSFP) (111).  The distinctive 
characteristics between different ASL methods has to do with both the pulse 
sequences used for labeling and the readout strategy (112) . 
Compared to BOLD fMRI, ASL has better spatial localization as it images 
the delivery in the tissue and not the susceptibility effects created by an 
endogenous intravascular tracer (113). Its temporal resolution though is worse 
than BOLD. Its major advantage is that it allows for quantitative perfusion 
measurement. In BOLD, a baseline acquisition and an acquisition after a task 
are typically performed, allowing only for qualitative assessment of the 
difference between the two (113). The BOLD signal relies on the local changes 
in concentration of oxy- and deoxy-hemoglobin and the magnetic susceptibility 
differences that induces, whereas ASL images the hydrogen protons within the 
vasculature directly. 
 
2.4.1.1 CASL, PASL, pCASL and other ASL variants 
The four major ASL categories are: pulsed ASL (PASL), continuous ASL 
(CASL), pseudo-continuous ASL (pCASL) (figure 2.9) and spatially non-
selective ASL (114). Sometimes pCASL is presented as part of CASL, however 
due to its hybrid nature it can formulate a category on its own. 
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Figure 2.9: CASL, PASL and pCASL philosophy. In CASL the labeling is continuous, in PASL 
a short pulse is applied and in pCASL a train of short pulses instead of a continuous labeling is 
applied. A post-labeling delay allows for the tracer to arrive in the tissue of interest and perfuse 
it. Subsequently, in the readout period, the image is acquired. 
 
CASL, uses a long RF pulse along with a slice-selective gradient, the 
slice being relatively thin. The spins passing through this slice are continuously 
inverted using flow-driven adiabatic inversion. It has a higher SNR compared to 
the other techniques (82). PASL uses short RF pulses to tag a blood volume in 
a thick slab and its competitive advantage is its high tagging efficiency (115, 
116). 
CASL was the first ASL technique suggested. Nowadays its usage is 
limited due to the hardware requirements and the high RF deposition to the 
scanned individual. This results from the requirement for a continuous long RF 
labeling pulse. Pulsed ASL on the other hand has limited hardware 
requirements compared to continuous ASL, lower RF deposition, better 
inversion efficiency but lower SNR. pCASL is a pseudo-continuous technique 
achieving labeling by using multiple short RF pulses. The SNR of pCASL is 
higher compared to PASL but the inversion efficiency is lower since the pulses 
used are not adiabatic (117). Four popular ASL techniques are shown 
schematically in figure 2.10. 
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Figure 2.10: Control, label and imaging planes shown schematically for four ASL 
implementations. FAIR, PICORE and EPISTAR are all pulsed ASL variants. In the last 
column, the pCASL scheme is depicted. Green (labeling) and blue (control) regions represent 
the areas whereby inversion pulses are applied. The red slice represents the anatomical area 
which is imaged.  
 
Spin inversion is of utmost importance in ASL since labelling is either 
applied in a big slab for a small time-window or in a small slab for a more 
extended time-frame and the labelling of moving spins needs to be effective. 
Non-effective spin labelling could result in erroneous perfusion estimation since 
the ASL contrast relies on the difference between labelled and non-labelled 
images. Hence an inversion efficiency of 70% would imply that around 30% of 
the perfusion differences could be masked out due to identical signal between 
the control and labelled images. As a result, an approach that reassures spin 
inversion will be efficient needs to be utilised. In order for the inversion to be 
successful (i.e. the majority of spins to be inverted efficiently) the adiabatic 
condition needs to be fulfilled, that is, the moving spins need to be inverted at a 
particular rate so that their magnetization is effectively tipped. During the 
adiabatic inversion the B1 field passes gradually from off-resonance to on-
resonance and then beyond resonance. This is achieve by modifying its 
frequency and holding steady its amplitude. Application of an initial off-
resonance field results in the magnetization precessing around an effective 
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field. The gradual increase of the frequency of the B1 field will result in the net 
magnetization vector following the effective field in its transition from off to on 
and finally beyond resonance. The adiabatic pulses utilised in PASL, are 
frequency and magnitude modulated hence they influence spins in different 
positions differently and more effectively than flow-driven adiabatic inversion 
does. The conventional RF pulses utilised in MRI are simply amplitude 
modulated and not frequency modulated as the adiabatic pulses. 
Pulsed ASL utilises adiabatic pulses and this is what gives the PASL 
techniques higher inversion efficiency. In CASL and pCASL the adiabatic 
inversion can be achieved using flow-driven adiabatic inversion which is not as 
effective (117). This is the reason for the lower inversion efficiently of (p)CASL. 
Being a hybrid technique, pCASL (118) combines some of the 
advantages of CASL and PASL, as it has higher SNR than PASL and higher 
inversion efficiency than CASL. Instead of a continuous pulse, a sequence of 
RF pulses with short duration along with a slice selective gradient are applied. 
This technique is heavily used for perfusion quantification, providing results in a 
good agreement with the gold standard PET (119, 120).  
In 2015, scientists across Europe decided to produce a recommended 
ASL protocol to provide some standardization, without it being a 
discouragement to the development of new methods (108). They realised that 
the multitude of available labeling and readout schemes was having a negative 
impact on the translation of ASL-MRI into a standard clinically used protocol. 
Their recommendations suggest using pCASL as the optimal labeling scheme 
with one inversion time, no crusher gradients and a 3D readout scheme such as 
RARE or GRASE. In this ‘white paper’ the writers stress that using multiple 
inversion times renders processing more difficult, but might have the potential to 
provide more accurate quantification of CBF and the capacity to quantify ATT 
(108).  
One of the major disadvantages of the aforementioned techniques in 
their regular implementation (one inversion time, no-crusher gradients) is that 
they are not insensitive to the time that it takes for the labelled bolus to reach 
the tissue of interest (ATT). ATT is one of the most important parameters that 
characterise the perfusion process and needs to be taken into account for 
perfusion evaluation. It has been suggested that in patients with Moya-Moya 
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disease, atherosclerosis (105) and steno-occlusive disease (112), CBF might 
be overestimated due to residual label in the vasculature. On the other hand, 
especially in elderly cohorts, CBF might be underestimated due to increased 
ATT (121, 122). Two suggested methods that account for ATT are the use of a 
multi-PLD technique, or to estimate ATT by dividing CBF from a non-crushed 
experiment with CBF from a crushed experiment (123). 
Spatially non-selective ASL is a conceptually different technique, using a 
velocity or acceleration threshold as the criterion for imaging rather than a 
spatial constriction (114). The VS-ASL signal is the signal attributed to the 
spins, which at the time of labeling, have a velocity more than a specified 
threshold, but at the time of imaging, less than this threshold (124).  
Indicative of the proactivity of the ASL community, is that following the 
publication of the consensus paper in 2015, there have been at least three 
review papers discussing exciting new developments (125-127). The primary 
areas of current research can be summarised as the development of 
techniques that are ATT-insensitive without SNR compromise (time-encoded 
ASL), territory mapping ASL, ASL fingerprinting, combined angiography and 
perfusion ASL and spatially non-selective ASL (125). 
Since its introduction, ASL has been used to assess perfusion changes 
mainly in the brain (128) but also in the kidney (129), liver (130), skeletal 
muscle (131), bone marrow (132), placenta (133), pancreas (134), lungs (135) 
and myocardium (136). Conditions affecting the brain that have been 
investigated include: Traumatic brain injury (137), schizophrenia (138), 
depression (139), Parkinson’s (140), Alzheimer’s (141), chronic fatigue 
syndrome (142), multiple sclerosis (143), sickle cell disease (144) and diabetes 
(36). Following the ASL white paper which focused on the description of the 
optimal labeling and readout schemes, a guide targeted at neuroradiologists 
has been released by members of the consortium covering mainly the topics of 
acquisition parameters and clinical conditions in which ASL has identified 
successfully perfusion deficits (145). 
 
2.4.1.2 Multi-TI/PLD ASL 
There are numerous ways to acquire measurements with multiple post-
labeling delays in order to capture differences in ATT. The first and crudest 
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solution is to acquire images at multiple inversion times in separate 
acquisitions, which is time-consuming. A second approach is to use a Look-
Locker readout strategy (146) which has the ability to sample the recovering 
magnetization at multiple times by using low flip-angle EPI excitations (147). 
This allows for the retention of the whole magnetization recovery curve, 
however, every excitation reduces the magnitude of the signal and hence the 
SNR. 
Time-encoded ASL with Hadamard encoding aims to create multiple 
sub-boli within the labeling scheme and the PLD time (148). It can be 
implemented using either CASL or pCASL. Sub-boli, either label or control, are 
interleaved within the labeling scheme based on a Hadamard matrix. The 
driving idea behind this scheme is to use non-identical repetitions in order to 
make full use of the scanning time (148-150).  
 
2.4.1.3 Perfusion quantification 
Quantification of perfusion relies on the indicator-dilution theory 
proposed by Zierler (151) and aims to quantify perfusion by employing a bolus 
tracking philosophy. Transit times of individual particles of the tracer forming the 
bolus are monitored and modelled as a distribution. The bolus can be either a 
magnetically labelled bolus (as in ASL), or an injected or inhaled contrast agent. 
Let the probability density function (PDF) of the transit times for every particle in 
the bolus be named h(t) (equation 2.7). Then: Q ℎ(𝜏)𝑑𝜏 = 1									[2.7]WB  
The residual bolus in the tissue of interest is modelled as the cumulative 
distribution of transit times remaining in the tissue at the imaging time, thus 
taking the form of a residue function R(t). At a time-point t, the residue signal 
can be calculated as follows (equation 2.8): Q ℎ(𝜏)𝑑𝜏 = 1 ⇛ Q ℎ(𝜏)𝑑𝜏 + Q ℎ(𝜏)𝑑𝜏 = 1 ⇛WZZBWB 𝐻(𝑡) + 𝑅(𝑡) = 1 ⇛ 𝑅(𝑡) = 1 − 𝐻(𝑡)		[2.8] 
The volume of interest (VOI) has a single arterial input (Cart) and a single 
venous (Cven) output (figure 2.11). The amount of tracer that has entered and 
left from this system in a time interval [0,t] is as in equation 2.9. 
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𝑡𝑟 a = 𝐹Q𝐶deZ	(𝜏)𝑑𝜏							,								𝑡𝑟ghZ = 𝐹Q𝐶ija(𝜏)𝑑𝜏ZB
Z
B 					[2.9] 
where F is the volume flow. The tracer inside the VOI will be trvoi = trin - trout 
From the system in figure 2.10, it follows (equations 2.10 - 2.12) that: 𝐶ija(𝑡) = 𝐶deZ(𝑡)lℎ(𝑡)		[2.10]		 
𝑡𝑟ig` = 𝐹	Q(ZB 𝐶deZ(𝜏) − 𝐶ija(𝜏))𝑑𝜏 = 𝐹Q[𝐶deZ(𝜏) − Q𝐶deZ(𝜏)ℎ(𝜏 − 𝑢)𝑑𝑢]𝑑𝜏
o
B
Z
B  
by taking into account that ∫𝑓(𝑡)𝛿(𝑡 − 𝜏)𝑑𝑡 = 𝑓(𝜏) 
𝑡𝑟ig` = 𝐹Q𝐶deZ(𝜏)Qs𝛿(𝜏 − 𝑢) − ℎ(𝑡 − 𝑢)t𝑑𝑢𝑑𝜏 = 𝐹Q𝐶deZ(𝜏)𝑅(𝑡 − 𝜏)𝑑𝜏			[2.11]ZB
o
B
Z
B  
CBF is calculated as 𝐶𝐵𝐹 = uvwxy  
Hence, the venous output is: 𝐶ija(𝑡) = 𝐶𝐵𝐹 ∗ 𝐶deZ(𝑡)⨂𝑅(𝑡)				[2.12] 
 
Figure 2.11: Schematic representation of a voxel (VOI) in perfusion MRI. The arterial signal 
(Cart) is the input, the venous (Cven) signal is the output and inside the VOI  capillary water 
exchange occurs. (Figure recreated based on Fieselmann et al. 2011). 
 
For techniques that measure tissue perfusion, the tissue signal is 
modelled as a multiplication of the CBF by the convolution between the Arterial 
Input function (AIF) (or else Cart) and the residue function (R) multiplied by the 
CBF value (equation 2.13). Following the described approach, the perfusion 
system when an ASL acquisition whereby tissue signal is recorded is 
implemented can be approximated as a system with AIF as an input, CBF * R(t) 
as an impulse response and the tissue signal C(t) as the output (figure 2.12).  
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Figure 2.12: Perfusion system at the tissue level. AIF is the input, C(t) is the output and the 
transfer function of the system is CBF*R. 
 𝑇𝑖𝑠𝑠𝑢𝑒	𝑠𝑖𝑔𝑛𝑎𝑙(𝑡) = 𝐶𝐵𝐹 ∗ 𝐴𝐼𝐹(𝑡) ⊗ 𝑅(𝑡)		[2.13] 
 
Buxton’s general kinetic model (equation 2.14) is the most heavily used 
model in pulsed ASL. The acquired tissue signal is denoted ΔM(t) and is 
modelled as follows: 𝛥𝛭(𝑡) = 2 ∗ 𝑀d,B ∗ 𝑓 ∗ Q 𝑐(𝜏) ∗ 𝑟(𝑡 − 𝜏) ∗ 𝑚(𝑡 − 𝜏)𝑑𝜏		[2.14]ZB 	 
• Ma,0 is the arterial blood equilibrium magnetization  
• f is the CBF value,   
• r(t-τ) is the remaining label in the vasculature after time τ,  
• c(τ) is the tissue delivery function and  
• m(t-τ)  is the magnetization relaxation term.  
 
Theory suggests that the residue function decreases monotonically and 
has its maximum at time t = 0 s. However, dispersion effects, vascular anatomy 
and pathology, usually cause the residue function to deviate from the theoretical 
shape. In order to account for this effect, CBF is calculated as the maximum of 
the residue function. In signal processing, the impulse response (the residue 
function) is typically determined by taking the Laplace transform of the equation, 
ending up with a multiplication rather than a deconvolution. A transfer function 
can be calculated and by taking the inverse Laplace transform, the impulse 
function can be determined, if the AIF and tissue signal are known. When the 
signal is discrete, the Z-transform is used instead. An alternative technique for 
the determination of the transfer function, is to use an algebraic approach, more 
specifically, singular value decomposition (SVD) based techniques (152). 
Finally, model-based approaches can be used to model the shape of the 
residue function as an exponentially decaying function (153) . 
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The AIF is one of the most important parameters that need to be 
determined in order to quantify perfusion, since it constitutes the input function 
of the system. Perfusion quantification requires that the actual shape of the AIF 
in the tissue of interest is known in order to be able to differentiate between a 
narrow AIF with a high value and a wide AIF with a lower value. The AIF can be 
measured either globally from a large artery, or locally, giving rise to numerous 
regional AIFs. A local approach is usually adopted when a cohort with 
pathology affecting the vasculature is examined. The most commonly used 
model for the AIF is a gamma-variate function (153). Other models commonly 
applied for the AIF are a box-car function and a gamma-variate function 
multiplied by a dispersion kernel (154). 
 
2.4.1.4 QUASAR ASL  
In 2006, a new model-free ASL approach for perfusion quantification was 
proposed (155). In this approach, the PULSAR (pulsed STAR labeling of arterial 
regions) labeling scheme (156), was combined with a Q-2 TIPS pulse scheme 
(157), which permits accurate definition of a labeling bolus. A multi-slice single-
shot gradient-echo EPI readout was combined with a Look-Locker readout 
sampling (146). In this work, quantification of CBF by means of deconvolution 
was compared to fitting the acquired signal to Buxton’s general kinetic linear 
model (158). Both approaches were used on the same dataset derived by using 
the newly developed quantitative STAR (signal targeting by alternating 
radiofrequency pulses) labeling of arterial regions (QUASAR) scheme and their 
efficiency was evaluated using simulations. SVD deconvolution for SNR = 10 
and 15, led to CBF underestimation whereas parameter fitting to CBF 
overestimation. 
As part of the QUASAR technique, pairs of control and labelled images 
were acquired for two different sets of experiments (with and without crusher 
gradients). The crusher gradients null the signal emerging from fast flowing 
spins due to residual tracer in major arteries, which is responsible for bright 
artifacts. Crusher gradients are particularly important as intraluminal artifacts 
can imply perfusion overestimation, leading in multiple cases in the need to 
exclude scans (89). However, they are not used in neonates due to 
unacceptably low SNR (159). Subtraction of these two images with and without 
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crusher gradients, delineates the shape of AIF. In order for the AIF to be 
defined in its wholeness, it needs to be normalized so as to take into account 
arterial Blood Volume (aBV). Hence when using QUASAR two distinct signals 
can be retained, one emerging from the intravascular compartment connected 
to aBV and one emerging from the extravascular compartment connected to 
CBF (figure 2.13). 
	
Figure 2.13: Qualitative depiction of the crushed (arterial compartment) and non-crushed 
(CBF compartment) signals obtained during the QUASAR acquisition.  
In 2007, a short while after the technique was introduced, Petersen et al. 
(160) suggested a method to account for field inhomogeneities by including a 
low flip angle acquisition, which allows spatial mapping of the actual flip angle, 
rather than just assuming the nominal one. Chappell et al. (154) have proposed 
a correction factor for the calculated flip angle.  After the introduction of 
QUASAR ASL, a multi-centre study took place in order to evaluate its 
effectiveness in perfusion quantification and its reproducibility, with very 
promising results (161).  
The use of a Look-Locker readout, allows for retention of images at 
multiple inversion times, making the acquisition insensitive to ATT (162, 163). 
The fact that QUASAR ASL allows for quantitative CBF, aBV and ATT maps to 
be generated, the ability to label different vascular territories (164) and to 
calculate regional AIFs, render it a conceptually different technique from the 
commonly used single inversion time techniques. In particular, it can be useful 
Non-crushed
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ΔΜ
Time(s)
	 40	
for studies focused on conditions, which can affect the transit time of the label 
from the arterial to the tissue compartment. QUASAR ASL has been used for 
perfusion imaging in studies investigating disease related hemodynamic 
changes in: multiple sclerosis (143); carotid stenosis (165);  Parkinson disease 
(166); tumour, mainly gliomas (167, 168); Alzheimer’s disease (141); and 
cognitive decline in middle-aged men (169). It has proven to be adept for 
quantification of CBF in GM, although with a tendency to underestimate it (170). 
QUASAR ASL has been shown to provide comparable results to PET (171) and 
good correlation has been found between QUASAR ASL and DSC-MRI (106). 
The QUASAR pulse sequence as described in the original QUASAR 
publication, is shown in figure 2.14. An initial WET saturation scheme, which is 
typically used in spectroscopy, is applied in the imaging region (156). 
Subsequently, labelling takes place at the level of the carotids. The labelled 
acquisition comprises an 180o pulse. The control acquisition comprises two 
180o pulses of half the power to induce identical magnetization transfer effects 
to the imaging region. Following that, a post-saturation scheme is applied. After 
a certain time, which in the typical QUASAR scheme is 650ms, the labelling 
region is saturated using a QUIPSS II scheme for a well-defined duration of the 
bolus. Subsequently, a small flip angle excitation (35o) is applied followed by 
crusher gradients where applicable (crushed acquisition). Finally, a 2D EPI 
readout is used. 13 such small flip angle excitations and EPI acquisitions are 
applied allowing for dynamic signals to be acquired. 
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Figure 2.14: QUASAR pulse sequence; figure adapted based on Petersen et al. 2006. An 
intial pre-saturation WET pulse scheme is applied in the imaging area. Subsequently the 
labeling scheme is applied (light blue when the control scan is acquired). Post-saturation is 
applied in the imaging region. After a certain time a small flip angle excitation is applied and a 
QUIPSS II bolus saturation scheme is used for an accurate definition of the time-duration of the 
bolus (light pink). Crushers (light green) are turned on for the crushed acquisition. Finally an 
image is acquired using an EPI-readout. 
 
2.4.2 Dynamic Susceptibility Contrast MRI (DSC-MRI) 
In DSC-MRI a contrast agent (typically gadopentetate dimeglumine) is 
injected and passes through the vasculature. In the case of an intact BBB it 
remains largely intravascular within the brain and perfusion quantification relies 
on the induced susceptibility effects. One of the issues with this technique is 
that since the site of injection tends to be a vein in the arm, the injected tracer 
has a high degree of dispersion by the time it reaches the brain. At the time of 
imaging (7-10 seconds after injection), gadopentetate dimeglumine which is a 
paramagnetic agent, induces non-uniformities in the local magnetic field 
(susceptibility effects) which are imaged (172). Significant considerations 
regarding perfusion quantification with DSC-MRI include the definition of an 
accurate AIF and the second passage of the contrast agent (153). 
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The main drawback of using DSC-MRI is the injection of the contrast 
media. In 2006, a study connected Gadolinium to the development of 
nephrogenic systemic fibrosis, a very serious condition, in patients with 
abnormal kidney function (173). Following this, multiple studies investigated 
whether gadolinium-based contrast agents had any impact in persons without 
kidney dysfunction. It is now well-established that gadolinium is deposited in the 
brain, bones, liver and skin (174). Kanda et al. (175) have shown that there is 
an increase in gadolinium deposition in the brain, especially in dentate nucleus 
and globus pallidus in subjects without impaired renal function. In the 
meantime, a study group for Gadolinium toxicity found that people subjected to 
MRI scans with the use of gadolinium are reporting pain, skin irritation and 
confusion (176). 
DSC-MRI has been for years the primary choice of clinicians for MR 
perfusion imaging due to its straightforward implementation and good contrast. 
Despite the quantification challenges, with an accurate AIF identified (153), it is 
more straightforward in interpretation, implementation and quantification 
compared to ASL variants (145). However, due to the increased concerns 
regarding gadolinium deposition, a trend toward techniques such as ASL is 
noted. 
 
2.4.3 Vascular space occupancy MRI 
The main idea behind vascular space occupancy (VASO) MRI is that the 
blood signal is nulled, resulting in an image dominated by tissue signal. Any 
change in the tissue signal can be attributed to changes in the inflowing blood, 
reducing the signal of the static tissue (177). VASO is an indirect technique to 
measure cerebral blood volume and it provides relative quantification, rather 
than absolute values. Variants of the VASO scheme have been proposed such 
as inflow-based VASO (iVASO) (178) and iVASO with dynamic subtraction 
(iVASO-DS) (179).  
VASO is sensitive to both changes in arterial and venous compartments. 
The variant, iVASO, nulls only the signal from the blood directly beneath the 
imaging slice moving upwards, leading to a higher SNR and to selective 
sensitivity to the arterial compartment (178). In iVASO-DS, an additional control 
image without nulling is acquired, following a similar approach to the ASL 
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principle of control-label pairs (179). Good agreement of the cerebral blood 
volume values obtained with VASO and PET and iVASO and DSC-MRI has 
been reported (105). 
  
2.4.4 Intravoxel incoherent motion MRI 
Le Bihan et al. (83) developed a technique utilising motion sensitising 
diffusion gradients for perfusion assessment, so called intravoxel incoherent 
motion (IVIM). Perfusion was thus approached as a diffusion-associated 
process. At low b-values the signal attenuation in a diffusion weighted image is 
greater than expected solely from diffusion, due to the additional contribution to 
signal losses from water perfusing in the capillary bed.  This additional signal 
attenuation can be modelled and used to calculate parameters associated with 
the perfusion contribution.  Fitting the signal acquired over a range of relevant 
b-values to a bi-exponential model allows for separation of diffusion from 
microcirculatory perfusion effects. One of IVIM’s interesting advantages is that 
both the microvasculature and the microstructure can be evaluated 
simultaneously (46). A direct equivalence between parameters calculated with 
IVIM and with conventional perfusion MRI techniques has been drawn. IVIM 
parameters involve blood perfusion fraction (f), diffusion coefficient (D) and 
pseudo-diffusion coefficient (D*) of intravascular water, from these fD* is the 
direct equivalent to CBF, f equivalent to CBV and D* equivalent to mean transit 
time (180).  
The technique has been used in the field of T2DM unravelling abnormal 
perfusion patterns in the hippocampus (46). Good agreement between IVIM 
and DSC-MRI in a study examining gliomas has been shown where the 
equivalence of fD* to CBF was validated, but not the relationship between MTT 
and D* (181). High correlation has also been found between IVIM and CBF 
calculated using pCASL (182, 183).  
IVIM is a promising perfusion imaging technique, however the utilised 
fitting algorithms, range of b-values and quantification efficiency have not been 
thoroughly investigated (181). Compared to DSC-MRI it is non-invasive without 
the need to use contrast agents and measures perfusion at the level of the 
capillaries, on the contrary DSC-MRI depends on how leaky the BBB is and 
contamination from big arteries might be prominent. The technique, when 
	 44	
implemented for brain imaging, suffers from low SNR since the signal attributed 
to microcirculatory perfusion is at the level of 4%. IVIM is particularly popular for 
studying organs other than the brain (for example kidneys, prostate and liver) 
(184). 
 
2.5 Structural, diffusion weighted MRI and MRA  
Being an extremely versatile tool, MRI can provide many different ways 
to gain an insight of the brain’s structure, function and physiology. In the 
following subsection a brief overview of some of the most important MR-based 
imaging modalities used in the present thesis is presented. The description of 
each technique was based mainly on Haacke and Brown (64). 
 
2.5.1 3D T1-weighted image 
As mentioned previously, to acquire a T1-weighted image the TR and TE 
times need to be short (with respect to underlying tissue T1 and T2) in order for 
the T1 effect to provide the majority of image contrast. Typical T1-weighted 
acquisitions are of high resolution and, depending on the vendor, they have 
commercial names such as magnetization-prepared rapid gradient-echo 
(MPRAGE) (185) and spoiled gradient echo (SPGR). MPRAGE is a purely 3D 
acquisition in the sense that data are not acquired slice by slice but rather the 
3D encoding is achieved by using an additional phase encoding gradient in the 
slice encoding direction. Compared to its spin-echo counterparts, MPRAGE 
being a gradient-echo sequence is faster, more prone to artifacts and has a 
lower SAR. 3D T1-weighted images are popular in clinical settings since they 
are of high resolution and provide great anatomical details. Due to these 
attributes they are the main images used for brain volumetry. Useful biomarkers 
such as cortical thickness, GM, WM and CSF volume can be extracted from 
these images using appropriate software tools. 3D T1-weighted scans such as 
MPRAGE have been used in the past for studying structural changes in the 
diabetic brain, unraveling atrophies and regional differences in structures of 
interest (40). 
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2.5.2 Anatomical T2-weighted imaging  
For T2-weighted imaging, the TR needs to be prolonged to enhance the 
T2 effect and reduce the T1 effect. In standard T2-weighted imaging long TR 
and TE (with respect to the underlying T1 and T2) times are used. Basic T2-
sequences are: turbo spin echo (TSE) and FLAIR. With T1 values being on the 
order of 1s and T2 values being on the order of millisecond, T2 imaging is 
extremely useful in detecting abnormalities associated with an underlying 
condition. FLAIR is an inversion recovery imaging technique where the CSF 
signal is nulled (186). TR and TE are chosen in order to introduce heavy T2 
weighting. Without the suppression of the CSF signal, typical T2 weighted 
images are of limited diagnostic usefulness since the tissue signal decays faster 
than the CSF signal (186).  FLAIR is adept for depiction of white matter 
hyperintensities and tumors and can detect them with greater accuracy than T1-
weighted sequences and T2-weighted sequences without CSF suppression 
(187). FLAIR has been used in diabetes studies to detect leukoaraiosis in WM 
with the findings being inconsistent (188). 
 
2.5.3 MR Angiography 
MRI can also be used for vasculature imaging. MRA imaging techniques 
are based on the fact that spins inside the vasculature are in motion. MRA 
acquisitions can be contrast enhanced MRA, using gadolinium as a contrast 
agent or non-contrast enhanced. The non-contrast enhanced methods include 
TOF-MRA and PC-MRA (189). Both are gradient-echo techniques with a short 
TR. Recently, ASL implementations have been used for quantitative MR 
Angiography (190). 
 In TOF MRA multiple RF pulses are used in the imaging region resulting 
in a steady state for static spins, while moving spins inside the vasculature do 
not experience all the RF pulses so they are left with a higher magnetization. 
One of the important factors to be carefully controlled when TOF-MRA is used 
is the applied flip angle to avoid saturation of the spins within the labeling slab; 
a large flip angle implies quicker saturation with a lower number of RF pulses 
(64).  
In 2D phase contrast MRI, flow is acquired in one thick slice. The 
rationale is that velocity information can be encoded in the phase of the spins 
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using bipolar gradients. When a flow-encoding gradient is used, spins flowing in 
the gradient direction accumulate a phase. When a second opposite gradient is 
implemented then for every pixel there is an accumulated phase difference Δφ. 
One of the most important parameters to be determined by the user is velocity 
encoding (Venc), a velocity threshold introduced to de-phase fast moving spins 
above a certain velocity. Velocities lower than the chosen threshold are 
represented with a phase shift within the range from -180o to 180o. Velocities 
higher than the applied threshold are suppressed since they are assigned 
values greater than 180o, this results in mapping them to lower angles. For 
example a velocity exceeding Venc by 25% would be mapped to 225o and this is 
indistinguishable from -45o. The value of Venc is controlled by changing the 
amplitude, time separation and duration of the bipolar gradients. 
A single acquisition is not sufficient to resolve phase difference due to 
field inhomogeneities and susceptibility effects. Hence, two sets of 
measurements are typically acquired, the difference being that the polarity of 
the gradients is inverted. These two images are subtracted (ΔΜ) and the result 
is proportional to velocity. The pulse sequence diagram for PC-MRA is shown in 
figure 2.15. 
 
Velocity is proportional to the phase difference and the quantities are 
connected by the following relationships (equation 2.15): 𝑉𝑒𝑙𝑜𝑐𝑖𝑡𝑦 = 𝛥𝜑 ∗ v = -∗     [2.15] 
In PC-MRA the typical recorded images are hence a magnitude image, a 
complex phase difference image and a phase difference image (191). 
The choice of the velocity threshold is a trade-off between a high value to 
avoid potential aliasing effects and a lower value since the SNR is reduced with 
a higher threshold and the ability to decouple slower velocities is influenced. 
Having calculated the velocity inside a big vessel, it is trivial to quantify the flow 
in the vessel by multiplying the mean velocity over the pixels with the area of 
the vessel. 
A recent study by Yashiro et al. (192), has shown changes in the 
vasculature of T2DM patients using TOF-MRA analysis. PC-MRA has been 
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used in the past to assess flow in diabetes pointing towards reduced carotid 
flow (193). 
	
Figure 2.15: Pulse sequence diagram for PC MRA based on Haacke et al. 1999 [64]. 
 
2.5.4 Diffusion weighted MRI 
Diffusion imaging focuses on the determination of the displacement of 
water molecules due to thermal energy. The contrast of the technique depends 
on the accumulated dephasing due to random spin movement.  In the pulsed 
gradient spin-echo implementation one dephasing and one rephasing gradient 
are applied after the 90° RF pulse either side of a 180° pulse resulting in the 
dephasing of moving spins (figure 2.16) (194). In a gradient echo 
implementation the pair of diffusion gradients differs in polarity and follows the 
90o pulse. High mean displacement results in greater signal attenuation and 
corresponds to darker regions on a diffusion-weighted image (195). The 
readout is usually a fast one such as EPI. 
The sequence’s sensitivity to molecular diffusion is determined by the ‘b-
value which incorporates information about the amplitude, duration and 
separation of the applied gradients and can be calculated using the following 
equation 2.16, where the gradient and timing parameters are defined as in 
figure 2.16: 𝑏 = 𝛾E𝐺E𝛿E L𝛥 − 𝛿3O [2.16] 
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Figure 2.16: Diffusion weighted imaging pulse sequence diagram based on Haacke et al. 
1999 [64]. 
The simplest diffusion imaging technique is diffusion weighted imaging 
(DWI) whereby data are acquired in three orthogonal directions to characterize 
the water movement in 3D. The diffusion apparent coefficient (ADC) can be 
quantified by measuring the signal (S) obtained from an acquisition with a non-
zero b-value and a signal with b = 0 (S0) which is actually a conventional T2-
weighted image (equation 2.17). The signal at a certain b-value can be 
calculated as the geometric mean of the signal from the three orthogonal 
directions. The higher the b-value the stronger the diffusion weighting. 
However, the higher the b-value the lower the achieved SNR due to TE 
prolongation 𝑆𝑆𝑜 = 𝑒& 	⇒ 𝐴𝐷𝐶 = 1𝑏 ln	(𝑆B𝑆 )			[2.17] 
  
Equation 2.12 demonstrates that two b-values typically suffice to 
determine ADC, however, acquisition of additional b-values can allow for a 
more accurate estimate. Two b-values is sufficient for the calculation of ADC 
when using a monoexponential model where ADC can be calculated from the 
slope of the b=f(S) plot which is a straight line, as in equation 2.12. However, 
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inclusion of more b-values can allow for more complex models to be fitted to the 
data than the simple monexponential model.  At present, the vast majority of 
clinical diffusion imaging sequences in the neuroimaging domain use two b-
values of approximately 0 and 1000 s / mm2. 
More advanced diffusion imaging modalities allowing for the complete 
characterization of the displacement of water molecules include diffusion tensor 
imaging (DTI), diffusion kurtosis imaging (DKI), diffusion spectrum imaging 
(DSI), q-ball imaging (195). The basic difference of these techniques from a 
DWI acquisition has to do with the fact that acquisitions are performed for a 
bigger set of b values and gradient orientations. Diffusion kurtosis imaging 
differs from DWI in that it avoids assuming a Gaussian distribution as a pattern 
for the water diffusivity (196). DSI and Q-ball imaging are capable to resolve 
small differences in the directionality of the tracts within a voxel (197).  
 Neuroimaging studies have reported increases in mean diffusivity (198) 
and decreases in fractional anisotropy (199) in patients with T2DM. 
 
In the present study, QUASAR ASL was used to evaluate cerebral 
hemodynamics in IGT and T2DM. An MPRAGE and a FLAIR scan were 
acquired to detect structural changes in the brain. TOF and PC-MRA 
scans were acquired to investigate the cerebral vasculature and finally a 
DWI scan was acquired to detect alterations in water movement. 
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Chapter 3: 
Brain MR Image Processing 
 
The output from every medical imaging modality is a clinical image 
providing structural, physiological or functional information. The varying 
intensity levels present in the image are associated with the structural or 
physiological parameter under consideration. Through image analysis, regions 
or properties affected by a potential disease, and existing patterns indicative of 
the pathological condition, can be unveiled. In terms of image processing, the 
image comprises of entities termed pixels (2D) or voxels (3D). The number of 
pixels comprising an image depends on its field of view and sample array size. 
The intensity of each pixel is associated with the parameter that the specific 
technique is measuring. Image resolution in MRI can vary from small voxels (i.e. 
0.125mm3) to voxels of several mm depending on the implementation and the 
desirable SNR.  Functional imaging techniques are often constrained by SNR 
and have larger voxel sizes than structural imaging methods. 
While it is often desirable to make imaging “measurements” on a single 
individual, as in traditional diagnostic imaging, research studies frequently 
perform group comparisons to try and identify general differences in measured 
parameters between specific cohorts (or groups) of patients.  To enable these 
group comparisons, several pre-processing steps have been developed. Motion 
correction and registration of the image to a standard template coordinate 
system by applying a geometrical transformation are examples of such pre-
processing steps which might be implemented. Temporal filtering and spatial 
smoothing can be used in order to filter out frequencies that might not be of 
interest, or frequencies irregularly high (101, 200). These pre-processing steps 
are widely used to ensure that images from different subjects are comparable.  
Numerous software tools have been developed with a focus on 
processing of brain images. Some of the most popular ones used in 
neuroimaging research are: Statistical Parametric Mapping - SPM (201); 
FMRIB’s Software Library - FSL (202); FreeSurfer (203) and Analysis of 
functional neuroimages - AFNI (204).   
	 52	
In this chapter image processing techniques utilised in the present thesis 
are discussed in the context of the existing research and bibliography. These 
techniques range from regular pre-processing to advanced methods based on 
machine learning. Focus is put on segmentation using fuzzy c-means clustering 
(FCM), voxel-based morphometry (VBM), linear support vector machine (SVM) 
classifiers and feature ranking with SVM – RFE (recursive feature elimination). 
 
3.1 Pre-processing steps  
An example slice from an individual is shown in figure 3.1 before and 
after bias field correction, brain extraction and tissue segmentation. 
 
Figure 3.1: Preprocessing steps demonstrated in one coronal slice. The original/acquired 
image, is bias field corrected, the brain is extracted and subsequently segmented. 
 
 
3.1.1 Bias field correction 
Bias field correction (BFC) attempts to account for signal variation 
introduced by field inhomogeneities during the image acquisition process. 
These inhomogeneities cannot be attributed to a single factor. One of the 
potential sources is the RF coil(s) used for MRI signal transmission and 
reception, which does not have a perfectly uniform field (205). The bias field is 
not always visually obvious; but it can greatly influence the subsequent 
Original	 Bias	ﬁeld	corrected	 Brain	extracted	
GM	map	 CSF	map	WM	map	
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analysis. Its presence might imply intensity changes in the same tissue type 
across the image, independent of underlying pathology, and it usually increases 
the variance within individual tissue classes, thereby reducing sensitivity to 
detecting abnormal tissue. Several methods have been developed for BFC. 
Two broad categories exist: correction at the level of acquisition by adjustments 
in the hardware and approaches relying on the acquired image and in some 
cases prior knowledge. The latter approaches can correct for bias introduced 
both by the scanner and by the scanned object (206). 
The typical model used to describe the acquired image is given in 
equation 3.1, where the acquired image (I) is modelled as the original 
uncorrupted image (Ioriginal) with a multiplicative slow varying field (B) and 
additive noise (n). Other suggested models are as on equations 3.2 & 3.3 (206, 
207). 𝐼 = 𝐵 ∗ 𝐼ge``ad + 𝑛																																					[3.1] 𝐼(𝑥) = s𝐼ge``ad + 𝑛t ∗ 𝐵																											[3.2] 𝑙𝑜𝑔𝐼 = logs𝐼ge``adt + 𝑙𝑜𝑔𝐵 + log(𝑛)			[3.3] 
All cases tend to assume that n is approximately Gaussian. When B is 
determined, it is removed from the image and the resulting image is described 
as bias field corrected. 
Currently, the most popular and robust bias field correction algorithm is 
N4ITK (208), which is based on the N3 (non-parametric non-uniformity 
normalization) algorithm (209). This algorithm uses the first model for BFC and 
determines via an iterative procedure the bias field. The idea is that the 
histogram of the acquired image is a convolution of the histogram of the true 
image and the histogram of the bias field. The algorithm utilises deconvolution 
to determine the bias field. A deconvolution step is followed by an updated 
estimation of the bias field. The procedure ends when the difference of the 
standard deviation between two subsequent bias field estimations falls bellow a 
pre-defined threshold (210). Differences between the N4 and N3 algorithm are 
centered on the estimators used for the calculation of the bias field and 
equation used for iterative estimation, with the N4 using in every iteration the 
residual bias field from the previous iteration and not the total bias field. For 
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more details the reader is referred to Larsen et al. (210) and Tustison et al. 
(208). 
 
3.1.2 Brain extraction  
Extraction of the brain, otherwise known as ‘skull-stripping’ is of great 
importance as remaining non-brain tissue (i.e. skull, skin, eyes) might distort the 
results of the subsequent analysis. Manual extraction is an extremely time-
consuming task even for experienced radiologists. Hence, automated skull 
stripping is regularly used and the resulting brain mask can be inspected for 
potential failures.  
Available brain extraction methods can be classified into several distinct 
categories: morphological algorithms, intensity-based, deformable surface 
approaches and atlas-based models (211). The morphological approaches aim 
to use thresholding and/or edge detection for an initial stripping followed by 
morphological operations such as erosion or dilation. Intensity based 
approaches are usually based on the image intensity histogram and changes in 
local intensity gradient to separate tissue and non-tissue entities. Deformable 
surface models rely on an initial closed curve that dynamically evolves using 
energy metrics until it fits the surface limit. Atlas-based methods utilise prior 
information from generated atlases in order to exclude the skull, following 
registration of the subject’s brain into the atlas space. Hybrid and more 
sophisticated methods have been developed as well, with the recent trend 
being to use deep neural networks (212) for the task.  
The major neuroimaging research software tools have all incorporated 
brain extraction methods into their pipelines. FSL’s BET (213) uses deformable 
surface models and SPM’s algorithm relies on an atlas-based model used for 
tissue segmentation (214). AFNI’s (204) 3dSkullStrip utilises a modified BET 
technique and Freesurfer’s tool (215), combines a watershed algorithm with 
deformable surface models and an atlas. 
 
3.1.3 Image registration 
Image registration is concerned with the determination of an appropriate 
geometrical transformation that maps the pixels of one image (moving image) to 
a reference image. The major linear geometrical operations are translation, 
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rotation, scaling and shearing (216). Rigid transformation comprises translation, 
and rotation, whereas affine transformation comprises all four linear geometrical 
operations.  The optimum transformation is identified as that which minimises 
(or maximises) a defined similarity metric between the two images, such as 
normalized cross-correlation, normalized mutual information, etc. Once the 
optimum transformation has been found, the moving image is warped using the 
resulting transformation so that it is in spatial registration (or as close as 
possible) to the reference image. Linear registration can be used when there 
are no major differences between the two images.  
A linear registration takes the form of y = Ax where y is the resulting 
image, x is the moving image and A is the transformation matrix. The 
transformation matrix can be represented as a matrix multiplication of the 
individual translation, rotation, scaling and shear matrices. 
While linear registration may be sufficient for intra-subject motion 
correction, the consensus in medical imaging is that linear registration is not 
sufficient for successful inter-subject anatomical structure alignment. A study 
published in 2009 examined in great depth 14 non-linear registration algorithms 
and came up with certain recommendations (217). The best two algorithms 
were the SyN (218) and the ART (219). Another popular non-linear method, 
aimed at preserving topological information and utilised by SPM, is 
diffeomorphic registration, which approaches registration as a problem of an 
image flowing to match another image (220). This algorithm came fourth in the 
evaluation of non-linear registration algorithms. 
Registration is used for motion correction, to match images of different 
resolutions, images from different subjects, different imaging modalities, or to 
register images to an already existing atlas (normalization). It is important to 
use a robust registration approach, although care must be taken as the original 
image values are usually modified in the procedure due to interpolation. 
Additionally, it is important to evaluate the registration result to reassure that the 
automated process has been successful and that there are no gross 
misalignments between the registered image and the target. Potential imperfect 
registration might imply that the extracted metrics do not reflect the actual 
values from the region under consideration.  
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Spatial normalization utilises image registration in order to align the 
subjects image space with a reference image space such as the Montreal 
Neurological Institute (MNI) (221) or the Talairach-Tournoux (222) coordinates 
system. Registration into a “standard” reference space is commonly used in 
neuroimaging, as it allows for easy correspondence of spatial information 
between studies and for utilisation of developed atlases. 
 
3.1.4 Tissue segmentation 
Medical image segmentation can be described as the task of assigning 
each voxel to a distinct category/class. Specifically, for a healthy brain, the most 
typical considered classes are GM, WM and CSF. Segmentation results from 
this procedure are typically used for volumetric quantification. Complex 
segmentations are also possible, where the brain is separated into detailed 
anatomical sub-regions.  Segmentation is frequently performed so that 
measurements can be obtained from the region, or tissue of interest.  These 
can be physiological and functional parameters, which can be calculated by 
registering the segmented region of interest (usually emerging from a structural 
scan) onto quantitative images (e.g. emerging from functional acquisitions). 
The main segmentation approaches are: manual, region-based, 
threshold-based, classification-based and clustering-based (223). Region-
based approaches for segmentation are very similar to brain extraction region-
based approaches, in that starting from a certain region, they expand an initial 
curve or seed point until a termination criterion (usually energy-related) is met. 
Threshold-based approaches are among the most popular for image 
segmentation. Thresholding can be local, adaptive or global. The optimal 
threshold in all cases can be determined using techniques such as Otsu 
thresholding and entropy-based criteria (223).  
Classification based segmentation approaches relying on SVM 
classifiers (224), deep neural networks (225) and k- nearest neighbors (226) 
have also been use for tissue segmentation.  
Tissue segmentation can be approached as a problem of clustering 
using algorithms such as K-means (227) and FCM clustering (228). Clustering 
for tissue segmentation can have two forms: soft (whereby a voxel does not 
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need to belong to one class exclusively, as in FCM and mixture models); or 
hard (where a voxel belongs only to one class, as in k-means). 
The first category of soft clustering-based approaches involves mixture 
models. Usually the segmentation problem is addressed by fitting Gaussian 
shaped curves to the histogram of the image, or of a region, and assigning to 
every voxel a probability of belonging to a certain class. FSL’s FAST tool 
utilises an expectation maximization algorithm combined with Gaussian Mixture 
Models (GMM). SPM’s segmentation routine also makes use of GMM along 
with prior probability maps. Mixture models have the disadvantage of making 
assumptions about the underlying intensity distribution, i.e. the data conforms to 
a Gaussian distribution with a certain number of tissue classes. Utilising prior 
probability atlases introduces an additional bias to the segmentation task, so 
their use needs to be weighed carefully against the potential for increased 
robustness.  
FCM clustering originally proposed by Dunn (229) and adapted by  
Bezdek et al. (228) is a classification technique of great interest for image 
segmentation and is based on the fuzzy logic theory (230). In fuzzy logic, a 
function termed the “membership function” determines the degree of belonging 
to a specific cluster. The concept of fuzziness intends to describe variables with 
vague edges, in an attempt to avoid a binary logic of belonging or not 
belonging. This property renders FCM a promising technique for tissue 
segmentation and partial volume estimation (231).  
The philosophy underlying FCM is that a pixel does not belong explicitly 
to a class, but has a degree of membership in all clusters with a value in the 
interval [0 1], with 1 suggesting strong membership in a cluster. Calculation of 
the membership level is an iterative process. Initially, an informed estimate is 
made about the centroid locations of every cluster. Subsequently, equation 3.4 
is minimized. Minimization occurs when pixels with values close to the centroid 
acquire a high membership function for this particular cluster. The membership 
value and the centroid of every cluster are updated until convergence is 
achieved (equation 3.5) (228, 232). 
J = ¡¡u£¤¥ ¦§x¤ − v£§¦	E			[3.4]ª£«N¬¤«N  
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Where, c is the number of clusters, uij is the membership value, xj is the 
pixel under consideration, m is the degree of fuzziness and vi is the centroid of 
a cluster. 
 u£¤ = 1∑ ®¦§x¤ − v£§¦¦§x¤ − v¯§¦°
E¥&Nª¯«N
			 , where	v£ = s∑ u£¤¥x¤¬¤«N t∑ u£¤¥¬¤«N 		[3.5] 
In its original implementation, FCM does not take into account the local 
neighborhood of a pixel. Techniques to circumvent this limitation have been 
suggested, mostly focused on modifying the membership function to 
incorporate spatial information, thus making the classification dependent on the 
information from the local neighborhood. Focusing on medical image 
segmentation, one such algorithm performing spatial fuzzy c-means (SFCM) 
clustering was proposed by Chuang et al. (232). The algorithm incorporates 
information from a 5*5 window in the classification task and modifies 
accordingly the membership function (equation 3.6).  u£¤µ = u£¤¶h£¤·∑ u¯¤¶ h¯¤·ª¯«N 				,						where	h£,¤ = ¡ u£¯								[3.6]	¯∈¹£º(»¼)  
Where win (xj) is a k*k size window centered at pixel j. 
 Ahmed et al. (233) introduced a technique to incorporate BFC to FCM 
(not accounting for spatial information). In some studies an effort was made to 
incorporate in the fuzzy classification both spatial information and BFC by 
modifying the membership function accordingly (234, 235). Recently all FCM 
based algorithms for MR image segmentation have been compared (236) and 
the best performance was demonstrated by SFCM. 
 
 
WMH segmentation 
Segmentation of hyper-intense WM regions is a non-trivial problem. 
Several software tools have been developed, however, none of them is 
considered a gold standard. The difficulty arises from the fact that WMH regions 
can have an unpredictable appearance; they can consist of very small localized 
regions, large diffuse areas, or a combination of both (237). Their distinct 
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intensity profile makes them recognizable with a bare eye, however automated 
detection has generally proved to be suboptimal. Currently, the most reliable 
and commonly used approach is to use an automated tool with subsequent 
manual correction for regions that have been missed, or were mistakenly 
labeled as abnormal. Some of the automated tools are: Lesion segmentation 
toolbox (238) and BIANCA (FSL) (239). 
 
3.2 Partial volume phenomenon and correction 
The lower the resolution of an image the bigger the volume of the voxel 
or area of the pixel for a given field of view. This means that there is a higher 
probability of a pixel/voxel containing information from more than one tissue 
type. This problem is dubbed the ‘partial volume effect’ (PVE). Another factor 
associated with PVE is the imperfect point spread function of the imaging 
system, which is more important in PET imaging. In higher resolution images, it 
is less of a problem, however, in perfusion imaging, and especially in ASL, it 
can lead to underestimation of GM CBF. Asllani et al. (240) have shown that in 
an ASL experiment, the GM CBF value can be underestimated by up to 50% 
and have proposed a method to account for PVE based on linear regression. 
This method introduces a degree of smoothing to the data, as it assumes 
relatively stable perfusion values in a kernel. Chappell et al.  (241) have shown 
that an alternative to this method for multiple inversion time-point ASL, could be 
to fit the signal with kinetic curve equations based on Buxton’s model for every 
tissue type. This technique has also been used in single-PLD ASL (242). Both 
approaches use a high-resolution anatomical image to generate fractional 
volume maps.  
Ahlgren et al. (243) have implemented a different approach for partial 
volume correction (PVC), using only the information obtained from the 
QUASAR ASL sequence, without reliance on a high-resolution anatomical 
image. Tissue maps were generated by fitting Gaussian distributions to the low 
resolution ASL-derived images for every tissue type (244). The saturation 
recovery signal was modelled as a linear combination of the saturation recovery 
from the tissue types (GM, WM and CSF).  
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3.3 Group-comparisons 
In cross-sectional and longitudinal studies, comparisons are made 
between different scans of different individuals, or of the same person, in order 
to unravel patterns of localized or global differences. Various approaches exist 
to perform comparisons between different scans. One approach is to use 
manual or semi-automated segmentation of regions of interest (ROI), usually 
focusing on areas known to be affected by the examined condition and any 
differences can be identified by statistical comparisons. Another option is to use 
morphometric approaches, which avoid making assumptions about the extent, 
location and number of ROIs. 
The most heavily used morphometric technique is VBM, which is 
designed to detect regions in the brain (typically GM) that differ in volume 
between groups, by applying group comparisons at a voxel level (245). The 
pipeline behind VBM has been implemented in both FSL and SPM with both 
implementations being highly similar. In its regular implementation, the initial 
step of the pipeline is brain extraction. Subsequently all brains need to be 
normalized to a common space to facilitate group-wise comparisons. It is a 
common approach for a study-specific template to be constructed at this stage 
from some, or all scans. This template is used as a registration target for the 
next step where all segmented PV maps, are registered to the common space. 
At this stage an optional processing step described as ‘modulation’ which 
preserves volumetric information can be applied. The GM and WM segments 
are subsequently smoothed using a Gaussian filter (with kernels ranging from 
6mm to 18mm FWHM) to render the intensity more normally distributed, in 
order to facilitate parametric statistical tests. The endpoint result of the pipeline 
is therefore a series of images in a common space, where the information in 
each voxel effectively describes the density of tissue for each subject. 
Subsequently, statistical tests between equivalent voxels determine 
whether these voxels differ significantly between the groups. Usually, these 
comparisons take place using the partial volume maps. Comparisons are 
typically based on the general linear model and study-specific designs are 
generated and implemented. The applied statistical tests depend on the cohort, 
time-points and states. Due to the thousands of comparisons equivalent to the 
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number of non-zero voxels it is of utmost importance to correct for multiple 
comparisons and account for the false positive rate.  
The VBM implementation in SPM and FSL is almost identical, but 
differences arise in the specific pre-processing tools, which are used to achieve 
the same conceptual steps.  
Alternative suggested morphometric approaches involve deformation-
based morphometry (focused on the position of the structures), tensor-based 
morphometry (focused on the shape of structures) (246) and pattern-based 
morphometry (247). 
Morphometric techniques, such as VBM, are mass-univariate 
(comparisons are conducted at a single voxel level) and cannot capture a 
spatially distributed pattern, nor can they be used as a stand-alone model for 
individual prediction (248). These concerns are addressed by using machine 
learning approaches. Such approaches have been used extensively in 
dementia classification and more specifically in Alzheimer’s using mainly 
structural scans (249).  
When using machine learning, the scans need to be registered to a 
common space. The whole image can be used as an input to a classification 
algorithm along with the respective classes in order to determine optimally 
differentiating regions. Due to the high resolution of the structural scans, the 
classification task involves thousands of features (each voxel can be one 
feature) so the dimensionality of the problem needs to be greatly reduced. An 
approach is to down-sample the considered image and utilise methods for 
dimensionality reduction. Of utmost importance when detection of regions of 
difference is of interest, is to retain the original features, hence a feature 
preserving technique ought to be used (250, 251).  
The important difference of such approaches compared to VBM is that 
they can be used for classification of a single individual and not just in the 
context of group-wise comparisons once a model is constructed (250). 
Additionally these techniques are multivariate (248). 
 
3.4 Feature extraction and classification 
In the era of big data, processing using machine learning, or more 
recently deep learning, is a particularly appealing approach. The difference 
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between machine learning and deep learning, is that deep learning is purely 
neural network - based with numerous hidden layers (hence the term ‘deep’), 
whereas, in machine learning there is no such hidden deep neuronal structure. 
In the context of medical imaging, numerous characteristics can be extracted 
from one, or multiple, modalities and multiple regions. Every such characteristic 
is considered to be a feature. Every subject is characterised by a collection of 
features; comprising its feature vector. The task of classification is essentially 
the task of classifying the feature vector, referred sometimes as ‘pattern’ into 
one of the categories, or else ‘classes’, under consideration. The extracted 
features can be used as an input to a classifier, with a view to classifying 
individuals into specific categories based on extracted features.  
The two main categories of learning are supervised (for example 
classification and regression) and unsupervised (e.g. clustering). In supervised 
machine learning both input data and their corresponding classes are used as 
input to the algorithm for training purposes. Classification techniques are used 
for categorical outputs, whereas regression techniques are used for continuous 
outputs. In unsupervised techniques, the algorithm finds intrinsic data patterns. 
Learning techniques are not confined to supervised or unsupervised; but 
learning can also be semi-supervised or reinforced. 
 
3.4.1 Feature extraction 
Multiple features can be extracted from an image. For example, features 
that characterise the shape of structures include their circularity, area, or 
perimeter. Textural analysis is a term reserved to describe the investigation of 
changes in the gray level pattern of an image. Textural features involve 
amongst others statistical features of first or higher order and spectral features. 
This type of features has been used for analysis of gray level patterns in 
conditions such as brain tumors, epilepsy and multiple sclerosis (252). First 
order statistical features are the mean, standard deviation, skewness and 
kurtosis. The gray-level co-occurrence matrix (253) is a popular approach for 
textural feature determination. The features derived from this matrix are 
second-order statistical features such as entropy, energy and contrast.  
Transform-based features can be determined using transformations 
analysing the frequency content of the image. Such methods can utilise 
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amongst others: Fourier, wavelet and Gabor transforms (254). The Fourier 
transform is capable of disentangling the spatial frequencies present in an 
image by using a number of superimposed sinusoidals. Wavelet transforms are 
less restricted than Fourier, since the basis functions used for the frequency 
content analysis are not confined to sinusoidals (252). Gabor filters are 
sinusoidal waves modulated by a Gaussian. Their interesting property is that 
they approximate the way the human visual system works. By implementing 
several modifications, they can be rotationally invariant (255).  
Following calculation of features of interest with one or more of the 
described methodologies, all extracted features are positioned in a feature 
vector.  
 
3.4.2 Dimensionality reduction 
An important step prior to classification, particularly when the 
dimensionality of the problem is higher than the number of available 
observations, is dimensionality reduction. Especially in the medical field, the 
number of features can greatly outweigh the number of available observations, 
giving rise to the ‘curse of dimensionality’. Dealing with this ‘curse’ mandates 
that an appropriate feature selection, or reduction, technique is used to reduce 
the number of features used in the classification task. This step is of great 
importance since it is crucial in order to avoid overfitting. Classification 
algorithms, trained on a large number of features, might present a superficially 
high performance for the training set (overfitting), however, when the classifier 
is used on a testing set, the performance might be very poor (256). Overfitting 
results from the classifier having learned the idiosyncrasies of the available 
training dataset and when presented with a new one it cannot generalise. The 
smaller the available dataset, the more likely it is for the classifier to identify 
patterns with poor generalisability. 
Feature selection techniques choose a subset of the available features, 
whereas feature reduction techniques might reduce dimensionality by using 
linear combinations of the features.  A multitude of feature reduction and 
selection techniques have been developed and under the main branches 
numerous subcategories have emerged (256). 
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Examples of popular dimensionality reduction algorithms include 
principal component analysis (PCA) and linear discriminant analysis (LDA), 
both these algorithms do not examine non-linear feature relationships. An 
alternative approach, capable of unravelling non-linear relationships between 
the features, is a feature ranking technique which can be used for feature 
selection known as SVM-RFE (257). 
SVM-RFE which was used in the present thesis, was introduced as a 
feature ranking method by Guyon et al. (257). The philosophy behind the 
technique is that the weights of a SVM classifier are used as a criterion to rank 
the features. Following feature ranking, a subset of the features can be retained 
for further analysis leading to dimensionality reduction. An important advantage 
of SVM-RFE is that the features are maintained in their original form, following 
feature reduction, allowing for further analysis. The pseudo-code for its 
execution is as follows (257, 258): 
1) Train a classifier and retain the weights of every feature. 
2) Select a subset of features (higher weights). 
3) Proceed with a backwards elimination approach eliminating one, or 
multiple, features per iteration. 
4) Repeat until all features are removed. 
5) Rank the features based on the sequence of their removal. 
 
In their paper introducing SVM-RFE, Gyuon et al. (257) decided to 
analyse the top-7 features with the highest weighs in a study about colon 
cancer. One of the top-scoring features for distinguishing colon cancer patients 
from normal volunteers had to do with a parasitic protozoon, trypanosoma. 
Initially, they thought this was a failure of their method; however, they actually 
found out that people infected by trypanosoma develop resistance to colon 
cancer, thus demonstrating the robustness of the developed technique and the 
potential new insight it can offer. Especially for classification tasks in the 
medical field, such a method allowing for retention of the top features in their 
original form and their further analysis could be of great importance and could 
provide us with candidate disease biomarkers. 
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3.4.3 Classification techniques 
A binary classifier utilises a decision function D(x) which if positive the 
pattern is assigned to the +1 class, if negative, the pattern is assigned to the -1 
class. There are two main classifier types, those that rely on Bayesian theory 
and those that attempt to optimize a cost function by determining a decision 
boundary (259). Classification based on Bayesian inference usually assumes a 
PDF of a certain type (typically Gaussian) and seeks to optimize the parameters 
of the function to better describe the data (i.e. mean and covariance matrix). 
The within class PDF needs to be known or estimated before the classification 
task. Estimation of the PDF can be performed using maximum likelihood 
estimation or by using mixture models combined with an expectation-
maximization algorithm (259). 
Classifiers based on a decision surface rather than on PDF estimation 
seek to deduce the optimally differentiating surface separating the classes in 
the N-dimensional space. These classifiers can result in better classification 
when the available data-points are limited. Examples of these algorithms 
include the perceptron, the least-squares classifier and SVMs (259). 
 
3.4.3.1 Support Vector Machines (SVM) 
One of the most popular classification algorithms is the SVM classifier, 
which is adept for two outcomes of a particular state but can be expanded to 
more than one outcome categories. SVMs introduced by Cortes and Vapnik 
(260) are particularly stable, well-studied, with open-access and easy to 
implement software  (libraries are available in Matlab, Python, etc.) and more 
importantly they work well with relatively small data sizes, which doesn’t tend to 
be the case with neural network based methods. For these reasons, they were 
the preferred classifier in this project. 
SVM attempts to separate the data by determining an optimally 
separating hyper-plane (maximum margin) (260). The dimensionality of the 
problem is determined by the number of available features. In a toy problem 
where 2 or 3 features are available, the problem is equivalent to finding the 
optimally separating hyper-plane in 2D or 3D where the axis is determined by 
the feature value (figure 3.2). For problems defined in a higher dimensional 
space it is mathematically trivial to expand the methodology, but difficult to 
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visualize and depict the hyper-plane. In this case, all instances are placed in the 
N-D space, with N determined by the dimensionality of the feature vector and 
the SVM algorithm determines a N-D hyper-plane. SVM is one of the classifiers 
that is considered to be relatively robust regarding overfitting. 
 
Figure 3.2: SVM optimally differentiating hyper-plane in 2D and 3D.  	
Non-linear SVM operates by projecting the feature vector in a higher 
dimension using a kernel function. Kernel functions can be: polynomial, radial 
basis function and sigmoid. The linear SVM is a particular case of polynomial 
SVM whereby there is no projection to a higher dimension using a kernel 
function. 
In the rest of this section the mathematical concepts underpinning SVM 
are briefly discussed, following the lectures of Professor Patrick Winston (261)  
and tutorials from (262-264). 
A linear classifier has the form of wTx+b=0 where x is the feature vector, 
w are the weights associated with each feature and b corresponds to a bias. 
Numerous planes can separate the data into two classes and SVMs search for 
the hyper-plane that maximizes this margin. 
In SVM, the optimally separating hyper-plane is defined by wTx + b = 0 
and the maximum margin is defined by two hyper-planes: wTx + b = 1 and wTx 
+ b = -1. The distance between the two hyper-planes defining the margin is 2 / 
||w||. This distance arises by considering the distance between a point and a 
hyper-plane. For the sake of simplicity in the distance calculation we will 
consider the 2D case where we calculate the distance between a point and the 
2D	 3D	
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hyper-plane, which for the 2D paradigm is a line. Let a point on the line 
consisting the hyper-plane (i.e. w1x1 + w2x2 + b = 0) be C(x1o,y1o) and a line of 
the form wTx + b = 1 (one of the two lines defining the maximum margin), which 
could be written as w1x1 + w2x2 + b – 1 = 0. Then for point C, it follows that w1x1o 
+ w2x2o + b = 0 
The distance between them is given by equation 3.7. 𝑑 = |𝑤N𝑥Ng + 𝑤E𝑥Eg + 𝑏 − 1|¿𝑤NE + 𝑤EE = |0 − 1|¿𝑤NE + 𝑤EE = 1||𝑤||					[3.7] 
 
It follows that the distance between a point situated on one of the lines 
defining the maximum margin and the hyper-plane (being a line in this 2D 
example) is 1 / ||w||. As mentioned previously the goal of SVM is to maximize 
this margin; it follows that 1 / ||w|| needs to be maximized so ||w|| needs to be 
minimized, having in mind that all observations need to be situated outside this 
margin. 
The classifier should have the following behavior based on whether the 
class y of every instance is 1 or -1 which could be summarised in the following 
expression (equation 3.8):  𝑦 ∗ (𝑤+𝑥 + 𝑏) ≥ 1					[3.8] 
So when wTx + b > 1 then y = 1 and when wTx + b < -1 then y = -1 
The optimization task seeks to maximize 1 / ||w|| (or minimize ||w||) so 
the distance between the hyper-planes is maximized according to constraints. 
Minimizing ||w|| is actually the same as minimizing 0.5 * |w||2. One of the 
advantages of formulating the problem as such, is that the function to be 
minimized is convex, meaning that the minimum will be global. Problems 
involving a cost function minimization with equality and / or inequality 
constraints can be solved using Lagrange multipliers. The basic idea is that the 
gradient of the function to be optimized is equal to the gradient of the constraint 
multiplied by ai - the Lagrangian multipliers.  
So, the problem becomes an optimization problem with the following 
constraint (equation 3.9) where the equality holds only for the points situated on 
the margin. min¹,Ã 12 §|𝑤|§E	𝑠𝑢𝑏𝑗𝑒𝑐𝑡	𝑡𝑜	𝑦(𝑤𝑥 + 𝑏) − 1 ≥ 0		[3.9] 
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This is the so-called ‘primal’ problem when the optimization is focused on 
finding the weights. The Lagrangian for this problem is: 𝐿 = 12 §|𝑤|§E −	¡𝑎`[𝑦`(𝑤𝑥` + 𝑏) − 1]		[3.10] 
In order to find the extremes of L, the partial derivatives with respect to w 
and b are calculated as follows: 𝜕𝐿𝜕𝑤 = 0	 ⇒ 𝑤 −¡𝑎`𝑥`𝑦` = 0 ⇒ 𝑤 =¡𝑎`𝑥`𝑦`					[3.11] 𝜕𝐿𝜕𝑏 = 0 ⇒¡𝑎`𝑦` = 0							[3.12] 
By substituting 3.11 and 3.12 into 3.10, the problem becomes 
𝑚𝑎𝑥𝐿d = ¡𝑎𝑖 − 12¡¡𝑎)𝑎Ç𝑦)𝑦Ç < 𝑥), 𝑥Ç >ÊÇ«NÊ)«NÊ)«N 			[3.13] 
Subject to the following constraints: ai ≥ 0 and ∑ 𝑎`𝑦` = 0Ê`«N .  
This is the so-called dual problem, since the focus has been shifted from 
the weights (primal problem) to the Lagrangian multipliers (dual). In equation 
3.13, αi are the Lagrangian multipliers. The majority of them are zeros and 
those with non-zero values are the support vectors.  
The final decision function for SVMs is D(x) = wTx + b with  𝑤 =¡𝑎`𝑦`𝑥`	` 				[3.14] 
In other words, having calculated the Lagrangian multipliers, in order to 
decide the class of a pattern we only need to calculate its inner product from 
some of the vectors, those with positive ai values or in other words: the support 
vectors. 
For non-linear SVM classifiers equation 3.13 is slightly different, in the 
sense that instead of the product of the two vectors, the product is < φ(x), φ(xj) 
> where k(xi,xj) = < φ(x), φ(xj) > is the kernel function mapping the vectors into a 
higher dimension.  
 
3.4.4 Cross-validation 
In order for the classification results to be generalisable, the available 
data points are normally separated into a training and a testing set. When large 
datasets are available the algorithm is usually trained on a percentage of them 
	 69	
(ranging between 60-80%) and tested on the rest. The performance is usually 
reduced when the test data are presented to the classification algorithm. The 
disadvantage of these hold-out techniques is that not all available data-points 
are used for training. This problem is particularly important when small datasets 
are considered and using all of the available sample is highly desirable. Cross-
validation aims to use all available samples and evaluate the model’s 
performance through repeated resampling (265).  
Numerous techniques exist for cross-validation and these can be 
exhaustive or non-exhaustive. An example of exhaustive cross-validation is 
“leave-p-out” cross-validation whereby p observations are used for testing and 
the classifier is trained on the remaining ones; subsequently it is tested on the 
remaining p. This approach runs for every possible partitioning of the data 
hence it can be computationally expensive depending on the available features 
and data-points. A special case of leave-p-out cross validation is leave-one-out 
cross-validation (LOOCV) whereby a single observation is left out in every 
iteration. For every iteration, the mean square error in classification of the 
testing sample (s) is measured. The performance of the classifier is calculated 
as the mean performance over all iterations (265). 
An example of a non-exhaustive method is k-fold cross-validation where 
the data points are separated in k-folds and in every iteration, one fold is kept 
for testing and the rest for training. In all cases, the average performance is 
reported and is indicative of the generalisability of the model. This method is 
less computationally expensive than exhaustive methods examining all possible 
partitions. It has been shown that using LOOCV reduces bias, however k-fold 
has been shown to have less variance (266). 
It needs to be noted that as the sample size decreases the ‘curse of 
dimensionality’ might lead to underestimation of the generalisation error when 
cross-validation is used (267). 
 
3.4.5 Machine learning and MR brain imaging 
Classification based on features extracted from MRI images is used at 
an increasing rate in studies investigating conditions such as: mild cognitive 
impairment and Alzheimer’s, (246, 249, 268), brain tumors (269), Parkinson’s 
(270), mental disorders (271) and mild traumatic brain injury (272).  
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Structural MRI is by far the most thoroughly examined modality when 
attempting to detect patterns of difference between examined groups and 
perform classification of subjects into a certain class. The majority of studies 
looking into patient classification using structural MR images, seek to identify 
regions leading to optimal class-separation, hence the initial feature vector 
comprises all the image voxels. When machine learning approaches are used 
to detect differences at a voxel-wise level, it is essential that the images are 
registered to a common space as is the case with voxel-based morphometry 
since every voxel is examined individually in terms of its classification power. 
Only a few studies have evaluated features from MRI modalities outside 
of structural imaging, such as resting state fMRI, DSC-MRI and diffusion 
imaging (249, 269). In terms of ASL only two studies have incorporated single-
PLD ASL-derived metrics and these were limited to values extracted from the 
CBF maps (273, 274). One of the most popular classifiers used in such studies 
is SVM due to its competitive advantages such as good generalisation, stability 
and most importantly good performance in small datasets. A review from 2012 
nicely summarises the use of SVM classifiers in neurological and psychiatric 
disorders for classification, prediction of conversion to un-healthy state and 
response to treatment (275). 
In Alzheimer’s disease, classification and feature selection based on 
structural MRI images is highly popular and multiple algorithms have been 
explored (249, 268). The popularity of such methods led to a global challenge 
for classification of Alzheimer’s using information from T1-weighted structural 
MRI scans (CADDementia 2015 challenge - https://caddementia.grand-
challenge.org/).  
Currently there is no published study looking into classification of T2DM 
patients using MRI data. This could be due to multiple reasons. First of all, 
diabetes is not considered to be a neurological disease, but rather a disease 
with several neurological complications, which are not present in every patient. 
In Alzheimer’s disease, structural and functional changes are prominent and 
consistently seen in the brain. For this reason, structural scans with high 
resolution are heavily used for feature extraction and classification. In T2DM 
though, the pattern is more subtle and depending on the disease stage, 
neurological complications might not be present. The disease’s indistinct 
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pattern is a hindering factor to using such techniques, since it is difficult to 
capture the disease’s spectrum in the typically small samples used for training. 
Additionally, diabetes patients can present with a wide range of microvascular 
complications, which can have their own distinct neurological pattern such as 
retinopathy and neuropathy. Diabetes might be well controlled or non-well 
controlled, the subjects might or might not be on insulin. All these factors 
contribute to complicating the classification process, since the disease’s 
spectrum is broad and the structural abnormalities may or may not exist. 
With the majority of research to-date being focused on using structural 
scans for brain MRI based classification, it does not come as a surprise that the 
neuroimaging field in T2DM is not rife with papers attempting classification of 
T2DM vs healthy controls. 
 
3.5 Theory Summary 
In this, and the previous chapters, the theoretical background of the MR 
imaging modalities used in this study was presented, along with the brain image 
processing and machine learning approaches chosen to analyse the available 
datasets. The condition under investigation, T2DM, and the relevant 
neuroimaging findings have also been presented. ASL was discussed in detail 
and QUASAR ASL, the core modality in this project used for perfusion imaging, 
was introduced. The described brain image processing techniques ranged from 
brain extraction, segmentation and registration to VBM. Finally, the triplet of 
feature extraction, feature selection and classification was introduced and the 
theory of the classifier used in this project, SVM, was discussed. 
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Chapter 4: 
Retrospective cohort - MR protocol - Utilised 
software 
 
The aim of this PhD thesis was to provide a deep insight into the 
changes occurring in the brain of type-2 diabetes patients and in subjects with 
pre-diabetes. The key imaging modality was QUASAR ASL, used for perfusion 
quantification. At the same anatomical level where QUASAR was acquired, T1- 
and T2-weighted scans were conducted to shed light onto structural 
abnormalities. DW images were acquired as a means to detect potential 
changes in the diffusivity of water molecules. A TOF-MRA scan was acquired to 
delineate the whole cerebral vasculature of the subjects and finally PC-MRA 
was used to determine the velocity of the inflowing blood at the level of the 
carotids. The approximate spatial coverage of the considered MRI techniques is 
as in figure 4.1. 
 
Figure 4.1: Approximate anatomical coverage of the utilised MRI protocol 
QUASAR	coverage	
	
MPRAGE,	FLAIR,	
DWI	coverage	
	
TOF-MRA	coverage	
	
PC-MRA	coverage	
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4.1 Available cohort 
Data from 45 subjects (table 4.1) were collected in 2011 as part of the 
“Magnetic Resonance characterisation of Cerebrovascular Disease in type-2 
Diabetes” study. The participants belonged to one of the following groups: 
healthy individuals; individuals with IGT; and T2DM patients who were 
neurologically asymptomatic. Individuals having suffered stroke or other acute 
neurological conditions were excluded from the study. Ethical approval was 
obtained by the NHS South Sheffield Research Ethics Committee (REC 
reference number 06/Q2305/57). All subjects provided written, informed 
consent. The analysis, storage and management of the data was in line with 
this ethical approval. Data were kept at all times in STH and University of 
Sheffield premises and equipment, all files were anonymised before processing. 
 
Table 4.1: Details of the retrospective cohort 
 HV IGT T2DM 
N 16 12 17 
Age (y) 50.0±12.0 54.8±5.3 55.6±12.5 
sex 8♀  8 ♂ 5♀  7 ♂ 8♀  9 ♂ 
BMI (kg/m2) 26.0±34.7 32.3±3.2 31.3±3.7 
Hypertension 
(subjects) 
4 6 7 
Diabetes 
duration (y) 
N/A N/A 10.0±4.4  
HbA1c (%) - - 9.5±1.8 
Microvascular 
complications 
- - 5 neuropathy 
3 retinopathy 
1 nephropathy 
insulin - - 4 
Smoking history 3 ex-smokers 3 ex- 3 current 7 ex – 2 current 
 
 
The sample size for the present study was quite small, hence conclusions 
drawn from the subsequent analysis should be interpreted with caution. This is 
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a preliminary study which will be used as a pilot study to examine subtle 
changes occurring in subjects with pre-diabetes and T2DM without neurological 
or cardiovascular complications. The groups were age matched (p = 0.2), 
however the HV group was on average younger (but not significantly). 
Additionally, the age range was quite large, hence some of the effects that 
might be observed could be attributed to age differences. The ultimate goal of 
this study is to use the pilot results in a larger study population to examine 
whether the observed effects generalise to the T2DM and pre-diabetes 
population. 	
4.2 MR Imaging Protocol 
Imaging was performed at 3T (Achieva 3T, software version 2.1.3.5, 
Philips, Healthcare, Best, NL). Radiofrequency transmission utilised the in-built 
body resonator for all subjects. Radiofrequency reception used an 8-channel 
localised head coil enabling sensitivity encoding (SENSE) methodology when 
appropriate. The magnet gradient system (dual mode Quasar, Philips) had a 
maximum peak amplitude of 80 mT/ m with a slew rate of 100 mT/ m/ ms. The 
superconducting magnet had a 0% liquid helium cryogen boil-off rate. Data 
acquisition was conducted in 2010, five years prior to the commencement of the 
PhD resulting in the present thesis. 
Details of the sequences acquired in the imaging protocol, the reasons 
why they were acquired (i.e. key project contribution) and the methods used to 
analyse those images are provided below: 
 
4.2.1 QUASAR ASL 
 
Key project contribution: Evaluation of multiple perfusion-related parameters. 
Following pilot scans for localization of intracranial anatomy, five 
QUASAR ASL scans were acquired for every individual, one before and four 
after they were subjected to an ACZ pharmacological stress test. After the first 
QUASAR scan the participants were intravenously administered with 1g of ACZ 
(Diamox Sodium parenteral, Wyeth laboratories, Maidenhead, UK) through a 
cannulated antecubital vein while they remained in the scanner over 10 
minutes. Following this step, 4 further consecutive QUASAR scans without a 
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time-gap between them were acquired to evaluate the response of the subjects 
to the hemodynamic vasodilating stimulus.  
The characteristics of the QUASAR acquisition were as follows: 
TR/TE/ΔTI/TI1=4000/23/300/40ms, 13 inversion time-points (40 - 3640ms) 
Matrix = 64x64, 7 slices, in-plane resolution=240x240 (mm2), flip angle (FA) = 
35/11.7°, SENSE factor = 2.5, inversion slab=150mm. 84 averages were 
acquired (48 with Venc = 4cm/s, 24 without crusher gradients and 12 low flip 
angle acquisitions), all implemented in a single sequence (interleaved). The 
duration of every scan was 5min 36s.  The gap between slices was 2mm and 
the thickness of every slice was 6mm. The readout was conducted using single-
shot Look-Locker EPI (147). 
 
Analysed with: Software developed in-house using the Matlab platform 
(described in detail in chapter 5) and the QUASIL ASL tool (154) from FSL. 
QUASAR data from the cohort were analysed in detail in chapter 6. 
 
4.2.2 3D- T1 weighted (MPRAGE) 
 
Key project contribution: Evaluation of brain structure, atrophy and volumetric 
changes. 
A high-resolution 3D magnetization prepared rapid gradient echo 
(MPRAGE) scan was acquired with the following characteristics: TR/TE = 
7.2/3.2ms, FOV= 218.5x240x162 mm3, Matrix = 288x288x180, scan duration 
5min 52s and a FA=8o. 
 
Analysed with: Software developed in-house using the Matlab platform, FSL 
(276, 277), SPM (214) and Freesurfer (203). Detailed description and analysis 
results are presented in chapter 7. 
 
4.2.3 FLAIR 
 
Key project contribution: White matter hyperintensities detection and 
quantification of their number and volume. 
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The parameters for the FLAIR acquisition were as follows: 
TR/TE=11s/120ms, inversion time=2.8s, FOV=230x172.5x141.5mm3, 
matrix=512x512, scan duration 4min 24s, slice thickness=5mm, gap =1.5mm, 
22 slices and FA=90o.  
 
Analysed with: Brain lesion toolbox (238) and textural analysis. Detailed 
results can be found in chapter 7. 
 
4.2.4 PC-MRA 
 
Key project contribution: Measurement of flow and velocity at the level of the 
carotids. 
The parameters for this acquisition were as follows: TR/TE=8/4.39ms, 
FOV=220x178.75 mm2, matrix size=256x256, scan duration 1min 53s, slice 
thickness=5mm, max number of cardiac phases=40, FA=10o and 
Venc=120cm/s along the slice encoding direction. One scan was acquired 
before and one after ACZ injection. The acquisition was optimised for the right 
carotid. 
 
Analysed with: Software developed in-house using the Matlab platform. 
Description of the software and analysis results can be found in chapter 7. 
 
4.2.5 DWI 
 
Key project contribution: Local and global quantification of the apparent 
diffusion coefficient. 
The scanning parameters for the DWI scan were: TR/TE=2667.41/88ms, 
FOV=230x230mm2, matrix=256x256, slices=22, scan duration 50.7s, slice 
gap=1mm, slice thickness=5mm, FA=90o, at b-values of 0 and 1000 s/mm2, 
number of diffusion orients: 3. 
 
Analysed with: Software developed in-house using the Matlab platform. 
Results can be found in chapter 7. 
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4.2.6 TOF-MRA 
 
Key project contribution: Evaluation of the cerebral vasculature. 
The parameters of the TOF-MRA scan were set as follows 
TR/TE=25/3.45ms, FOV=210x199.5x111mm3, matrix size= 512x512, 
slices=222, slice thickness=1mm, scan duration 6min 55s and FA=20o.  
 
Analysed with: Software developed in-house using the Matlab platform. Details 
about the software tools and analysis results are in chapter 7. 
 
4.3 Overview of utilised software tools 
Processing took place using a MacPro under OS X (Apple, Inc., 
Cupertino, California, US). Images were exported from the scanner in 
.PAR/.REC  format (Philips Healthcare, Best, NL). 
Software tools were built on the Matlab 2016a platform (The MathWorks, 
Inc., Natick, Massachusetts, US) for all the aforementioned modalities. 
Wherever applicable the results were compared with those obtained with other 
post-processing tools. The Matlab toolboxes used in this thesis were: fuzzy 
logic toolbox, image processing toolbox, statistics and mathematics toolbox and 
LibSVM (278). Additional downloaded functions from third parties found on the 
Matlab file exchange were: fuzzy c-means clustering (279) used for image 
segmentation, SVM-RFE (280) used for feature ranking, registration toolbox 
(281) used for all registration steps implemented in Matlab and Frangi’s 
vesselness filter (282) used for segmentation of the acquired angiogram. 
ITK SNAP (283) was used to generate an affine transformation to be 
used for normalization to the Montreal Neurological Institute (MNI) space. The 
MNI map used was the 2mm smoothed map (91x109x91 voxels) based on 152 
individuals. The transform was implemented using the convert3D tool provided 
as part of the ITK-SNAP toolkit. 
Software tools utilised throughout the thesis apart from Matlab were: 
advanced normalization toolbox (ANTs) (208, 218) for registration and bias field 
correction purposes, ITK-SNAP for registration and FSL, Freesurfer and SPM 
for analysis of the MPRAGE scan. A more detailed description of the specific 
tools used from FSL, Freesurfer and SPM can be found in the associated 
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chapters where they are explained as part of the methodology. For statistical 
comparisons either Matlab or SPSS (IBM Corp. Released 2017. IBM SPSS 
Statistics for Mac, v. 25, Armonk, NY: IBM Corp) were used.	  
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Chapter 5: 
Developments in brain perfusion image 
processing 	
Abstract 
Cerebral perfusion evaluation using QUASAR ASL has had limited 
clinical uptake due to the technique’s low SNR, image artifacts and non-trivial 
quantification of blood flow. The aim of this part of the study was to improve the 
QUASAR processing pipeline by introducing three modifications: weighted AIF 
assignment, AIF re-evaluation and artifact detection. Additionally, we evaluated 
approaches for PVC using linear regression based on both high and low-
resolution T1-weighted data. Changes were evaluated using the model-free 
QUASAR ASL variant whereby determination of the CBF relies on 
deconvolution of the tissue and arterial signals rather than on fitting the signals 
to well-defined curves. 
In this Chapter, a k-radius AIF weighting method is introduced, where 
AIFs are assigned to every voxel based on a weighted average of neighboring 
AIFs within a sphere of radius k. The AIF re-evaluation step relies on an initial 
CBF calculation used to determine and exclude from the AIF assignment step 
voxels with unrealistic CBF values. A technique based on edge detection on the 
ASL difference images was built for artifact detection. Simulated and in-vivo 
data (twelve healthy subjects) were used to evaluate the methods. CBF from 
the in-vivo data was compared to values obtained using available QUASAR 
processing software. Additionally, CBF values were calculated by creating 
pseudo-single time-point pulsed ASL experiments for every time-point to 
evaluate inter-subject variability in the timing of the perfusion peak.  
Simulations indicated that k-radius AIF weighting results in accurate GM 
CBF estimates with lower mean absolute percentage errors for voxels with high 
GM content, especially in the presence of hyper/hypo intense regions which are 
typically present in pathology (e.g. stroke). The QUASAR artifact detection 
algorithm effectively identified a water-fat shift artifact in simulated and in-vivo 
data. PV maps generated based on a combination of PV estimates from high 
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and low-resolution data demonstrated good performance in terms of variance 
and structural similarity to QUASAR-T1 maps. The CBF values obtained for the 
examined subjects were physiologically realistic when using the developed 
pipeline, which also demonstrated a lower inter-subject coefficient of variation in 
GM CBF estimation when compared to existing analysis software. Variation in 
the timing of the perfusion peak was observed in this healthy cohort, suggesting 
that due to transit time variability, in general, multi-PLD approaches might be 
beneficial for accurate perfusion quantification.  
The novel model-free QUASAR processing pipeline described in this 
chapter produced realistic perfusion values with reduced variance and provided 
an effective mechanism for artifact detection. These improvements can be 
targeted toward enhancing the applicability of the QUASAR method to clinical 
studies. 
 
5.1 Introduction 
Cerebral perfusion relates to nutrient and oxygen delivery to brain tissue 
by the bloodstream and can be measured using a medical imaging technique 
such as ASL MRI (82). Multiple ASL variants have been devised and can be 
grouped in different categories using criteria such as the labeling technique, the 
read-out method and the PLD. In 2015 the ISMRM Perfusion Study Group 
recommended the use of a particular ASL implementation, that of pCASL (284) 
with a single PLD, along with the preferred readout schemes (108). The 
advantages of this method included relatively high SNR, simplicity in 
implementation and sequence availability. 
One disadvantage of the proposed pCASL scheme is its sensitivity to 
ATT variations. ATT is an important factor to be considered when CBF is 
quantified, since in aging or neurodegenerative conditions, an increase in ATT 
can result in erroneous perfusion estimates when single-PLD approaches are 
used (121, 122). A promising multi-PLD approach termed time-encoded ASL is 
based on adding multiple labeling/control sub-boli within the previously ‘empty’ 
PLD of pCASL. The distribution of these boli is based on a Hadamard-encoded 
matrix (150, 285). One of the early multi-time-point ASL techniques that 
overcame the single-PLD limitation by acquiring images at multiple inversion 
times (TI) is QUASAR ASL. This pulsed ASL technique, combines vascular 
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signal crusher gradients with a Look-Locker EPI read-out strategy (146, 155). 
Its reproducibility has been validated in a multi-center study (161). 
 The Look-Locker read-out involves small flip angle excitations allowing 
for rapid read-out in multiple time-points (147). Sampling of the recovering 
magnetization at multiple time-points (13 for the regular QUASAR 
implementation) allows for signals rather than single data-points to be acquired. 
Hence the term ‘signal’ in the rest of the chapter, when used, will refer to the 
evolution of the measurement under consideration (e.g. tissue signal) during the 
acquired 13 time-points at a voxel-wise level.  Vascular crushing is achieved by 
applying gradients of the same magnitude and inverse polarity to suppress 
signal from fast moving spins exceeding a certain velocity threshold.  
Perfusion evaluation using QUASAR ASL can be a cumbersome task 
due to the technique’s relatively low SNR and non-trivial quantification. The goal 
of this part of the thesis was to improve the QUASAR model-free processing 
pipeline by introducing and evaluating a number of modifications. Several parts 
within the pipeline lend themselves to optimization. We have focused on the AIF 
assignment strategy, detection of a water-shift artifact and partial volume 
correction. A strategic choice was made to avoid techniques that might 
introduce bias in the processing by means of model fitting and introduction of 
normality assumptions, since the pipeline is to be used in a non-healthy cohort. 
One of the advantages of QUASAR is that based on the difference signal 
between non-crushed and crushed acquisitions, multiple local AIFs can be 
identified. AIFs are typically determined in voxels with aBV exceeding 1.2%. 
Alternative approaches for AIF determination are their statistical reduction using 
factor analysis of dynamic studies (FADS) (163) and de-noising by fitting the 
arterial signal to a gamma-variate function (154). The common characteristic of 
these methods is that a single input function is assigned to every voxel by 
means of its closest neighboring AIF. A weighted approach accounting for noisy 
AIFs and the possibility of multiple inputs from more than one source has not 
yet been evaluated. Such an approach could be of great importance where, for 
example, disease-related topological changes in blood supply, for example 
Moya-Moya disease (286), may exist. 
Caveats associated with QUASAR ASL often relate to low SNR (a 
generalised ASL issue), a relatively large voxel size leading to PVE (240) and 
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acquisition-related artifacts. One such artifact that has been alluded to in 
several studies has been described as resulting from a ‘water-fat’ interface shift 
(106, 168). This effect can be cancelled during control-labeled subtraction; 
however, potential imperfect anatomical alignment between the experiments 
may result in non-physiological hyper- or hypo- intense regions in calculated 
CBF maps. Currently the mitigation technique to avoid potential impact of this is 
to exclude hyper-intense voxels from the analysis following CBF quantification. 
However, this approach does not ensure artifactual voxels are not used to 
determine AIFs and they may hence influence CBF values in neighboring 
voxels. 
Choosing a technique for PVC for the QUASAR data requires a decision 
over whether the PV estimates will be extracted from a high resolution T1-
weighted scan or directly from ASL data. The first approach requires 
segmentation of a high-resolution T1 scan, down-sampling and registration to 
the ASL data (240, 241). Considerations pertinent to this approach are the 
imperfect registration and the difference in point spread functions between the 
different scans (242). An alternative approach, FRASIER (FRActional Signal 
mapping from InvErsion Recovery), seeks to determine the tissue content of 
every voxel based on the QUASAR data. This is feasible by expressing the 
signal in every voxel as a linear combination of the signals arising from three 
different compartments- GM, WM and CSF (243, 244). The advantage of this 
technique is that it does not require registration; however it utilises low SNR 
data and hence it is susceptible to noise. When opting for a technique based on 
a high resolution scan, two of the most popular approaches are linear 
regression (240) and an approach based on spatially adaptive priors used in a 
Bayesian context (241).  
The developed pipeline described in detail in this chapter was 
constructed with a view to improving the model-free CBF quantification 
procedure. This new pipeline was validated using both simulated and in-vivo 
data and was compared with existing processing software.  
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5.2 Post-acquisition QUASAR ASL processing strategy 
 
5.2.1 Noisy scan rejection 
The acquired ASL data can be separated into six groups: high FA 
crushed control (24); high FA crushed labelled (24); high FA non-crushed 
control (12); high FA non-crushed labelled (12); low FA control (6); and low FA 
labelled (6). For every acquisition in each group, 13 time-points were acquired. 
In order to account for excessive motion, an algorithm for rejection of pairs of 
control-labelled images evidencing excessive motion was implemented 
following Knutsson et al. (163). Labelled images were subtracted from their 
controls and a mean image was generated. An artifact level was calculated for 
every pair of images by measuring the absolute difference from the mean 
image and summing up the values for every voxel. If the result exceeded the 
mean artifact level by more than one standard deviation, then the pair of images 
was rejected. Average images were generated for every acquisition, for every 
slice and every time-point.  
For the generation of brain masks, every slice’s histogram was 
thresholded using Otsu thresholding (287) and minor morphological operations 
(dilation, image filling) were carried out. The mask was manually corrected 
when not visually optimal. Following brain masking, a registration step was 
added to the processing pipeline to account for subject motion between the 
numerous QUASAR acquisitions. Every 2D image was registered using rigid 
registration to the first non-crushed control acquisition of each experiment using 
the Matlab registration function part of the Image Processing Toolbox. This 
procedure took place for every time-point. New average images were generated 
after registration and were used for the subsequent analysis.  
 
5.2.2 Tissue relaxation and magnetization quantification 
Effective values for tissue relaxation time, T1t (T1t,eff) and tissue 
equilibrium magnetization,  M0t (M0teff) were calculated by means of fitting to a 
saturation recovery curve (equation 5.1). The fitting procedure takes place for 
both the low (φn,low) and high (φn,high) flip angle data (155).  
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𝑆(𝑡) = 𝑀0𝑡jËË Ì1 − 𝐴 ∗ 𝑒& Z+NZ,jËËÍ		[5.1] 
The method used for the fitting was mean square error fit. The effective 
values are lower than the actual T1t and M0t, an effect attributed to signal 
reduction due to the application of small flip angle excitations as part of the 
Look-Locker EPI acquisition. The connection between the effective and actual 
values is as in equations 5.2 & 5.3. 
𝑀0𝑡jËË = lima→W𝑀:[𝑛] = 𝑀0𝑡 ∗ L1 − 𝑒&+Ï+NZ 	O1 − cos(𝜑) 𝑒&+Ï+NZ 				[5.2]		 
1𝑇1𝑡jËË = 1𝑇1𝑡 − ln(cos(𝜑))𝛥𝑇𝐼 						[5.3] 
Where φ is the actual flip angle and ΔΤΙ is the time between excitations. 
 The true relaxation time of the tissue is not dependent on the applied flip 
angle, hence an angle correction factor (g) incorporating the effects of field 
inhomogeneities can be calculated by minimizing the expression in equation 5.4 
(160) which is based on minimizing the difference between the true relaxation 
times calculated for both applied flip angles based on equation 5.3.  
1𝑇1𝑡jËËgÒ − 1𝑇1𝑡jËËÓ`Ó	 + ln Ì 𝑐𝑜𝑠(𝜑agÒ 	∗ 𝑔)𝑐𝑜𝑠s𝜑aÓ`Ó 		∗ 𝑔tÍ			[5.4] 
In order to minimize this expression, g values from 0 to 1 with a step of 
0.01 were evaluated and the one minimizing the equation was selected. When 
there was more than one such value, the average was taken into account. 
Having determined the angle correction factor at a voxel-wise level, it was 
feasible to calculate the actual values (accounting for the actual and not the 
nominal flip angle) for T1t and M0t by using equations 5.2 & 5.3.  
5.2.3 Arterial transit time calculation  
Arterial transit time can be evaluated by measuring the time interval 
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during which the tracer traveled from the site of the arterial input to the 
microvasculature. This calculation is feasible by identifying the arrival time of 
the signal in the tissue (τm) and subtracting from it the time of arrival in the 
arterial input (τα). The arterial and tissue signals were defined at a voxel-wise 
level based on the 13 inversion time-points. One suggested method to quantify 
τm and τα is to identify the rising edge of the signals by using Canny edge 
detection (155). The method applies convolution of the initial signal (tissue or 
arterial) with a Gaussian function to account for the noisy high frequency 
components. Subsequently Canny filter, which is capable of localizing the 
position of edges with great accuracy is used (288).  
In the present thesis localization of the rising edge of the tissue and 
arterial signals was conducted as follows: The signals were linearly 
interpolated. The peaks of the signals were identified and moving backwards in 
time the time-point at which the 30% of the maximum value of the signal was 
reached was determined. This procedure was implemented for every image 
voxel and voxel-wise estimates of τm and τα were extracted. Arterial Transit 
Time (ATT) was calculated using: ATT = τm - τα. 
 
5.2.4 Arterial blood volume and arterial input function calculation 
Arterial blood volume is modelled as the area underneath the curve 
formed by the subtraction of the crushed (ΔΜcr) from the non-crushed (ΔΜncr) 
signal, multiplied with an exponential factor to account for T1t relaxation of the 
blood and divided by the theoretical bolus area (equation 5.5).  
aBV = ∫ s×ØÙÚÛ(Ü)&×ØÚÛ(Ü)tÝ ÞßàáâÜãäã E∗åBæ∗çè∗æ∗ªéêÙ ë 							[5.5],   
• T1a Longitudinal arterial blood relaxation time   
• τb temporal length of the bolus  
• α inversion efficiency and  
n = floor(τ¥ − τî)ΔΤΙ 	[5.6] 
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The term cosnφ is used to account for incomplete renewal of the arterial 
blood between different acquisitions (289) and n is calculated based on 
equation 5.6. M0α can either be measured in a voxel filled with blood usually in 
the sagittal sinus (290), or it can be mapped as follows: M0α = M0t / λ, where λ 
is the blood-brain partition coefficient. 
Given the arterial blood volume (aBV), voxels with aBV of more than 
1.2% (as suggested by Petersen et al. (155)) can be used as candidate voxels 
to calculate regional AIFs by using equation 5.7. In published QUASAR papers, 
an AIF is assigned to every tissue voxel by means of its closest rAIF voxel. If 
more than one AIF is at the same distance then their average is used (155). 
𝐴𝐼𝐹(𝑡) = s𝛥𝑀aòe(𝑡) − 𝛥𝛭òe(𝑡)t𝑒 Z+Nd𝑎𝐵𝑉 ∗ 𝑒&Zó(oô&	oõ)+Nd 	[5.7] 
Another suggested approach relying on a model-based post-processing 
identifies candidate voxels using the same 1.2% threshold by fitting the arterial 
signal with a gamma variate function and choosing the voxels for which the 
peak amplitude of the fitted signal scaled by M0α exceeds 1.2% (154) or by 
using a statistical method (FADS) for reduction of the available AIFs (106). 
k-radius AIF weighting 
Typically, the closest AIF (or average if more than one) is assigned to 
every voxel. In this chapter, a novel method for AIF assignment termed, ‘k-
radius AIF weighting’, is introduced. The rationale behind this method is that 
AIFs are assigned to every voxel using a weighted average of a varying number 
of neighboring candidate AIFs situated within a certain radius of the voxel of 
interest (figure 5.1). The distances (radii) considered for each AIF component 
were as follows: the reference distance (d) was that of the closest neighboring 
AIF(s) (k = 1) following the conventional QUASAR AIF assignment approach. 
For increasing k, the considered radius was calculated as in equation 5.8. 
Hence for k = 1, this approach is the same as for the regular QUASAR 
processing. 𝑟𝑎𝑑(𝑘) = 𝑑 + (𝑘 − 1) ∗ 1.5									[5.8] 
where k = 1…N and rad(N) is the maximum radius considered which in the 
following simulations was N=6. The weight (w) assigned to each of the 
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component AIFs was given by wk = 1 / rad(k)3, and thus depended on their 
distance from the voxel of interest within the sphere of radius rad(k). The AIF 
assigned to each voxel was a weighted average of the neighbor component 
AIFs (equation 5.9). All distances were calculated between the voxel centers 
and rad(k) distance was measured in voxels rather than in mm.   
𝐴𝐼𝐹(𝑡) = ∑ (𝑤) ∗ ∑ 𝐴𝐼𝐹Ç)ö())Ç«N÷)«N 	∑ (𝑤) ∗ 𝑀(𝑘)÷)«N ) 											[5.9] 
Where M(k) is the number of identified AIFs at each considered radius, k. 
The resulting CBF was then quantified using a model-free approach 
(155). The deconvolution method used was singular value decomposition with 
an oscillatory index of 0.15 (oSVD) and was based on the implementation by 
Ahlgren et al.  (291). 
 
Figure 5.1: AIF weighting approach. The candidate AIFs situated within a sphere of a certain 
radius k are assigned a weight based on their distance from a voxel of interest. The procedure 
takes place in 3D but 2D slices are shown for simplicity. 
AIF re-evaluation 
Following CBF quantification it was noticed in some cases that several 
voxels had non-physiological CBF values, either extremely small positive (CBF 
< 5 ml/ 100g/ min) or negative, or excessively large (CBF > 150 ml/ 100g/ min). 
To account for the fact that these potentially noisy voxels might have been used 
as voxels for AIF determination, an ‘AIF re-evaluation’ step was added to the 
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pipeline. During this step, the voxels with non-physiological values that were 
used as for AIF determination were identified and the whole AIF assignment 
and CBF quantification step was re-run without them. This procedure was run a 
single time to avoid excessive regularization but has the potential to be applied 
numerous times.  
Following re-evaluation, voxels exceeding the chosen CBF thresholds 
were masked out in the end of the procedure. It is worth mentioning that mean 
normal values for GM CBF and WM CBF are considered 60 ml/ 100g/ min and 
20 ml/ 100g/ min respectively (241). Currently there is no mitigation technique 
for this effect. The typical approach is to threshold the final calculated CBF map 
with a threshold between 120-150 ml/ 100g/ min; this approach does not 
address the fact that even for the typical QUASAR quantification with k = 1, 
these noisy AIFs might have been used for AIF assignment thus impacting 
directly the whole area around them. Potential inclusion of voxels with 
artifactually high CBF values in perfusion quantification would imply over-
estimation of both GM and WM CBF values. Especially in a small cohort such 
as the one utilized in the present study this effect could directly impact on the 
drawn conclusion following estimation of perfusion in every considered group. 
Hence, it is of utmost importance to account for these artefactual voxels as 
early as possible in the analysis pipeline to reassure that they do not influence 
neither their local neighborhood nor the final estimated CBF values. 
 
5.2.5 Residue function and CBF estimation 
The residue function (R) and from this the CBF (f) can be calculated by 
means of deconvolution. SVD is an algebraic solution to the deconvolution 
problem, which can be used since the signal is discrete, so the deconvolution 
problem is reduced to a matrix problem (equation 5.10). In matrix formation, ΔM 
(which when both crushed and non-crushed data are acquired is typically the 
crushed acquisition - ΔΜcr) and the residue function acquire the form of vectors 
having as elements their values for every time-point. 
𝚫𝚳 = 𝐟 ∗ 𝐀𝐈𝐅 ∗ 𝐑			[5.10] 
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With the AIF matrix comprising weighted elements as in equation 5.11, in 
order to reduce noise (292).  
𝑎`,Ç = ÿ16 ∗ (𝛥𝑇𝐼(𝐴𝐼𝐹(𝑡`&Ç&N) + 4𝐴𝐼𝐹s𝑡`&Çt + 𝐴𝐼𝐹(𝑡`&ÇóN	))	, 0 ≤ 𝑗 ≤ 𝑖0		,																																																																																𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒 	[5.11] 
A block-circulant matrix can be constructed for every voxel to account for 
potential lag of the arterial signal compared to the tissue signal and can be used 
for circular SVD deconvolution. The square matrix dimensions (L*L) must be at 
least double the size of the initial AIF matrix (in order to meet the criteria of the 
Nyquist limit). The elements of the new matrix (B) are equal to the elements of 
the initial AIF matrix for j < I; for j > i the matrix lines are shifted one position to 
the right each time, resulting in a new matrix B (292). In order to calculate the 
residue function, the inverse of the B matrix needs to be found. If the B matrix is 
non-singular, there exists an SVD decomposition of the matrix (B = U*S*VT). If 
the matrix is singular, then the SVD algorithm returns the closest decomposition 
possible in a least-square sense (293). In SVD it is a common approach to 
threshold the diagonal elements of the W matrix (W = 1/S) to account for high 
frequency noise. This truncation is thought to underestimate the calculated CBF 
result (153). The scaled residue function can be calculated as follows (equation 
5.12): 
𝐑 = 	𝐕 ∗𝐖 ∗ 𝐔𝐓 ∗ 𝚫𝚳𝐳𝐩 [5.12]   
where ΔΜzp is the ΔΜ signal zero-padded to length L.                        
Circular deconvolution can be modified to account for the excessive 
oscillations, attributed to high frequency noise by using an oscillatory index (OI) 
(equation 5.13) (292).  
OI = 1L ∗ 1max	(R) ∗¡ |	R(k) − 2R(k− 1) + R(k− 2)|	[5.13]-&N¯«E  
For the present implementation, a block-circulant matrix was constructed 
for every voxel. The matrix had double the size of the AIF matrix moving from 
an initial size of 13*13 (for the 13 time-points comprising the AIF discrete signal) 
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to a size of 26*26. The tissue signal was zero-padded at a length of N=26. To 
account for excessive oscillations, a threshold was used for the eigenvalues of 
the diagonal matrix (S) emerging from the SVD decomposition. The starting 
value for the threshold was 20% of the maximum eigenvalue. Any value lower 
than that was zeroed. The OI was calculated again after zeroing; if it was higher 
than OI = 0.15 then the threshold value was increased by 1%. This step was 
repeated until the calculated OI had a value below the permitted 0.15.  
5.2.6 Artifact detection 
In several QUASAR ASL images the presence of an artifact was noticed 
as in figure 5.2A. A similar artifact has been reported in the literature as a 
‘chemical water-fat’ shift artifact (106). The existence of such an artifact can be 
attributed to absence of fat suppression pulses in the QUASAR pulse 
sequence. Potential inclusion of such pulses would require a longer and more 
complicated preparation scheme with an increased inversion time, which would 
end up in further attenuation of the signal and SNR reduction. Additionally, a 
separate background suppression scheme as instructed by the ASL consortium 
is not applied in QUASAR, however, the applied low flip angles compensate for 
this effect. 
By examining the QUASAR .PAR/REC files there appears to be a 
displacement between the water and the fat of 12-13 pixels in the phase 
encoding direction. In QUASAR ASL background suppression and fat 
suppression pulses are not used, to reduce the complexity of the acquisitions. 
The absence of such pulses is a potential confound to the artifact. A method 
described in QUASAR literature to compensate for its presence, is to exclude 
from the analysis voxels with values more than three times the average value of 
CBF (106, 168). However, this approach does not correct for the fact that some 
of these voxels might have been used for the calculation of regional AIFs.  
A new approach is presented in this chapter to compensate for the 
artifact. An algorithm was built to localize its position (figure 5.2). Initially, the 
crushed data were subtracted from the non-crushed data, giving rise to images 
whereby the arterial signal is brightened. The gradient magnitude image which 
highlights the regions with a sudden change in the intensity pattern of the 
resultant difference image was calculated and multiplied with the initial ΔΜncr-
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ΔΜcr image to amplify the effect of the edges. The result was squared for further 
effect amplification. This manipulation resulted in the artifactual voxels being 
brighter than the non-artifactual ones (figure 5.2A). As a result, a threshold 
could be used in the image to separate the artifact (figure 5.2B). This approach 
was run for every time-point, hence the application of the algorithm resulted in 
13 separate masks (one per time-point).  
It was noticed that some of the voxels were not influenced by the artifact 
in every time-point so the masks differed. The developed technique used a 
weighting approach allowing a maximum of three time-points to be influenced 
by the artifact. Weighting also accounted for the arterial bolus arrival (voxels 
exceeding the defined threshold at the 2nd and 3rd time-points when the 
intravascular signal will be at its peak had to be identified in at least 7 time-
points as being artifactual) and attenuation of the labeling effect (at the 13th 
time-point the inverted magnetization is expected to be fully recovered so all 
voxels exceeding the threshold at this time-point were considered artefactual 
even if they were not picked by the algorithm in earlier time-points). The 
resultant masks for every time-point, were weighted and summed up giving rise 
to an image as in figure 5.2C (middle). Voxels with a lower resultant weight 
were more likely to be artifactual. For their exclusion, a threshold was applied 
yielding an inclusive mask to define non-artifactual voxels. This mask was 
applied to every time-point and to both crushed and non-crushed data. The 
optimal threshold used was based on the results obtained by simulations (see 
section 5.2.10 case 3). Optimal thresholds ranged from a value of 3 (more 
relaxed criterion) to a value of 9 (stricter criterion). 
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Figure 5.2: Artifact detection and rejection methodology. (A) The artifact is apparent in the 
D=ΔΜncr-ΔΜcr difference image. D is multiplied by its gradient magnitude and then squared.  A 
threshold identifies voxels with excessive values.  (B) This procedure runs for all 13 time-points 
in every slice. Artifactual voxels in every iteration are assigned a value of 0. (C) After all 13 time-
points are considered for each slice, the masks are summed. A voxel which never exceeds the 
threshold, is allocated a value of 13; a voxel identified as artifactual each time has a value of 
zero. At this point a weighting is implemented followed by thresholding. 	
5.2.7 Partial Volume Correction 
The main cause of partial volume effects in ASL is the large voxel size 
used to account for the inherently low SNR of the technique. The extent of the 
problem can be grasped if one compares the voxel of a high-resolution T1 scan 
and an ASL voxel (QUASAR in this case) (figure 5.3). An ASL voxel is highly 
unlikely to contain only one tissue type and more likely to contain a combination 
of GM/WM, GM/CSF, or GM/WM/CSF. If the issue is left unaddressed then GM 
CBF might be greatly underestimated. In this study, the primary utilised PVC 
technique was the Asllani, Borogovac (240). In its regular implementation, this 
approach makes use of PV estimates extracted from a high resolution T1-scan 
to correct for PVE.  
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Figure 5.3: Partial volume effects in one Quasar voxel with respect to a 256*256 structural 
image. A QUASAR voxel can fit 112 voxels emerging from a high-resolution structural scan. For 
simplicity voxels emerging from the structural are depicted free of PVE. 
The linear regression method works as follows: The ΔMcr signal can be 
modelled as having only two components: a component attributed to GM and a 
component attributed to WM, omitting inclusion of the arterial vascular signal. 
The contribution of CSF was considered as negligible (241, 243). PVC was 
implemented to the CBF maps (equation 5.14). In its original implementation 
the method was implemented in the ΔΜ data, however it has been shown that it 
can be directly implemented in the final CBF images (243).  
CBF0é»Ý1 = PV3å ∗ CBF3å + PV4å ∗ CBF4å	[5.14] 
In PVC with linear regression, tissue specific CBF is considered to be 
stable in a certain pixel window. In matrix formation the expression takes the 
form: 𝐂𝐁𝐅𝐧𝐞𝐢_𝐯𝐨𝐱𝐞𝐥 = 𝐏𝐕𝐧𝐞𝐢_𝐭𝐢𝐬𝐬𝐮𝐞 ∗ 𝐂𝐁𝐅𝐭𝐢𝐬𝐬𝐮𝐞	[5.15] 
 
Where CBFnei_voxel is a vector comprised the CBF values in the defined 
kernel, the PVnei_tissue matrix has a size of 2*nei (nei is the number of 
neighbouring voxels, 2 tissue types) and comprises the tissue specific PV 
values for every voxel and CBFtissue is a vector containing CBFGM and CBFWM, 
stable quantities inside this kernel. PV values range from 0 to 1 and indicate the 
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volume of the voxel covered by a certain tissue type (1 for 100%). By 
determining the pseudo-inverse matrix of PVnei_tissue it is feasible to calculate 
CBF in the two different tissue types over the neighborhood for which the CBF 
values for the two tissue types are considered as stable (equation 5.16).  CBFÜ£êêCÝ = sPVºÝ£_Ü£êêCÝD PVºÝ£_Ü£êêCÝt&NPVºÝ£_Ü£êêCÝD ∗ CBFºÝ£EFGHI 		[5.16] 
 
Ahlgren et al. (243) have compared PVC results based on PV estimates 
extracted from the ASL data (FRASIER) and PV estimates from a 3D T1-
weighted scan. They have shown that the partial volume corrected GM CBF 
map generated based on the high-resolution scan tends to be less 
homogeneous, a factor they attributed to mis-registration between the high and 
the low-resolution scan.  
In this chapter, we have looked into both techniques for PV estimate 
extraction and also evaluated two ‘hybrid’ methods combining both the high and 
the low resolution extracted PV estimates. PVC was implemented directly on 
the CBF maps (240, 243). Overall, four variants were evaluated for the 
determination of the final PV maps. 
For variant 1, partial volume maps were generated from the MPRAGE 
image using SFCM clustering (232). This unsupervised algorithm does not 
require priors and does not make assumptions about the distribution of the T1 
relaxation times. For PVC based on MPRAGE-derived estimates, the adopted 
PVC pipeline comprised:  
1. N4 bias field correction of MPRAGE images. 
2. Identification of overlapping QUASAR and MPRAGE slices, as 
described in Section 5.2.8 (approximately 7 MPRAGE slices 
extracted in the transaxial plane overlap with each QUASAR 
slice). 
3. SFCM clustering (5x5 window) in the stack of T1-weighted data 
with the same anatomical coverage as the QUASAR slices. 
4. For every QUASAR slice, averaging of the respective MPRAGE, 
GM and WM PV maps. 
5. Down-sampling of the averaged PV and MPRAGE-T1 maps to the 
QUASAR spatial resolution. 
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6. 2D registration of the resultant low resolution MPRAGE-T1 to the 
QUASAR anatomical-1/T1 maps using affine transformation with a 
normalized cross-correlation cost function.  
7. Registration of the PV maps to the QUASAR anatomical-T1 maps, 
using the previously generated affine transformation matrix 
(variant 1). 
For the generation of PV maps using the ASL data (variant 2) the 
FRASIER method (243) was used. In this method Gaussian distributions are 
fitted to the QUASAR-derived T1 image histogram and the T1 of GM and WM 
are extracted. In the suggested implementation, due to the difficulty to detect 
the CSF peak in the histogram, a fixed value is used (T1CSF = 4.3s). 
Subsequently the signal in every voxel is expressed as a linear combination of 
the signal attributed to a certain tissue type and the tissue content. Hence, the 
tissue content of every voxel can be determined by solving a least square 
estimation problem (243, 294). 
More specifically, the recorded ASL signal attributed to all components 
can be written as: S(t) =¡[fê,£Mêê,£(1 − Ae& ÜDNHNN,O£ )]	[5.17] 
where 
Mêê,£ = 1 − e×PQDNO1 − cosφe×PQPNS 			[5.18] 
In matrix formation S = X*Fs where Fs is the CBF vector for every tissue 
and X is the signal without it being scaled with the CBF for every tissue. It is, 
hence, feasible to solve for the fractional values as follows using the pseudo-
inverse: Fs = (XTX)-1XTS. 
The third and fourth evaluated PVC variants in this study were hybrid 
methods combining FRASIER and MPRAGE-derived estimates. In the first of 
these two, the FRASIER estimates were used as a reference image for more 
accurate registration of the down-sampled MPRAGE estimates due to their 
similarity in contrast and measured information (variant 3). In the second, a 
mean PV estimate between variant 2 and variant 3 was constructed (variant 4).   
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In all approaches, the concept of the pseudo-inverse matrix instead of 
the inverse was used. The pseudo-inverse is typically used to calculate the best 
solution of a linear system of equations, in a least square sense, in cases where 
the system lacks a solution or when the optimal between multiple solutions 
needs to be determined (by choosing the one with the minimum Euclidean 
norm) (295). 
 
5.2.8 Correction for scan alignment and identification of overlapping 
slices 
The angulation between the slices and the reference axes of the scanner 
was different between the QUASAR and the MPRAGE scans for every subject. 
This misalignment was a result of the QUASAR labelling and acquisition 
strategy. Labelling took place based on the maximum intensity projection of the 
acquired cerebral angiogram so that it would be perpendicular to the flow. 
In order to account for that, the MPRAGE image was rotated into the 
same orientation as the QUASAR scan as a rotation to the reference 
coordinates would require a rotation of the QUASAR scan as well. The latter 
comprises of 7 slices with gaps between them, so interpolation would introduce 
significant re-sampling errors. As a result of rotation, the initial MPRAGE axial 
resolution changed from 288*180 pixels to a patient-specific value. The 
resulting images were resampled to 256*256 in-plane resolution to facilitate the 
PVC step. Downsampling to the 64*64 QUASAR in-plane resolution was 
applied by averaging over 4*4 voxel regions. 
The requirement for automated processing, requires that the equivalent 
anatomical slices to the low-resolution QUASAR slices are identified by an 
algorithm without manual intervention. The developed algorithm chose the 
slices for which the difference in the z-axis (head-foot) values between the two 
scans with respect to the initial coordinates was minimized. Subsequently 
based on these slices, the algorithm identified the overlapping QUASAR and 
MPRAGE slices based on the thickness of QUASAR slices. The anatomical 
slices overlapping spatially with the QUASAR slices were subsequently 
averaged. The similarity between the average slices and the R (1/T1t) QUASAR 
maps was visually assessed. In case the slices were not visually identical an 
offset was added or subtracted from the MPRAGE off-centre distance.  
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5.2.9 Brain-blood partition coefficient (λ) 
Having calculated fractional volume maps, it was possible to account for 
the different values of the brain blood partition coefficient for GM and WM. The 
PV values in every voxel needed to be scaled for the amount of WM and GM 
present to avoid underestimation of the λ value due to the presence of CSF. 
The blood-brain partition coefficient was calculated by equation 5.19. 
𝜆igUj = 𝑃𝑉Vö𝑃𝑉Vö + 𝑃𝑉Wö ∗ 𝜆Vö + 𝑃𝑉Wö𝑃𝑉Vö + 𝑃𝑉Wö ∗ 𝜆Wö	[5.19] 
5.2.10 Simulated data 
Every voxel can be approximated as a simplified system having an AIF 
as an input and the measured magnetization difference signal (ΔM) as an 
output. The system’s response is defined as R(t) = r(t)*m(t), where r(t) is the 
residue function and m(t) is the magnetization relaxation function. This system 
can be described using the general kinetic model (equation 5.20). 
 ΔΜ(t) = 2M0Ãa ∗ CBF ∗ AIF(t)⨂r(t) ∗ m(t)								[5.20] 
With AIF(t), r(t) and m(t) as described by equations 5.21-5.22. 
 AIF(t) = Yαe& ÜDàè				, Δt < t < Δt+ τ				[5.21]0,																		elsewhere  		r(t) = e&[\] Ü^ 																	m(t) = e& ÜDNHNN 	[5.22] 
 
By substituting AIF(t), r(t) and m(t) in equation 5.20 and solving the 
convolution integral, the crushed simulated signal is modeled as: 
 
ΔΜª_(t) = ⎩⎪⎨
⎪⎧ 																																0																																													,					t < τæ__2aM0ÃCBFe&Ü∗dáeese&çáÛÛ×d − e&Ü×dtΔR 	,					τæ__ < t < τæ__ + τÃ	2aM0ÃCBFe&Ü∗dáeese&çáÛÛ×d − e&(çèóçáÛÛ)×dtΔR ,				t > τæ__ + τÃ
	[5.23] 
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Where M0b is the blood equilibrium magnetization, α is the inversion 
efficiency, Ræ¶¶ = NDNÜ + [\]^ , ΔR = NDNÃ − Ræ¶¶ , T1t and T1b are the T1 of the 
tissue and blood respectively, λ is the blood-brain partition coefficient, τarr is the 
bolus arrival time and τb is the bolus duration. Values used in the simulations 
were: λGM = 0.98, λWM = 0.82, CBFGM = 60 ml/ 100g/ min, CBFWM = 20 ml/ 100g/ 
min, T1GM = 1.3s, T1WM = 0.83s, T1CSF = 4s, T1b = 1.65s, τb = 0.65s, α = 0.95, τarr 
= 0.6s and ΔΤΙ = 300ms (241, 296). 
M0a and aBV maps were generated from the in-vivo data (equations 5.1 
and 5.5). Masks for the whole brain, gray matter, white matter (WM) and 
cerebrospinal fluid (CSF) were generated from the same individual, based on 
segmentation of its MPRAGE scan (variant 1; 5.2.7 section).  
The non-crushed signal (ΔΜncr) was simulated as the summation of the 
crushed signal considered to emerge solely from GM, WM and CSF and the 
arterial signal (ΔΜart) (equations 5.24-5.25).  
 ΔΜæ_Ü(t) = 2 ∗M0æ ∗ AIF(t) ∗ aBV																[5.24] 
 ΔΜºª_(t) = ΔΜª_(t) + ΔΜæ_Ü(t)																						[5.25] 
 
 
Simulation cases 
In order to validate the new pipeline, simulations were run for the following 
cases based on the data generated as described above: 
a) Case 1 - homogeneous GM (60 ml/ 100g/ min) and WM (21 ml/ 100g/ 
min) flow regions were simulated and the pipeline was assessed for k = 
1,…6. 21 was used instead of 20 for WM since this value is divided by 
6000 during the simulation steps. 
b) Case 2 – GM hyper-intense (90 ml/ 100g/ min) and hypo-intense (10 ml/ 
100g/ min) regions were added (to Case 1) at one slice to simulate 
regions with abnormal perfusion. As in Case 1, the pipeline was 
assessed for k = 1,...6. 
c) Case 3 – the described artifact (as outlined in section 5.2.6, above) was 
added in both ΔΜcr and ΔΜncr simulated datasets with a single-pixel 
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offset between the crushed and non-crushed images. A random artifact 
pixel-value was assigned to every voxel in the interval between the 
maximum intensity value in the dataset and double this value. In this 
case the pipeline was assessed for k = 1, 4 & 6 and for each value of k. 
In order to determine the optimal threshold to be used as part of the 
newly introduced artifact detection algorithm, 7 thresholds values were 
tested. These thresholds were: thr1 = 1020, thr2 = 5*1019, thr3 = 1019, 
thr4 = 5*1018, thr5 = 1018, thr6 = 5*1017 and thr7 = 1017. The chosen 
values were based on the maximum intensity values, which are at the 
level of 106. Subsequent processing of the image using the developed 
algorithm (filtering, square, multiplication) leads voxels not influenced by 
the artifact having values at the level of up to 1014. Any value above 
these thresholds was considered artifactual. 
For Cases 1 and 2, three regression kernels for PVC were evaluated: one 
involving the four direct neighbors (minimum smoothing, PVC = 5 voxels); a 
3x3x1 voxel kernel (PVC = 9) and a 5x5x1 voxel kernel (PVC = 25). In Case 3, 
only PVC=5 (i.e. minimum smoothing) was considered. For all simulations, 
Gaussian noise was added to the ΔΜcr and ΔΜncr signal to produce simulated 
data with a SNR = 20 dB (161). PV maps generated from a single individual 
were used. The AIF re-evaluation step was evaluated for simulation cases 1 
and 2. 
 
5.2.11 In-vivo data 
The in-vivo analysis was run for 12 subjects (mean age 47.8 ± 17.4) out 
of the 16 available HV in the present study, with AIF re-evaluation, artifact 
detection where applicable (2 cases) and PVC = 5 for all examined k-values. 
The broad range of ages in our cohort could result in a quite variable AIF shape 
and potentially to more re-evaluated AIFs. Due to the small sample size, the 
effect of age was not examined in the present thesis, however, it could be an 
interesting further extension to this study. 
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5.2.12 Comparison with QUASIL (in-vivo data) 
 
Due to the lack of a gold standard pipeline for quantification of CBF in 
QUASAR ASL, the results were compared with a publicly available tool 
(QUASIL) provided as part of the FSL software package (154). FSL-based 
tools, require input images in a Nifti format, so Nifti QUASAR images were 
generated based on the .PAR/.REC images using dcm2niix (297). Based on its 
published description, QUASIL fits the local AIF signals using gamma variate 
functions and rejects from potential AIFs those curves that deviate from this 
specific shape. It has two modes, model-free and model-based, whereby the 
data are fitted to hemodynamic curves based on the Buxton model for CBF 
determination in order to avoid deconvolution. For comparison purposed the 
same PVC strategy was applied to the QUASIL derived CBF maps.  
 
5.2.13 Performance evaluation 
 
Simulated data 
To evaluate the performance of the developed methodologies, and to 
optimize values for weighting of neighboring AIFs, thresholds for the artifact 
detection step and PVC kernel size, eight metrics were used: 
• M1 - the estimated GM CBF value. 
• M2 - the estimated WM CBF value.  
• M3 - the voxel-wise mean absolute percentage error (MAPE) (equation 
5.27) for the calculated CBF map. 
• M4 - the voxel-wise MAPE for voxels with GM > 50%, for the final CBF 
map.  
• M5 - the voxel-wise MAPE for voxels with GM > 80%, for the final CBF 
map.  
• M6 - the voxel-wise MAPE for voxels with GM > 50%, for the GM CBF 
map calculated based on PVC.  
• M7 - the voxel-wise MAPE for voxels with GM > 80%, for the GM CBF 
map calculated based on PVC.  
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• M8 - the voxel-wise MAPE for voxels with WM > 50%, for the WM CBF 
map calculated based on PVC.  
𝑀𝐴𝑃𝐸 = 100 ∗ 1𝑁¡|𝑀Z −𝑀j|𝑀Z÷`«N 		[5.27] 
where Mt is the true value, Me is the estimated value and N the total number of 
instances.  
Metric M3 was calculated for the non-PVC CBF maps; all other metrics were 
calculated for both non-PVC and PVC-corrected CBF maps. For metrics M1 
and M2 and the non-PVC scenario GM and WM CBF were calculated as the 
mean value in voxels with GM or WM content higher than 50% respectively.  
Focus was put on GM as ASL is known to be adept for GM perfusion 
estimation. The signal in WM by the time of imaging due to the higher transit 
time is attenuated. Only a few ASL techniques such as the ones utilising 
background suppression are known to be adept for WM CBF quantification 
(108).  
Pipeline evaluation – in vivo data 
 
AIF re-evaluation 
For all subjects the analysis was run with and without AIF re-evaluation 
in order to record the number of re-evaluated AIFs and the impact on the final 
GM CBF value.  
 
Comparison with QUASIL 
The analysis was run with both the model-free and the model-based 
QUASIL modes and the same PVC strategy as previously described was 
implemented. The coefficient of variation for each technique was calculated as 
CoV = 100* σ / μ, where σ is the standard deviation and μ is the mean. 
 
Partial volume correction 
The metric used for evaluation of the PVC variants was the structural 
similarity index (SSIM) (equation 5.28), calculated between the QUASAR T1-
maps and the generated GM PV maps. This metric was chosen to evaluate the 
ability of the segmentation algorithms to preserve anatomical information. 
	 104	
𝑆𝑆𝐼𝑀(𝜉, 𝜂) = s2𝜇j𝜇k + 𝐶Nts2𝜎jk + 𝐶Ets𝜇jE + 𝜇kE + 𝐶Nts𝜎jE + 𝜎kE + 𝐶Et			[5.28] 
 
where ξ and η are two different images, μ refers to the mean and σ to the 
standard deviation. C1 = (0.01*DR)2 and C2 = (0.03*DR)2, where DR is the 
dynamic range calculated as the ratio between the maximum and the minimum. 
The SSIM for the different variants were compared using two-sample t-tests. 
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5.3 Results 
 
5.3.1 k-radius AIF weighting 
 
Simulation case 1 - homogeneous GM and WM regions 
 
Results for the first simulation case are shown in figure 5.4. No – PVC 
leads to lower estimated GM CBF values (k = 1 - 45.7 ± 0.09 ml/ 100g/ min; k = 
6 - 44.04 ± 0.08 ml/ 100g/ min) and higher WM CBF values (k = 1 – 24.56 ± 
0.03; k = 6 – 23.7 ± 0.01 ml/ 100g/ min). Calculated values for all PVC kernels 
can be found in figure 5.4 A,B. The performance of the developed pipeline was 
stable between repetitions with low standard deviation. Based on figure 5.4 (A), 
PVC = 5 with k = 2, 3 and PVC = 9 with k = 1, 2 consistently produce values 
closer to the simulated ones. This first set of results suggests that values are 
stable for an increasing weighting AIF kernel and PVC = 5, 9 are optimal.  
Figure 5.4 (E) suggests that errors in metrics M3, M4 and M5 reflecting 
voxel-wise CBF estimates are lower for an increasing k (except for k = 2). No-
PVC is connected with higher errors in GM estimation in voxels with high 
content of GM (figure 5.4 F, G) and lower error in voxels with high content of 
WM compared to instances where PVC was applied (figure 5.4 H). MAPEs are 
lower for a high PVC kernel (increased smoothing) when examining voxel-wise 
GM CBF values and higher when examining WM CBF values. Focusing on GM 
(figure 5.4 F, G), higher k-weighting is associated with slight reduction in errors 
with the only exception for k = 2 where an increase in the MAPE is observed. A 
good balance between voxel-wise MAPEs and global estimates is achieved 
with PVC = 5 with k = 3, 4 and PVC = 9 with k = 3. 
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Figure 5.4: Simulation Case 1 (homogeneous GM and WM). Mean GM (A) and WM (B)  
whole brain CBF values calculated using PVC (mean value in voxels with GM > 50% or WM > 
50% for the non-PVC scenario) are shown. Values are accompanied by error-bars reflecting the 
standard deviation for the 10 repetitions. Along with these, voxel-wise mean estimates for GM 
(C) and WM (D) CBF accompanied by standard deviation bars reflecting the within scan mean 
standard deviation. The dashed lines represent the simulated ground truth. E) voxel-wise 
MAPEs in CBF for the whole brain (blue), voxels with GM > 50% (orange) and voxels with GM > 
80% (yellow), F) voxel-wise MAPE  for the GM CBF maps for voxels with GM > 50%, G) voxel-
wise MAPE for voxels with GM > 80% and H) voxel-wise MAPE for voxels with WM > 50% 
when considering the WM map. 
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Simulation Case 2 – GM hyper- and hypo-intense regions 
Results for simulation case 2 are presented in two figures. The first figure 
(5.5) demonstrates the impact of increased weighting and different PVC kernel 
sizes in the calculated GM and WM CBF values. No-PVC leads to 
underestimation of GM CBF and overestimation of WM CBF (similar to case 1). 
From the examined PVC kernels PVC = 5 with k = 1, 2 and PVC = 9 with k = 1 
lead to values closer to the simulated ones for normal GM and WM. When GM 
hyper and hypo-intense regions were examined (figure 5.6), PVC = 5 and 9 
estimated values closer to the simulated ones. Especially for the hypo-intense 
GM region, PVC = 5 was optimal; PVC = 9 was optimal for the hyper-intense 
region.  
The voxel-wise MAPEs with and without PVC were similar to the ones 
obtained for case 1 for the examined PVC and k-value combinations. Higher k-
weighting results in lower MAPEs and larger PVC kernels were associated with 
reduced error in the mean voxel-wise calculated value when examining the GM 
CBF map. Example maps for a single slice where hyper- and hypo-intense GM 
regions were simulated are shown for an increasing k in figure 5.7. Accurate 
identification of the hyper-intense region is noticed for k > 3. Optimal 
combinations are the ones with lower MAPEs and accurate GM CBF estimates 
such as: PVC = 5 with k = 3, 4 and PVC = 9 with k = 3. 
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Figure 5.5: Simulation Case 2 (hyper and hypo intense areas). Mean GM (A) and WM (B)  
whole brain CBF values calculated using PVC (mean value in voxels with GM > 50% or WM > 
50% for the non-PVC scenario) are shown. Values are accompanied by error-bars reflecting the 
standard deviation for the 10 repetitions. Along with these, voxel-wise mean estimates for GM 
(C) and WM (D) CBF accompanied by standard deviation bars reflecting the within scan mean 
standard deviation. The dashed lines represent the simulated ground truth. E) voxel-wise 
MAPEs in CBF for the whole brain (blue), voxels with GM > 50% (orange) and voxels with GM > 
80% (yellow), F) voxel-wise MAPE  for the GM CBF maps for voxels with GM > 50%, G) voxel-
wise MAPE for voxels with GM > 80% and H) voxel-wise MAPE for voxels with WM > 50% 
when considering the WM map. 
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Figure 5.6: Simulation case 2, hyper and hypo intense GM CBF estimation. Mean GM CBF 
within the hyperintense (A) and hypointense (B) GM regions CBF values calculated using PVC 
(mean value in voxels with GM > 50% or WM > 50% for the non-PVC scenario) are shown. 
Values are accompanied by error-bars reflecting the standard deviation for the 10 repetitions. 
Along with these, voxel-wise mean estimates for GM hyper-intense (C) and hypo-intense (D) 
GM CBF accompanied by standard deviation bars reflecting the within scan mean standard 
deviation. The dashed lines represent the simulated ground truth. 
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Figure 5.7: Example maps for simulation Case 2 without PVC. A) The initial simulated CBF 
map with a hyper- and a hypo-intense region. B) Calculated CBF maps with increasing k-radius. 
 
Simulation Case 3 -artifact detection 
Simulation results for the identified artifactual voxels with a decreasing 
threshold are shown in figure 5.8. For k = 1 (figure 5.9) PVC = 5 is optimal for a 
decreasing threshold when GM CBF is considered. PVC = 5 and 9 are optimal 
when WM is taken into account. When focusing on voxel-wise CBF values 
without PVC (M3, M4 & M5) a decreasing threshold leads to lower voxel-wise 
MAPEs. Errors in the GM CBF maps are lower with a large PVC kernel and the 
general tendency is for them to increase with a decreasing threshold after a 
certain limit (thr4) for the detection of the artifact under consideration. A similar 
pattern is noticed for both k = 4 (figure 5.10) and k = 6 (figure 5.11). Errors in 
WM CBF and voxel-wise estimates are decreasing with a decreasing threshold. 
Κ=1	
Κ=6	Κ=5	Κ=4	
Κ=3	Κ=2	
A)	
CBF	(ml/100g/min	
B)	
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Optimal combinations based on case 3 are: k = 1 with PVC = 5, 9 and thr3 & 
th4; k = 1 with PVC = 25 and thr1, thr2; k = 4 with PVC = 25 and thr1, thr2; k = 4 
with PVC = 5, 9 and thr3, thr4; k = 6 with PVC = 25 and th4; k = 6 with PVC = 5 
and thr5. 
 
 
Figure 5.8: Artifact detection - Simulation case 3. A) Simulated ΔMncr image with a typical 
artifact plus binary masks with decreasing threshold cutoff levels.  B, C, D) MAPEs for error 
metrics (M2, M3, M4 & M5) and calculated GM CBF with decreasing thresholds for kernel size k 
= 1 (B), k = 4 (C) and k = 6 (D). Where: thr1 = 1020, thr2 = 5*1019, thr3 = 1019, thr4 = 5*1018, 
thr5 = 1018, thr6 = 5*1017 and thr7 = 1017.  
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Figure 5.9: Simulation case 3, metrics M1-M8 with a decreasing threshold and k=1. 
 
 
 
Figure 5.10: Simulation case 3, metrics M1-M8 with a decreasing threshold and k=4. 
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Figure 5.11: Simulation case 3, metrics M1-M8 with a decreasing threshold and k=6. 
 
• An increasing k-radius AIF weighting results in lower errors in the voxel-
wise CBF estimates (M3, M4 and M5 metrics).  
• The GM and WM CBF values (M1, M2) are relatively stable with an 
increasing k following PVC. 
• No-PVC is associated with underestimation of the GM CBF (M1) and 
overestimation of WM CBF (M2). 
• PVC = 5 with k = 3, 4 and PVC = 9 with k = 3 were optimal when 
accurate estimation of the GM CBF value (M1) was of interest. 
• In the presence of hyper and hypo-intense regions (case 2) PVC = 5 
results in better CBF estimates for the affected hypo-intense areas and 
PVC = 9 for hyper-intense areas. 
• Voxel-wise MAPEs in GM CBF for voxels with high GM content (M6 & 
M7) decreased with an increasing k. 
• When an artifact was present (case 3) the developed algorithm 
effectively identified it with a decreasing threshold.  
• MAPEs were reduced for the voxel-wise CBF estimates (M3, M4 & M5) 
and a decreasing threshold. 
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• After a certain threshold (thr5) MAPEs tend to increase (M6, M7) 
especially with a large PVC kernel and GM CBF values are 
underestimated. 
 
5.3.2 AIF re-evaluation 
Results for AIF re-evaluation can be found in figures 5.12 & 5.13. For all 
metrics the results were highly similar so values are shown for M1, M3, M5, and 
CBF within hyper- and hypo-intense regions (simulation case 2). The mean 
number of re-evaluated regional AIFs per k-value was: 7.9 ± 0.7 (k = 1), 79.1 ± 
0.3 (k = 2), 50.9 ± 1.2 (k = 3), 30.7 ± 1.3 (k = 4), 19.2 ± 1.3 (k = 5) and 18 ± 1.2 
(k = 6). 
 
Figure 5.12: AIF reevaluation simulation case 1.  Blue is used for AIF re-evaluation and red 
for no re-evaluation. 
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Figure 5.13: AIF reevaluation simulation case 2. Blue is used for the AIF re-evaluation step 
and red for no AIF re-evaluation. 
Overall, AIF re-evaluation did not have a big impact in the calculated 
MAPEs especially for k = 3, 4 and 5 which were identified in previous steps as 
optimal. A slight difference is noticed for case 2 and the calculated GM CBF 
values. No re-evaluation is connected with slight overestimation inside hyper-
intense and hypo-intense GM areas.   
Based on the simulation findings, when accurate GM and WM CBF 
whole brain values and voxel-wise CBF estimates are of interest, the optimal 
implementation is k-radius AIF weighting with k = 3, 4 or 5 and AIF re-
evaluation with PVC = 5. In case an artifact is present, the implementation of 
the developed algorithm with a threshold in the range 1018-1019 results in 
effective artifact detection and can be used along with the developed pipeline 
with a combination such as k = 4 and PVC = 5. 
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5.3.3 In-vivo results 
Calculated CBF for GM and WM for the examined healthy subjects along 
with the number of AIFs for varying k-radii can be found in table 5.1. QUASIL 
model-based and model-free results are also given in the same table. The PVC 
kernel used in this analysis was PVC = 5. In 10/12 subjects, the described 
chemical-shift artifact was not visually detected in the difference images. The 
lowest CoV in the calculated GM CBF with the developed pipeline was 
observed for k = 1 (CoV = 7.3%) and the highest for k = 5 (CoV = 10.4%). For 
QUASIL model-free analysis the CoV was 16.9% and for the model-based 
analysis, the CoV was 19.5% (CoVs are reported for 10/12 subjects). Within 
this group the mean number of neighboring AIFs identified for every voxel 
ranged from 1.3 ± 0.1 (for k = 1) to 92.2 ± 31.9 (for k = 6). The GM CBF values 
demonstrated stability with increasing number of considered AIFs, a finding 
consistent with the simulation results. Example AIFs obtained from different 
voxels using the 6 k-values can demonstrate varying effects of k on the 
resultant input functions (figure 5.14).  
 
Figure 5.14: AIFs from 10 voxels based on one subject for different degrees of AIF 
weighting (k). Examples in the first row indicate that choice of k impacts on AIF shape whereas 
examples in the second row demonstrate negligible impact. 
For the 5 chosen voxels in the first row in figure 5.14, the value of k 
impacts the shape and amplitude of the voxel AIF, for the other 5 voxels the 
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impact of k appears to be negligible. There is no clear pattern of difference in 
the number of recruited AIFs between the first and the second set of examined 
voxels for each k that could explain in a systematic way the reason for seeing 
noisy AIFs for lower k-values in the first set (figure 5.15). To visually evaluate 
the effect of different combinations of k-values and PVC kernels on the resultant 
CBF, maps are shown for one representative individual in figure 5.16. 
 
 
Figure 5.15: Number of averaged AIFs for each of the examined voxels with an increasing 
k. 
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Figure 5.16: Single slice CBF maps from a representative subject as a function of PVC 
level and k-radius AIF weighting.  As the PVC kernel size increases the blurring effect is more 
prominent. As the k-radius increases de-noising of the image occurs without introducing 
prominent smoothing/blurring. 
Two individuals were influenced by the presence of the multi-parametric 
artifact. The mean CBF values were calculated before and after artifact 
correction (Table 5.1). Correction led to the mean exclusion of 553 ± 141 voxels 
i.e. a 6.8 ± 1.4 % reduction.  
 For the AIF re-evaluation step, the mean CBF without re-evaluation was 
54.7 ± 5.5 ml/ 100g/ min as opposed to 54.5 ± 4.7 ml/ 100g/ min with AIF re-
evaluation. The number of identified AIFs without re-evaluation was 1915.2 ± 
585.2 and with AIF re-evaluation 1719.8 ± 570.5, leading to a mean of 195.3 ± 
60.6 excluded AIFs. The mean number of excluded voxels due to extremely low 
CBF values (<5 ml/ 100g/ min) was 187.3 ± 60.9 and a mean of 8.1 ± 4.5 voxels 
were excluded because their value was very high (150 ml/ 100g/ min). 
 
No	PVC	
PVC=5	
PVC=9	
PVC=25	
K=1	 K=2	 K=3	 K=4	 K=5	 K=6	
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Partial volume correction 
The SSIM was calculated for all PVC variants. When compared to the 
T1-QUASAR maps, the mean SSIM for variant 1 (PV maps generated based on 
the MPRAGE scan down-sampled and registered to the QUASAR-T1) was 0.18 
± 0.05. PVC using the FRASIER method (variant 2) resulted in a SSIM of 0.11 ± 
0.09. When using the FRASIER maps as an intermediate registration target for 
the MPRAGE derived GM PV maps (variant 3) the SSIM was 0.17 ± 0.06 and 
for variant 4 (mean of variant 1 and 2) SSIM was 0.15 ± 0.08. The SSIM value 
was significantly higher for variant 1 compared to variant 2 (p = 0.02). GM and 
WM CBF were quantified for all subjects with all the PV map generation 
methods for PVC = 5 kernel and k = 4 to measure the CoV for the GM CBF 
value. For the first variant the CoV was 10.1%, for the second CoV = 10.3%, for 
the third CoV = 9.1% and for the fourth CoV = 8.7%. 
Example maps for the PV techniques are shown in figure 5.17. 
 
Figure 5.17: Example slice from an individual of a 1/T1 slice and the determined PV maps 
generated with the 4 tested variants. 
 
Overall based on the in-vivo data an increase in the k-values did not lead to big 
differences in the calculated GM and WM CBF values. Artifact detection led to a 
slight reduction in calculated CBF. The CoV was lower with the developed 
technique compared to the QUASIL software. PV maps generated with 
methods based on a high resolution MPRAGE scan had higher structural 
similarity with the QUASAR-T1 maps compared to the FRASIER PV maps. 
Variant	4	Variant	1	 Variant	2	 Variant	3	1/T1	
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Table 5.1: GM CBF, WM CBF and number of identified AIFs for 12 subjects. 2 out of the 12 
subjects were influenced by a multi-parametric artifact. For these two subjects results are 
shown before and after artifact correction. The values shown are for an increasing k-radius and 
the results obtained using QUASIL model-free and model-based analysis. 
 
 
 
 
5.4 Discussion 
In this chapter, several modifications were introduced to the QUASAR 
processing pipeline. Optimization of the model-free post-processing version 
may hold great importance especially when the protocol is applied in clinical 
cohorts where assumptions about the shape of hemodynamic signals 
(introduced when using a model-based approach) might be violated due to the 
presence of pathophysiology. The introduced changes revolved around the AIF 
assignment and the mitigation of a common water-fat shift artifact. Additionally, 
four variants for PV map determination were evaluated. The pipeline was 
developed and evaluated specifically for QUASAR ASL. However, parts within 
the pipeline can also have application in other ASL implementations where the 
chemical-shift artifact is present or in multi-PLD protocols where AIFs are 
calculated at a local level. 
	
Artifact-free 
 k=1 k=2 k=3 k=4 k=5 k=6 QUASIL 
free 
QUASIL 
model 
GM CBF 
(ml/100g/min) 
54.4± 4.0 54.4±4.7 54.2±5.2 54.3±5.5 54.4±5.6 55.6±5.6 58.7±9.9 61.1±11.9 
WM CBF 
(ml/100g/min) 
24.1±1.9 22.8±2.2 22.7±2.4 22.6±2.5 22.7±2.7 22.7±2.7 25.4±3.4 29.9±3.7 
AIFs 1.3±0.1 7.4±1.0 23.1±5.4 44.3±12.8 66.7±21.3 92.2±31.9 N/A N/A 
         Influenced by the artifact before correction 
GM CBF 
(ml/100g/min) 
55.3±0.1 55.4±0.6 55.7±0.8 55.9±0.7 55.8±0.8 57.2±0.6 60.6±0.3 66.5±6.0 
WM CBF  
(ml/100g/min) 
25.7±0.5 25.5±0.1 25.2±0.4 25.3±0.5 25.2±0.6 25.2±0.6 26.7±0.4 31.3±1.3 
AIFs 1.3±0.1 7.3±1.0 22.1±1.9 42.4±5.5 64.3±9.0 90.7±14.6 N/A N/A 
Influenced by the artifact after correction 
GM CBF 
(ml/100g/min) 
53.8±0.1 54.0±0.1 54.2±0.2 54.2±0.2 54.0±0.8 54.5±0.7 N/A N/A 
WM CBF  
(ml/100g/min) 
25.3±0.5 25.1±0.1 24.9±0.2 25±0.3 25.0±.02 25.1±0.4 N/A N/A 
AIFs 1.1±0.0 5.8±0.1 15.8±0.6 28.3±1.5 41.7±2.3 57.0±4.4 N/A N/A 
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k-radius AIF weighting improves perfusion quantification 
Accurate AIF determination is essential in perfusion imaging since it 
directly impacts blood flow quantification (153). The introduction of k-radius AIF 
weighting aims at reaching a ‘golden mean’ between assigning a single, local 
input or an AIF based on a surrounding region (e.g. due to vascular territories or 
global brain blood supply). AIF weighting, leads to AIF de-noising by means of 
weighted spatial smoothing, rather than model-fitting. Considering more than 
one local AIF has the additional benefit of accounting for perfusion resulting 
from more than one local source. This effect is prominent in, for example, 
watershed areas within the brain parenchyma that are supplied by more than 
one arterial input. AIF weighting takes into account the hemodynamic 
characteristics in a sphere centered on the voxel of interest. The findings 
indicate that implementation of this approach can yield more reliable voxel-wise 
perfusion estimates compared to k = 1 which reflects the conventional QUASAR 
post-processing. This effect was captured by both the quantitative and 
qualitative analysis and is clearly depicted in figure 5.7, whereby the hyper and 
hypo- intense regions are clearly identified with k-values greater than 3. 
It was demonstrated that using k-radius AIF weighting can improve 
perfusion quantification, both in the presence of hyper- or hypo-intense regions 
and in normal cases. A consistent finding in simulation Cases 1 (homogeneous 
GM and WM CBF) and 2 (hyper and hypo-intense areas) was that increased 
AIF weighting led to reduced MAPE in voxel-wise CBF values (M3). This finding 
should be taken into account when ROI-specific CBF values are to be extracted 
or voxel-wise comparisons are conducted. On the other hand, a high k-value 
might result in slight GM CBF underestimation.  
The developed isotropic k-radius AIF weighting approach does not 
account for the complex topology of different vascular territories. An AIF 
weighting approach restricted within vascular territories (or within the two 
hemispheres) would be an interesting future development. This would require 
mapping of the vascular territories, for example, using TASL (an implementation 
based on QUASAR) (164) or ASL techniques without explicit territorial labeling 
combined with pre-defined vascular territory maps with which to restrict the AIF 
assignment step. 
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A small PVC kernel size results in lower errors  
Along with the degree of weighting, we evaluated PVC with linear 
regression using different kernel sizes. The use of either PVC = 9 or PVC = 25 
is common, due to superior noise suppression. Additionally, small kernel sizes 
are not typically evaluated since the matrix inversion problem involved in the 
quantification of GM and WM CBF is ill-defined when a small number of voxels 
is used. In the present implementation though, when this was the case, the 
utilized algorithm did not return the actual inverted matrix but a least square 
approximation. Our findings suggest that a kernel of 4 neighbors (PVC = 5) is 
sufficient to solve the regression equation in a stable manner and results in 
minor smoothing. This regression kernel demonstrated high accuracy in CBF 
quantification within hyper- and hypo-intense regions. In addition, final 
estimated GM CBF was closer to the simulated value with the lower kernel size; 
this was concomitant with minor increases in the other variance-related 
parameters (MAPEs). For simulation Cases 1 and 2, MAPEs in voxels with 
lower GM content tended to be higher with an increasing PVC kernel.  
The optimal choice of k-values and PVC kernel size is dependent upon 
subsequent analysis. If the mean GM CBF is of primary interest, then the 
optimal k-PVC combinations are: k = 1, 2 with PVC = 9 and k = 3, 4 with PVC = 
5. For an ROI-based approach, a combination giving the minimal error at a 
voxel-wise level (M3, M4 and M5) would be a better choice. Where hypo- or 
hyper-perfused regions are expected, a combination, which does not smooth 
out these regions and provides results closest to ground-truth values is likely to 
be beneficial such as k = 3, 4, 5 and PVC = 5. The simulation results for case 2 
(figure 5.16) imply that k > 3 delineates the hyper- and hypo-perfused regions 
from normal areas in a more robust manner. This suggests that spatial 
smoothing introduced with k-radius weighting does not smooth out abnormally 
perfused regions, an unwanted effect observed when large PVC kernels are 
implemented for noise reduction. Hence, a small PVC kernel accompanied by 
spatial smoothing at the level of the AIF assignment step might be a viable 
alternative to big linear regression kernels. 
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k-radius AIF assignment with AIF re-evaluation was optimal  
AIF re-evaluation introduced as a step here to account for potentially 
noisy AIFs had little impact on the final calculated CBF values in both the 
simulations and in-vivo data. Simulations indicate that the error in CBF 
estimates is slightly lower when re-evaluation is not used. This step could be 
omitted, however, it is reassuring that AIFs resulting in spurious CBF values are 
not used in the k-radius AIF weighting step and hence do not impact in any way 
on their local neighborhood.  
Of interest is that a mean of 195.3 AIFs (the mean number of identified 
AIFs was 1915.2) gave rise to non-physiological CBF values and the majority of 
them are below 5 ml/ 100g/ min. This effect could be attributed to the fact that 
for CBF quantification the crushed signal is used. Hence, in voxels containing 
large arterial compartments we would expect that the arterial signal will be 
nulled, hence the recorded crushed signal would be particularly low. However, 
the aBV rarely goes beyond 20% in any voxel, so we would expect a tissue 
signal from these voxels to arise as well. Suppression of the arterial signal due 
to the crushers, hence, is not sufficient to explain the unphysiologically low CBF 
values. It needs to be emphasised that these voxels are not excluded from 
subsequent analysis; they are just excluded as candidate AIFs in the AIF 
reassignment step. 
In the future an approach incorporating AIF re-evaluation as a 
regularisation step, implemented iteratively until all AIFs provide CBF values 
within the desired limits could be evaluated. 
 
A water-fat shift artifact was effectively detected  
The artifact detection algorithm is capable of identifying erroneous voxels 
in both simulated and in-vivo data. The artifact was successfully identified in two 
subjects and elimination led to reduction in GM and WM CBF. Simulations 
suggested that voxel exclusion up to a certain point results in a closer 
approximation to the underlying perfusion values. However, exclusion of a large 
number of voxels (i.e. using thr7) may result in higher errors in voxels with GM 
> 50%. Hence, a recommended threshold to be used with the developed 
algorithm ranges between 1018 and 1019. 
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Ideally, artifact mitigation should be a pre-reconstruction technique. 
Following reconstruction, if the artifact is not successfully removed during 
motion correction, only a post-processing technique can be applied. It needs to 
be highlighted that the developed artifact detection algorithm does not correct 
for the artifact; it detects influenced voxels and it relies on the user whether to 
include these voxels in the analysis or not. 
 
Partial volume correction using the MPRAGE-derived estimates was 
optimal 
In terms of the evaluated PVC variants, it was demonstrated previously 
that FRASIER performs well in relatively high SNR scenarios (243). When 
applied to the in-vivo data in this study it demonstrated the resulting GM, WM 
and CSF PV maps were realistic; there were cases though where it failed to 
determine accurately GM and WM, especially in the presence of enlarged 
ventricles. In such cases the generated PV maps were substantially different 
from the maps calculated based on the high-resolution T1-weighed scan, which 
are usually taken as the gold standard. On the other hand, when using the 
MPRAGE approach, in some cases, the registration was suboptimal.  
Accurate registration of the PV maps to the low resolution T1t maps is 
crucial since if there is a small degree of rotation or imperfect translation, the 
PV maps will not overlap with their respective voxels. A combination of these 
two PV generation methods might be beneficial, since the FRASIER map 
provides a good target for direct registration of the down-sampled PV maps. 
Taking into account the SSIM and CoV, the hybrid methods evaluated here 
improved on CoV and demonstrated a higher structural similarity to the 
QUASAR-T1 maps, when compared to FRASIER-derived estimates. In the 
present thesis we chose for subsequent processing variant 1, since the 
generated GM PV maps demonstrated a higher SSIM to the QUASAR-T1 
image. Variant 3 which used the FRASIER maps as a registration target had a 
lower SSIM but also a lower CoV compared to variant 2 and could be used 
alternatively when the between modality registration fails as an intermediate 
registration target. 
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The developed model-free pipeline provides realistic perfusion estimates. 
In a previous study where QUASAR was used (296), mean GM and WM 
CBF were 55.5 ± 9.5 and 21.8 ± 7.7 ml/ 100g/ min, respectively, when using 
stable spline deconvolution, whereas the values were 34.9 ± 5.2 and 17.3 ± 5.5 
ml/ 100g/ min when standard SVD deconvolution was applied. In the QUASAR 
reproducibility study, the mean GM CBF was 47.4 ± 7.5 ml/ 100g/ min (161). 
Finally, in another report (243) where linear regression was used for PVC, the 
mean value for GM CBF was 60.6 ± 1.5 ml/ 100g/ min. Hence, our findings are 
in line with previously reported values for GM CBF. In the majority of studies 
using QUASAR (155, 162, 163, 165, 166, 171), no correction was implemented 
for PVE and only in a few of them ROIs in areas thought to be minimally 
influenced by PVE were used (143, 159). In studies using QUASAR where PVC 
was not used the calculated GM CBF ranged between 34-47 ml/ 100g/ min 
(143, 155).  
It is worth mentioning that, throughout this thesis, a decision was made 
to avoid introduction of assumptions into the processing pipeline wherever 
possible. In the present QUASAR ASL processing optimisation, we tried to 
avoid excessive smoothing, fitting, and use of prior information. The inherent 
advantage of QUASAR is that it is a model-free technique allowing CBF 
quantification without assuming an explicit model for the hemodynamic signals 
and imposing it upon the data. Assumptions about the shape of the arterial 
input function, the tissue signal or the residue function would contradict this 
inherent advantage of the technique. On the other hand, the analysis and the 
results might be more robust and less noisy by fitting data with suggested 
model functions. For example, QUASIL uses priors and spatially adaptive 
priors. Additionally, there is the option to avoid SVD deconvolution by fitting the 
data to the general kinetic model (154). Ahlgren et al. (291) have suggested 
non-linear stochastic regularization for the deconvolution step and Castellaro et 
al. (296) have used stable splines. These literature suggestions were aimed at 
introducing regularisation steps for the residue and the arterial signal assuming 
a certain shape based on physiological models. Such approaches lead to 
beneficial noise suppression, however, they tend to introduce bias in the form of 
prior information based on healthy subjects. We have shown with this analysis 
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that accurate perfusion quantification is possible with the model-free QUASAR 
pipeline and we have contributed four modifications towards its optimisation. 
The net impact on the quantified values for all introduced modifications 
as judged by the final GM CBF and MAPEs is not high, however, an 
improvement is noticed with all introduced modifications. The absolute errors 
are reduced at a voxel-wise level and the values, especially considering the 
simulation steps, are close to the ground truth ones. 
Comparison with QUASIL 
When QUASIL was used (model-free and model-based), the mean GM 
CBF was higher than that obtained with the developed pipeline. The difference 
in mean GM CBF value compared to the model-free QUASIL approach may be 
attributed to the difference in AIF assignment. In QUASIL, local AIFs are fitted 
to a gamma variate function and assigned using a closest neighbour criterion 
(154). Lower GM CBF calculated from a model-free, as opposed to a model-
based approach, is a consistent finding usually attributed to the use of SVD 
deconvolution in the former method. WM CBF values calculated with the model-
based approach are higher compared to both the k-radius AIF weighting 
method and model-free QUASIL, giving a mean value of 30ml/ 100g/ min when 
that expected is 20ml/ 100g/ min. For the two subjects influenced by the multi-
parametric artifact, QUASIL GM and WM CBF were high compared to the 
calculated mean for the subjects not influenced by the artifact, suggesting that 
CBF quantification is influenced by its presence. 
It is worth noting that the coefficient of variation for the GM CBF 
measured with the suggested pipeline is lower than that obtained using the 
QUASIL tool, a result suggestive of a more stable performance, which carries 
potential importance in clinical research studies. When comparing the 
algorithmic execution times, a model-based QUASIL run requires 46s. With our 
pipeline implemented with k = 4 the execution time was 180s, when supplying 
directly the PV maps and 300s when generating PV maps within the pipeline. 
There are several limitations to this study. Firstly, the developed pipeline 
was tested in a limited cohort and it needs to be validated using a larger study 
population. Secondly, a discrete number of radii were considered for the AIF 
weighting step and alternative approaches could be tested to determine the 
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optimal approach, such as, AIF assignment being confined within specific 
vascular territories. Thirdly, in this study, SVD deconvolution was used for the 
determination of the residue function. SVD is known to underestimate perfusion 
values and alternative mathematical approaches could be used to determine 
the transfer function of the system on a voxel-wise basis. Finally, the artifact 
detection and rejection algorithm relies on the principle that hyper-intense 
regions at specific time-points are artifactual rather than reflecting true 
perfusion, an assumption that could be violated resulting in the rejection of non-
artifactual voxels. 
 
5.5 Conclusions 
QUASAR ASL is one of the first methods suggested by the ASL 
community having the potential to image perfusion dynamically in a non-
invasive manner. This technique was first suggested in 2006 (155). Since then, 
the only modification to the acquisition process has been the introduction of a 
small flip angle acquisition in order to map the nominal flip angle at a voxel-wise 
level (160). Petersen et al. have been working over the past years on TURBO-
QUASAR, however, it is still subject to optimization and a full-length paper on 
the technique has not yet been published (298). On the other hand, QUASAR 
post-processing optimization has been a vivid area of interest for some years, 
with the latest paper been published by Castellaro et al. suggesting stable 
spline deconvolution (296). At about the same time, the ASL white paper 
suggested pCASL as an optimal implementation (108). Since then, spatially 
non-selective ASL and time-encoded ASL have emerged as very promising 
alternatives, with promising insensitivity to transit time delays. These last 
techniques have not yet been thoroughly validated and are quite experimental 
(126).  
 The QUASAR post-processing optimization has mainly focused on four 
aspects: AIF assignment, deconvolution – residue determination, partial volume 
correction and modelling of the signals. In this chapter, we contributed towards 
optimization of the AIF assignment step, PVC step and in addition to these, we 
presented an algorithm for artifact detection. Using simulations and in-vivo data, 
we demonstrated an improvement in the quantification procedure and 
determined optimal values and approaches to be used in the subsequent 
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processing. More importantly, we have made our pipeline publicly available to 
be used and tested by the ASL community. This is the 3rd tool available for 
QUASAR- based ASL quantification. The first is the program written in IDL by 
Esben Petersen which is of a ‘black box’ kind, and the other is the QUASIL tool 
available as part of the FSL toolbox. 
 Aside from more challenging post-processing, QUASAR has the very 
important advantage of being ATT insensitive. Additionally, the entire 
hemodynamic signals used for perfusion estimation and not a single time-point 
are acquired at a voxel-wise level. Hence, a robust, open access pipeline, 
making use of the acquired signals without introducing excessive smoothing, 
regularisation or prior assumptions and which demonstrates a stable 
performance, could be a useful tool for clinical studies. This pipeline, with 
values optimised as described in this chapter, was used in the subsequent 
hemodynamic analysis (Chapter 6). 
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Chapter 6: 
Cerebral hemodynamic analysis in type-2 
diabetes and impaired glucose tolerance 
 
Abstract 
Perfusion impairment in T2DM is suspected due to potential 
neurovascular unit dysfunction leading to impaired delivery of energy to the 
tissue. Neuroimaging findings, however, have not been consistent. The aim of 
this part of the thesis was to evaluate cerebral hemodynamics in IGT and T2DM 
using, for the first time, an arterial transit time insensitive ASL technique, 
namely, QUASAR ASL.  
Data from 16 HV, 12 subjects with IGT and 16 T2DM patients were 
processed. Two analysis approaches were utilised, the first one involved 
calculation of commonly quantified QUASAR metrics accompanied by a 
conventional statistical analysis. The second approach involved quantification of 
novel hemodynamic features extracted from the QUASAR signals, which were 
subsequently analysed using a machine learning framework to detect optimally-
differentiating features between the groups. Overall, seven multi-parametric 
models were evaluated, each containing a different combination of 
hemodynamic features. Due to the large number of features and the small 
dataset, dimensionality reduction was implemented. Binary classification tasks 
were conducted using linear SVM.  
Commonly quantified perfusion parameters such as CBF, CVR and ATT 
differed between the groups suggesting hemodynamic differences. Baseline 
CBF in IGT and T2DM was increased, potentially indicating the presence of an 
early compensatory mechanism to account for reduced oxygen delivery to the 
tissue. A multitude of newly quantified hemodynamic features also differed 
between the groups. The applied extended hemodynamic analysis combined 
with a machine learning framework, resulted in high classification performance 
for all binary classification tasks examining HV vs hyperglycemic states, 
suggesting: a) a distinct hemodynamic pattern in the hyperglycemic groups 
compared to HV and b) that QUASAR ASL can provide important hemodynamic 
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information not typically captured by single time-point ASL, which may be 
pertinent to the correct classification of healthy vs. non-healthy brains. 
To evaluate the additional benefit of conducting an extended 
hemodynamic analysis, we compared the discriminatory capacity of the novel 
feature combinations to the commonly quantified QUASAR parameters and 
found that for all considered classification tasks, the classification performance 
increased with the newly considered metrics. The feature combination with the 
best performance was the one involving metrics extracted from non-processed 
QUASAR signals, followed by the one combining non-processed signals and 
typical QUASAR measurements. Interestingly IGT had a distinct hemodynamic 
pattern compared to HV, which was prominent after the administration of a 
vasodilating stimulus and bore similarities with the T2DM group.  
 
6.1 Introduction 
Several techniques have been devised in recent years for cerebral 
perfusion quantification. In the field of T2DM some studies have reported hypo-
perfusion (36, 42, 43), whereas others have concluded that there are no 
differences between T2DM patients and healthy subjects (44, 45). A few studies 
(46, 47) have reported increased baseline perfusion in T2DM with van Bussel et 
al. focusing on the hippocampus. This inconsistency in findings is highly likely to 
reflect differences in the utilised perfusion imaging techniques. Findings 
regarding CVR have been more consistent with a lower value observed in 
T2DM patients (36, 42, 44, 53). The study by Selvarajah et al. (53) has reported 
a decrease in brain blood flow in both T2DM and IGT.  
In these studies, flow has been examined with one of the following 
techniques: PC-MRA, TCD, BOLD fMRI, DSC-MRI, PET, ASL-MRI. When using 
PC-MRA the acquisition typically takes place at the level of the carotids and the 
acquired quantity is a blood velocity measurement. Transcranial Doppler also 
measures blood velocity rather than pure tissue perfusion. Techniques 
capturing a pattern close to the underlying perfusion based on MRI are BOLD 
fMRI, DSC-MRI and ASL MRI. BOLD fMRI captures changes in the amount of 
oxygenated and deoxygenated hemoglobin in response to a stimulus, which are 
coupled to neuronal activation (299). DSC and ASL MRI follow a tracer within 
the vasculature. DSC follows a gadolinium contrast agent that in normal 
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circumstances remains intravascular and creates a susceptibility gradient. 
Perfusion is captured during the first passage of the tracer. In cases of BBB 
disruption though, leakage of the tracer can lead to quantification errors (153). 
In ASL, the labeled hydrogen protons get delivered to the tissue, so perfusion 
measurements relying on ASL can be thought as more direct measurements of 
perfusion compared to the other techniques. In the study reported in this 
chapter we have used a multi-TI ASL technique to investigate in depth cerebral 
hemodynamics in T2DM utilising the assumption-free, model-free, processing 
pipeline explained and validated in detail in the previous chapter. 
 Such a technique accounting for ATT variations could be appropriate for 
perfusion quantification in cohorts of non-healthy subjects. QUASAR ASL is an 
implementation insensitive to ATT delays (155) since it samples the recovering 
magnetisation at multiple time-points. Due to the acquisition of dynamic signals 
at a voxel-wise level, QUASAR can provide rich hemodynamic information 
along with quantitative CBF maps. Such a technique has not yet been used to 
investigate cerebral perfusion in T2DM. 
 QUASAR ASL has the potential to provide multiple hemodynamic 
parameters that can be investigated using a machine learning approach to 
extract the most significant feature combination leading to optimal class-
differentiation. Machine learning approaches are becoming increasingly popular 
in neuroimaging and have been extensively used for MR biomarker 
identification in Alzheimer’s disease (246, 249, 268) and brain tumors (269). 
Structural MRI scans are usually the modality of choice; only a few studies have 
evaluated features derived from alternative MR acquisitions such as BOLD, 
pCASL and DTI (249, 274). In the field of diabetes, machine learning 
techniques have been used for identification of novel biomarkers though not 
relying on features extracted from MR images (300).  
 Typically, when machine learning approaches are applied to MR images, 
the focus is on the intensity of a voxel or of an ROI. Metrics directly connected 
to the intensity, statistical metrics and less frequently textural metrics are 
extracted.  In this study, we shift the processing focus from the 3D intensity 
images reflecting CBF, ATT and aBV to the dynamic ASL signals  acquired at a 
voxel-wise level. To our knowledge, this is the first study examining multi-TI 
ASL derived features using a machine learning analysis approach. Additionally, 
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classification of normoglycemia vs hyperglycemia based on perfusion MR 
features has not been investigated in the past.  
 In the present chapter, we utilised QUASAR ASL, which accounts for 
ATT delays to evaluate cerebral hemodynamics in IGT and T2DM. Multiple 
perfusion-related parameters were quantified in order to retain a descriptive 
hemodynamic pattern for every individual. The dimensionality of the problem 
was reduced by feature selection and the resulting pattern was used for 
supervised classification. The hypothesis under examination was that cerebral 
hemodynamics are altered in T2DM and its prodromal condition IGT. We 
attempted to take advantage of the potential of QUASAR ASL to provide rich 
hemodynamic information not confined to the calculation of CBF maps. We 
investigated the impact of the additional hemodynamic parameters in optimal 
class differentiation by quantifying the classification accuracy using only CBF, 
CVR, aBV and ATT measurements on the one hand, and using all the 
suggested additional hemodynamic parameters on the other. Overall 
classification was performed for 7 different feature combinations and 4 tasks 
(HV vs T2DM, HV vs T2DM & IGT, HV vs IGT and IGT vs T2DM) in order to 
conclude the optimally differentiating pattern. Finally, the data were analysed 
using the pseudo-single-PLD approach described in the previous chapter. 
 
6.2 Methods 
Data from 16 healthy volunteers (HV), 12 people with IGT and 17 
patients with T2DM were acquired on a 3T Philips Achieva scanner. Scans from 
2 subjects with IGT and 1 subject with T2DM were discarded due to poor image 
quality (cohort details in table 6.1). Image quality was deemed poor if following 
registration and noisy scan rejection, the resultant mean crushed and non-
crushed images demonstrated strong motion artifacts that would influence the 
subsequent processing. The quality was assessed visually by a single individual 
(M.E.D). 
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Table 6.1: Details about the subject cohort analysed in the present chapter. 
 HV IGT T2DM 
N 16 10 16 
Age (y) 50.0±12.0 54.1±5.5 54.9±11.8 
sex 8♀  8 ♂ 5♀  5 ♂ 8♀  8 ♂ 
BMI (kg/m2) 26.0±34.7 31.6±3.4 31.1±3.9 
Hypertension 
(subjects) 
4 5 6 
Diabetes 
duration (y) 
N/A N/A 9.9±4.6  
HbA1c (%) - - 9.4±1.9 
Microvascular 
complications 
- - 5 neuropathy 
2 retinopathy 
1 nephropathy 
insulin   4 
Smoking history 3 ex-smokers 3 ex- 3 current 7 ex – 2 current 
 
 
6.2.1 MR protocol 
1) A T1-weighted MPRAGE scan. 
2) Four QUASAR ASL acquisitions. The first QUASAR scan was acquired 
at baseline and the next three were acquired consecutively 15 minutes 
after ACZ injection.  
For more details regarding the MR protocol, please refer to Chapter 4. 
 
6.2.2 Partial volume correction 
The high resolution anatomical scan was corrected for bias field using 
N4 (208). Subsequently the scan was segmented using SFCM (232). 
Overlapping QUASAR and MPRAGE slices were determined and the PV maps 
were averaged over the overlapping slices. Subsequently the PV maps were 
down-sampled to the QUASAR resolution and registered to the T1-QUASAR 
maps. PVC was implemented using linear regression (240) with a kernel 
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involving the four direct neighbours of a voxel, which was found to be optimal in 
Chapter 5.  
 
6.2.3 Quantified parameters 
Typically, CBF is calculated as the maximum of the residue function, and 
ATT as the difference between the rising time of the tissue curve and the AIF. 
Arterial blood volume is associated with the area under the curve of the non-
crushed – crushed difference signal (155). Hence, this is the current 
hemodynamic information used in QUASAR ASL studies to investigate 
perfusion abnormalities. Other metrics, characteristic of the curves, and hence 
the acquired signals, are currently not considered in the QUASAR 
implementation and quantification. Such metrics were evaluated in the present 
chapter to investigate whether potential hemodynamic information not captured 
by ATT, aBV and CBF can be extracted. 
 As described in Chapters 2 and 5, every voxel can be modelled as a 
system having an AIF as the input, the tissue signal as the output and the 
residue function is the system’s transfer function (figure 6.1). The AIF describes 
the distribution of the ‘tracer’ in the arterial compartment, the tissue curve the 
distribution in the output. The residue curve is associated with the tracer 
retention by the tissue and represents the amount of labeled spins remaining 
inside the system at the time of imaging (151). The tissue signal is considered 
to be the acquired crushed signal (ΔΜcr) and the arterial signal can be 
calculated by subtracting the tissue signal from the mixed arterial & tissue 
signal (ΔΜncr); the residue signal is determined via deconvolution. These three 
signals have the potential to shed light onto the hemodynamic pattern in every 
region allowing for the extraction of multiple perfusion-related parameters.  
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Figure 6.1: Example demonstration of the tissue, arterial and residue function signals. 
Overlapping the AIF are example metrics not currently considered such as the time-to-peak 
(green), full width half maximum (orange) and the peak (red). Modified based on Ahlgren et al. 
2011 (301). 
A multitude of hemodynamic features were quantified at a local and 
global level. These metrics were: the time-to-peak (TTP), peak height, full width 
at half maximum (FW), half width at half maximum of the left (HWL) and the 
right (HWR) part of the signal peak, skewness (SKEW) and kurtosis (KURT). 
The metrics were recorded for: a) the assigned weighted AIFs (AIF), b) the AIFs 
before assignment and weighting (AIFSH), c) the residue function (R), d) the 
tissue signal (ΔΜcr) and e) the mixed tissue & arterial signal (ΔΜncr). In addition 
to this, CBF, ATT and aBV, as normally quantified with QUASAR, were 
determined. It should be noted that the GM CBF value calculated with QUASAR 
differed from the peak of the residue function since PVC was incorporated in 
the pipeline. So, the peak of the residue is actually the non-PVC corrected CBF 
value within that voxel. Additionally, GM and WM CBF were calculated using 
PVC; CVR was determined as the percentage change of the GM CBF following 
ACZ injection. 
 All described metrics were extracted from the following regions of interest 
(ROIs): the whole brain (WB), anterior, medial and posterior cerebral artery 
(ACA, MCA, PCA) vascular territories and watershed (W) areas. A mask 
created by Mutsaerts et al. (121) was used for the vascular territory analysis. 
The mask was registered to the low-resolution GM partial volume maps using 
affine registration with normalized cross correlation. The watershed area mask 
was generated based on the vascular territory mask. A summary of the 
identified hemodynamic curves, the metrics extracted by them and the ROIs 
can be found in figure 6.2. 
C(t)	 AIF(t)	 CBF	*	R(t)	
t	 t	 t	
=	
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 The response time to ACZ is known to vary between individuals (93). To 
address this issue, four scans were acquired following injection; the scan used 
to evaluate the response to the stimulus was the one with the highest residue 
function peak (reflecting CBF). All described features were acquired from the 
baseline and post-ACZ scans. 
 
Figure 6.2: Overview of the calculated hemodynamic metrics. A single slice for a single 
time-point is shown for the 5 considered signals. In the second column we see the signal for a 
single voxel and all time-points, following that there is a representation of the extracted metrics 
from a curve and finally the considered ROIs.  
 
6.2.4 Vascular territory and watershed area analysis 
Maps published by Mutsaerts et al. (121) involved nine separations of 
the vascular territories. In the present analysis the three subdivisions for ACA, 
MCA and PCA were merged and the territory masks were registered as 
previously described. The watershed area masks were defined based on the 
vascular territory maps as in figure 6.3. An overview of the calculated metrics, 
each named according to the vascular territory and the measured parameter is 
shown in table 6.2. In this table, metrics are shown for the three (AIF, R, ΔΜcr)  
out of a total of five considered QUASAR-derived time-signals (AIF, R, ΔΜncr 
ΔΜcr and AIFSH). The omitted ones are the non-crushed signal, referred to as 
1)	ΔΜncr	 2)	ΔΜcr	
5)	Residue	
			3)	ΔΜncr-ΔΜcr	
4)	Weighted	AIF	
1	
2	
3	
4	
5	
Skewness	
kurtosis	
Peak						FW	
HWL						HWR	
									TTP	
				Curves	/single	-me-point								Curves	/single	pixel													Metrics																												ROIs	
W
M
CA
PCA
ACA
+whole brain
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ΔΜncr and the AIFs before assignment (AIFSH). Overall 351 hemodynamic 
features were extracted from the QUASAR signals and used in the subsequent 
analysis. The number of features is very high especially when considering the 
available cohort, hence a number of models examining different feature 
combination was evaluated. Additionally, state-of-the-art feature reduction 
techniques and cross-validation were used to reduce the risk of overfitting and 
noise-modelling. 
 
 
Figure 6.3: Vascular territory masks based on Mutsaerts et al (121) and watershed areas 
for all 7 QUASAR slices. 
 
Table 6.2: An overview of features extracted from 3 curves and the 5 considered ROIs. 
Each feature is named according to the vascular territory (anterior cerebral artery-ACA, middle 
cerebral artery-MCA, posterior cerebral artery – PCA and watershed areas) and hemodynamic 
parameter. 
Metric\ROI WB ACA MCA PCA watershed 
CBF WB CBF ACA CBF MCA CBF PCA CBF W CBF 
ATT WB ATT ACA ATT MCA ATT PCA ATT W ATT 
A
C
A
M
C
A
A
C
A
A
C
A
M
C
A
M
C
A
M
C
A
M
C
A
M
C
A
M
C
A
PCA PCA PCA PCA
A
C
A
A
C
A
A
C
A
A
C
A
White-bands= 
watershed areas
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aBV WB aBV ACA aBV MCA aBV PCA aBV W aBV 
AIF FW WB FWAIF ACA FW AIF MCA FW AIF PCA FW AIF W FW AIF 
AIF HWR WB HWR AIF ACA HWR AIF  MCA HWR AIF  PCAHWR AIF  W HWR AIF 
AIF HWL WB HWL AIF  ACA HWL AIF MCA HWL AIF PCA HWL AIF  W HWL AIF 
AIF TTP WB TTP AIF ACA TTP AIF MCA TTP AIF PCA TTP AIF W TTP AIF 
AIF 
skewness 
WB SKEW 
AIF 
ACA SKEW 
AIF 
MCA SKEW 
AIF 
PCA SKEW AIF W SKEW AIF 
AIF kurtosis WB KURT AIF ACA KURT 
AIF 
MCA KURT 
AIF 
PCA KURT AIF W KURT AIF 
AIF peak WB PEAK  
AIF 
ACA PEAK 
AIF 
MCA PEAK 
AIF 
PCA PEAK AIF W PEAK AIF 
ΔMcr FW WB FW ΔMcr ACA FW ΔMcr MCA FW ΔMcr PCA FW ΔMcr W FW TIS 
ΔMcr 
ΔMcr HWR WB HWR ΔMcr ACA HWR 
ΔMcr 
MCA HWR 
ΔMcr 
PCA HWR ΔMcr W HWR ΔMcr 
ΔMcr HWL WB HWL ΔMcr ACA HWL 
ΔMcr 
MCA HWL 
ΔMcr 
PCA HWL ΔMcr W HWL ΔMcr 
ΔMcr TTP WB TTP ΔMcr ACA TTP ΔMcr MCA TTP ΔMcr PCA TTP ΔMcr W TTP ΔMcr 
ΔMcr 
skewness 
WB SKEW 
ΔMcr 
ACA SKEW 
ΔMcr 
MCA SKEW 
ΔMcr 
PCA SKEW 
ΔMcr 
W SKEW 
ΔMcr 
ΔMcr 
kurtosis 
WB KURT 
ΔMcr 
ACA KURT 
ΔMcr  
MCA KURT 
ΔMcr 
PCA KURT 
ΔMcr 
W KURT 
ΔMcr 
ΔMcr peak WB PEAK 
ΔMcr 
ACA PEAK 
ΔMcr 
MCA PEAK 
ΔMcr 
PCA PEAK 
ΔMcr 
W PEAK 
ΔMcr 
R FW WB FW R ACA FW R MCA FW R PCA FW R W FW R 
R HWR WB HWR R ACA HWR R MC AHWR R PCA HWR R W HWR R 
R HWL WB HWL R ACA HWL R MCA HWL R PCA HWL R W HWL R 
R TTP WB TTP R ACA TTP R MCA TTP R PCA TTP R W TTP R 
R skewness WB SKEW R ACA SKEW R MCA SKEW R PCA SKEW R W SKEW R 
R kurtosis WB KURT R ACA KURT R MCA KURT R PCA KURT R W KURT R 
R peak WB PEAK R ACA PEAK R MCA PEAK R PCA PEAK R W PEAK R 
 
 
6.2.5 Feature reduction and classification 
The primary purpose of implementing a machine learning approach was to 
determine which feature combination provides for a better class-differentiation. 
Due to the large number of features and the limited amount of data with regards 
to the current dataset it is good practice to reduce dimensionality in order to 
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avoid overfitting. A framework proposed by Zacharaki et al. (269) was utilised, 
with minor modifications. The investigated binary classification tasks were:  
a) HV vs T2DM,  
b) HV vs IGT&T2DM,  
c) HV vs IGT and  
d) IGT vs T2DM. 
 
For every task, t-tests were run to retain only the features that were 
significantly different between the groups; the significance threshold was p < 
0.05. Subsequently the retained features were normalized (0 mean, 1 variance) 
and used as an input to the SVM-RFE algorithm (257, 258). SVM-RFE is a 
subset selection method, which allows for the reduction of the problem’s 
dimensionality. This algorithm leaves one feature out in every iteration and 
trains an SVM classifier with the remaining ones. Ranking of the features is 
obtained using the weights assigned to every feature during the classification 
task. The Matlab implementation by Yan and Zhang (280) was utilised. It needs 
to be noted that utilisation of t-tests is highly likely to yield a number of false 
positives resulting from the multiple comparisons between the groups. 
However, the utilised feature dimensionality reduction technique based on the 
SVM classifiers deals with redundant features with overlapping information by 
reducing their associated weights. Hence, it is not necessary to account for 
multiple comparisons since the outcome of t-tests is utilised in a dimensionality 
reduction framework based on SVMs. 
 SVM-RFE was run N times (N is the number of considered subjects in 
the task), leaving one subject out in every iteration ending up with N separate 
rankings for all features which were stored in a table having dimensions [N, 
number of features]. The top-ranked features from every iteration were retained 
and used for the subsequent classification task (figure 6.4). In order to 
determine the classifier’s performance with an increasing number of features 
and identify the ones comprising the optimally differentiating combination, we 
tested several values regarding the number of the retained top-ranked features 
ranging from M = 1 to 50. If, for any of the classification tasks, the number of 
significantly different features between the groups was lower than 50 then the 
actual number of different features was used as a limit. The classification 
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accuracy of linear SVM was evaluated for an increasing M. Following this, the 
optimal M was determined. The number of features associated with this M was 
recorded. Additionally, the number of times every feature occurred in the top-M 
(measured as explained in figure 6.4) was recorded and is presented in the 
results section inside parentheses. 
 
Figure 6.4: Philosophy of the feature ranking and selection method. The SVM-RFE 
algorithm is trained leaving out one subject every time and a ranking occurs for every iteration 
of this procedure, which is stored in a table. Subsequently, a decision is made on the top 
features to be retained. In a simplified experiment with 5 subjects (5 shown rows), retention of 
the top-1 features would end up with 5 features being considered (unique features in the first 
column). If the top-2 features were considered, 7 features would be chosen (8 and 1 occur three 
and two times respectively and so on for an increasing number of top-M retained features. 
 
Classification was run using Matlab functions supplied as part of the 
statistics and machine learning toolbox and linear SVM was chosen. The 
feature combinations evaluated in the classification tasks were: 
1) Hemodynamic features extracted from the ΔΜcr, ΔΜncr, AIFSH curves. 
This feature combination is completely independent from the analysis, as 
these are the original QUASAR curves. The only processing prior to the 
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determination of these signals is the registration of the scans, averaging 
and noisy scan removal (model 1). 
2) Hemodynamic features extracted from the curves comprising the linear 
perfusion system (ΔΜcr, AIF, residue). Both the AIF and residue curves 
depend on the post-processing. The AIF depends on the AIF assignment 
technique and the residue function on the post-processing and 
deconvolution techniques (model 2). 
3) Hemodynamic features extracted from all five hemodynamic curves 
(ΔΜcr, ΔΜncr, AIFSH, AIF, residue) (model 3). 
4) CBF, ATT and aBV maps. These are the typically quantified perfusion 
parameters when the technique is used and are analysis-dependent 
(model 4). 
5) Combination of models 1 & 4 (model 5). 
6) Combination of models 2 & 4 (model 6). 
7) Combination of models 3 & 4 (model 7). 
 
The first three models were built purely to evaluate the ability of the 
hemodynamic curves to provide features leading to an optimal class 
differentiation. With model 4 we wanted to evaluate and present in quantitative 
terms the potential benefit from an analysis approach not confined to the typical 
QUASAR-derived features by evaluating the classification performance based 
solely on these. Hence, we evaluated the accuracy using typically quantified 
QUASAR ASL metrics (CBF, ATT, aBV and CVR) from the considered ROIs. 
We compared the performance of the linear SVM classifier using these, as 
opposed to the performance obtained using a detailed hemodynamic analysis 
as described here. In models 5, 6 and 7 we combined the typically quantified 
QUASAR metrics with the detailed hemodynamic features extracted from the 
first three combinations. For all classification tasks, age, was added in the 
feature vector. In addition to these, the classification was run for models 1, 4 
and 5 only with the baseline data to evaluate the classification accuracy and 
derived patterns assuming the acquisition did not include post-ACZ scans. 
 This combination of t-tests, SVM-RFE and linear SVM was used in order 
to preserve the original features, which cannot be retained if methods such as 
principal component analysis are selected. Hence, it is feasible working 
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backwards to identify the specific features comprising the optimally 
differentiating pattern, potentially leading to biomarker identification.  
 In order to evaluate the classification performance and the 
generalisability of the models leave-one-out cross-validation (LOOCV) was 
used. Cross-validation is an important step in statistical and machine learning 
analysis associated with the predictable power of a model. In small datasets, 
where the ability to separate the available data in training and testing does not 
exist, cross validation is used to evaluate the generalisability of the developed 
model instead.  
 All classification steps were run in Matlab. An SVM model was generated 
using the fitcsvm function, which was used as an input to the crossval function 
by specifying that the desired cross validation scheme is LOOCV. Finally, 
kfoldloss was used to assess the generalisability of the model and the 
prediction accuracy. Furthermore, in order to provide reassurance of the 
reproducibility of our results, the random number generator in Matlab was set to 
‘default’ in every iteration. The alternative approach is to run the classification 
procedure numerous times and record the mean value. Recorded values were: 
accuracy (percentage of correctly classified samples), specificity (percentage of 
correct true positives) and sensitivity (percentage of correct true negatives). A 
model was considered to be optimal by judging the following attributes: a) 
classification accuracy and b) number of features contributing towards optimal 
accuracy. The desirable behaviour of a model is to provide the highest possible 
accuracy with the lowest possible number of features to avoid overfitting. 
 
6.2.6 Statistical comparisons 
Comparisons between the groups were conducted using one-way 
analysis of variance (ANOVA), or its non-parametric equivalent (Kruskal-Wallis), 
when the normality and equality of variance assumptions were violated.  
 
6.3 Results 
6.3.1 Conventional analysis approach 
The mean hemodynamic curves comprising the linear perfusion system 
at a voxel-wise level (AIF, residue, tissue) calculated for every subject group 
	 143	
along with a semi-transparent region corresponding to the standard deviation 
are plotted in figure 6.5. 
 
Figure 6.5: Hemodynamic time series curves for every group. From top to bottom AIF, the 
residue function and the tissue curve are shown for the 3 groups for 4 ROIs (ACA, MCA, PCA, 
watershed areas) pre and post-ACZ injection. 
 
 
 
 
Ar
te
ria
l	i
np
ut
	
fu
nc
.o
n	
Re
sid
ue
	
fu
nc
.o
n	
Ti
ss
ue
	c
ur
ve
	
HV	
IGT	
T2DM	
HV	
IGT	
T2DM	
HV	
IGT	
T2DM	
	 144	
 
 
Results for the whole brain ATT, aBV, GM and WM CBF pre and post- ACZ, 
CVR and the volume of GM, WM and CBF inside the brain volume covered with 
the ASL protocol are shown in table 6.3. 
 
Table 6.3: Quantified values for CBF, aBV, ATT and CVR using the developed QUASAR 
ASL quantification pipeline for the scanned cohort. 
 HV (16) IGT (10) T2DM (16) p-value 
Age (years) 50.0±12.0 54.1±5.5 54.5±11.8 0.47 
GM CBF 
baseline 
(ml/100g/min) 
55±5.9 55.7±4.7 60.8±4.2 0.01 
GM CBF post-
ACZ  
(ml/100g/min) 
63.6±5.9 59.8±3.6 61.2±4.8 0.17 
WM CBF 
baseline 
(ml/100g/min) 
23±2.4 23.3±2.1 24.6±1.6 0.15 
WM CBF post-
ACZ  
(ml/100g/min) 
24.8±1.7 24.8±2.1 24.7±2 0.98 
CVR (%) 16.4±13.1 7.7±6.5 0.8±5.7 < 0.001 
ATT baseline 
(s) 
0.62±0.04 0.61±0.05 0.65±0.05 0.13 
ATT post-ACZ 
(s) 
0.55±0.07 0.62±0.07 0.59±0.08 0.08 
aBV baseline 
(%) 
1.1±0.4 1.3±0.3 1.1±0.3 0.05 
aBV  post-ACZ 
(%) 
0.9±0.3 1.1±0.4 1±0.2 0.19 
 
Significant differences were detected for GM CBF baseline (F(2,39) = 
5.807, p = 0.01), CVR (χ2(2) = 16.826, p < 0.01) and aBV baseline (χ2(2) = 
5.832, p = 0.05). When examining specific ROIs, the only significant difference 
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was for ACA ATT post-ACZ (F(2,39) = 3.89, p = 0.03). The absence of 
differences between the groups in CBF within the examined vascular territories 
and watershed areas (when in the meantime differences were identified for GM 
CBF and CVR) could be attributed to the fact that the CBF values within the 
examined vascular territories were not PV corrected and hence reflect the total 
GM and WM CBF. Following multiple comparison correction with FDR the only 
remaining significant difference was for CVR (p=0.004). 
 
Metrics differing between the groups based on conventional QUASAR analysis 
were: baseline GM CBF, CVR, baseline aBV and ACA ATT post-ACZ.  
 
6.3.2 Extended hemodynamic analysis 
In this section, results based on the newly quantified hemodynamic 
features are presented. Every model is examined separately. Results are also 
presented solely for the baseline perfusion data. For every model, accuracy, 
specificity and sensitivity values are reported for the best performing (highest 
accuracy) feature combination. Additional recorded data involve: a) the number 
of features (NF) giving optimal performance; b) the top-M features, where M 
differs from NF as described in figure 6.4; c) the top features (maximum = 10); 
d) the number of SVM-RFE iterations for which the feature under consideration 
was identified in the top-M. The number of subjects included in a task defines 
the maximum occurrence for a feature. For the HV vs T2DM task maximum 
occurrence was 32; for the HV vs IGT&T2DM 42; for HV vs IGT 26 and for IGT 
vs T2DM 26. 
 
First feature combination 
Overall number of quantified features: 211. 
For the HV vs T2DM task, 59 features were significantly different 
following t-tests. The maximum accuracy was 96.9% (sensitivity = 100%, 
specificity = 93.8%) achieved with 27 features identified in the top-12 of the 
SVM-RFE matrix. 10 out of the 27 features (the ones with maximum 
occurrence) are shown in table 6.4. 
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Table 6.4: Model 1, HV vs T2DM task top-10 features identified with SVM-RFE giving 
optimal performance, accompanied with a number indicating their occurrence (Occ.) in 
the top-M.  
Feature Occ. (times) Feature Occ. (times) 
ACA TTP AIFSH post-ACZ 32 ACA KURT AIFSH 
baseline 
31 
ACA SKEW AIFSH  
baseline 
32 ACA TTP ΔΜncr post-ACZ 28 
ACA HWL AIFSH post-
ACZ 
32 ACA SKEW ΔΜcr post-
ACZ 
27 
PCA HWR ΔΜcr post-ACZ 32 W KURT ΔΜcr baseline 27 
PCA FW ΔΜcr post-ACZ 32 WB HWL AIFSH post-ACZ 25 
 
For the HV vs IGT&T2DM task, 85 features were significantly different. 
Maximum accuracy of 92.9% was achieved (sensitivity = 93.8%, specificity = 
87.5%) with 14 features identified in the top-4 of the SVM-RFE matrix (table 
6.5). 
 
Table 6.5: Model 1, HV vs IGT&T2DM task top-10 features identified with SVM-RFE giving 
optimal performance along with their occurrence in the top-M. 
Feature Occ. (times) Feature Occ. (times) 
PCA HWR ΔMcr post-
ACZ  
42 PCA HWL AIFSH baseline 15 
MCA SKEW ΔMcr post-
ACZ 
35 ACA SKEW AIFSH 
baseline 
7 
ACA SKEW ΔMcr post-
ACZ 
18 ACA HWL AIFSH post-
ACZ 
6 
W KURT ΔMcr  baseline 18 W KURT AIFSH baseline 4 
ACA KURT AIFSH 
baseline 
17 ACA TTP ΔΜncr post-ACZ 3 
 
For the HV vs IGT task 85 features differed significantly between the 
groups. Maximum accuracy of 100% was achieved with 5 features that made it 
to the top-3 of the SVM-RFE matrix; these were: PCA HWL AIFSH post-ACZ  
(26), PCA TTP AIFSH post-ACZ (26), W KURT ΔΜcr post-ACZ (17), PCA HWL 
ΔΜncr post-ACZ (8) and ACA TTP ΔΜncr post-ACZ (1). For the IGT vs T2DM 
task, 6 features differed significantly and the accuracy was 65.4% (specificity = 
40%, sensitivity = 81.3%) with 4 features (top-1 in the SVM-RFE matrix); These 
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were W HWR ΔΜcr baseline (14), MCA TTP AIFSH baseline (8), ACA KURT 
ΔΜncr post-ACZ (2), PCA HWL ΔΜncr post-ACZ (2). 
 
Second feature combination 
Overall number of quantified features: 211. 
For the HV vs T2DM task, 71 features differed significantly. Maximum 
accuracy was achieved with 7 features (top-3 in the SVM-RFE matrix) and was 
84.4% (sensitivity = 87.5%, specificity = 81.3%); these were: WB TTP R post-
ACZ (32), WB HWL R post-ACZ (32), ACA HWL R post-ACZ (25), PCA TTP R 
post-ACZ (4), ACA TTP R post-ACZ (1), MCA HWL R post-ACZ (1) and W 
KURT ΔΜcr baseline (1). For the HV vs IGT&T2DM task 85 features differed 
significantly. Maximum accuracy was 83.3% (sensitivity = 88.5%, specificity = 
68.8%) achieved with 5 features (W KURT AIF baseline (2), WB HWL R post-
ACZ (37), MCA SKEW ΔΜcr post-ACZ (1), WB TTP R post-ACZ (1), PCA HWR 
ΔΜcr post-ACZ (1)) that made it to the top-1 of the SVM-RFE matrix.  
For the HV vs IGT task 86 features were significantly different, maximum 
accuracy was 92.3% (sensitivity = 80%, specificity = 100%) with 7 features that 
made it to the top-3 (SVM-RFE matrix); these were: PCA TTP R post-ACZ (26), 
PCA HWL R post-ACZ (26), PCA HWR AIF post-ACZ (13), PCA FW AIF post-
ACZ (10), W KURT ΔΜcr post-ACZ (1) and PCA HWL AIF post-ACZ (1) and WB 
TTP AIF post-AZC (1). For the IGT vs T2DM task, 10 features differed 
significantly between the groups. Maximum accuracy was 69% (sensitivity = 
87.5%, specificity = 50%) achieved with 5 features that made it to the top-1 of 
the SVM-RFE matrix. These were: MCA HWL R baseline (17), MCA HWL AIF 
baseline (4), W HWR ΔΜcr baseline (2), ACA PEAK AIF baseline (2) and WB 
HWL AIF baseline (1). 
 
Third feature combination 
Overall number of quantified features: 351. 
For the HV vs T2DM task, the significantly different features were 116. 
The maximum accuracy was 93.8% (sensitivity = 87.5%, specificity = 100%) 
achieved with 9 features that made it to the top-3 of the SVM-RFE matrix (table 
6.6). 
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Table 6.6: Model 3, HV vs T2DM task top-10 features identified with SVM-RFE giving 
optimal performance along with their occurrence in the top-M. 
Feature Occ. (times) Feature Occ. (times) 
WB HWL R post-ACZ  32 PCA TTP R post-ACZ 3 
WB TTP R post-ACZ 28 W KURT AIFSH baseline 2 
ACA SKEW AIFSH 
baseline 
18 PCA HWL R post-ACZ 1 
ACA TTP AIFSH post-
ACZ 
7 W KURT ΔΜcr baseline 1 
ACA HWL R post-ACZ 4   
For the HV vs IGT&T2DM task 153 features differed, the maximum 
achieved accuracy was 88.1% (sensitivity = 92.3%, specificity = 81.3%) 
achieved with 42 features (table 6.7) that made it at least for one iteration of the 
SVM-RFE to the top-19 features. 
 
Table 6.7: Model 3, task HV vs IGT&T2DM top-10 features identified with SVM-RFE giving 
optimal performance along with their occurrence in the top-M. 
Feature Occ. (times) Feature Occ. (times) 
WB HWL R post-ACZ 42 ACA HWL ΔΜncr post-
ACZ 
42 
WB TTP R post-ACZ  42 PCA TTP R baseline  41 
ACA TTP ΔΜncr post-
ACZ 
42 PCA HWL R post-ACZ 41 
PCA HWL AIFSH post-
ACZ 
42 PCA HWR ΔΜcr post-
ACZ 
41 
W KURT ΔΜcr 
baseline  
42 W KURT AIFSH baseline  39 
 
For the HV vs IGT task 148 features differed; for 2 features that made it 
to the top-1 (SVM-RFE matrix) the accuracy was 92.3% (70% sensitivity, 100% 
specificity). These features were: PCA HWL AIFSH post-ACZ (21) and PCA TTP 
R post-ACZ (5). For the IGT vs T2DM task 15 features differed significantly, 
maximum accuracy was 69.2% (sensitivity = 75%, specificity = 50%) achieved 
with 11 features that made it to the top-4 (SVM-RFE matrix). These were as in 
table 6.8. 
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Table 6.8: Model 4, IGT vs T2DM task, top-10 features identified with SVM-RFE giving 
optimal performance along with their occurrence in the top-M. 
Feature Occ. (times) Feature Occ. (times) 
W HWR ΔΜcr baseline 21 MCA TTP AIFSH baseline  9 
ACA KURT ΔΜncr post-
ACZ  
20 PCA HWL ΔΜncr post-
ACZ  
6 
W PEAK R baseline  14 MCA HWL AIFSH baseline  4 
MCA HWL R baseline  13 MCA KURT ΔΜncr post-
ACZ  
2 
ACA PEAK AIF baseline  12 MCA HWL AIF baseline  2 
 
Fourth feature combination 
Overall number of quantified features: 34. 
For the HV vs T2DM task, 3 features were different following t-tests, the 
maximum accuracy was 81.3% (sensitivity = 87.5%, specificity = 75%) achieved 
with 1 feature (CVR - 32). For the HV vs IGT&T2DM task 7 features were 
significantly different, maximum accuracy of 81.0% (sensitivity = 92.3%, 
specificity = 62.5%) was achieved with minimum four features (top-3 in the 
SVM-RFE matrix): CVR (42), GM CBF baseline (32), ACA ATT post-ACZ (41) 
and PCA CBF post-ACZ (11).  
For the HV vs IGT task, 6 features were significantly different, maximum 
accuracy was 73.1% (sensitivity = 50%, specificity = 81.3%) with 6 features 
(WB ATT post-ACZ (2), ACA ATT post-ACZ (26), PCA aBV post-ACZ (25), ACA 
CBF post-ACZ (2), W CBF post-ACZ (22) and MCA ATT post-ACZ (1)) 
identified in the top-3 of the SVM-RFE matrix. For the IGT vs T2DM task, 4 
features were significantly different and the accuracy was 73.1% (sensitivity = 
81.3%, specificity = 70%) with all 4 features (GM CBF baseline, CVR, W CBF 
baseline, ACA aBV baseline).  
 
Fifth feature combination 
Overall number of quantified features: 244. 
For the HV vs T2DM, 62 features were different, maximum accuracy was 
90.6% (sensitivity = 93.8%, specificity = 87.5%) with 6 features identified to the 
top-3 of the SVM-RFE matrix (PCA HWR ΔΜcr post-ACZ (3), ACA TTP AIFSH 
post-ACZ (30), ACA SKEW AIFSH baseline (1), ACA HWL AIFSH post-ACZ (27) 
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GM CBF baseline (3), CVR (32)). For the HV vs IGT&T2DM task 92 features 
differed, the maximum accuracy was 92.9% (sensitivity = 96.2%, specificity = 
87.5%) achieved with 11 (table 6.9) features that made it to the top-3 of the 
SVM-RFE matrix. 
 
Table 6.9: Model 5, HV vs IGT&T2DM task top-10 features identified with SVM-RFE giving 
optimal performance along with their occurrence in the top-M. 
Feature Occ.(times) Feature Occ. (times) 
CVR 36 PCA HWL AIFSH post-
ACZ  
2 
MCA SKEW ΔΜcr post-
ACZ 
31 ACA TTP ΔΜncr post-
ACZ  
2 
ACA HWL AIFSH post-
ACZ 
23 GM CBF baseline  2 
PCA HWR ΔΜcr post-
ACZ  
20 W KURT ΔΜcr baseline 1 
ACA SKEW AIFSH 
baseline  
7 ACA TTP AIFSH post-
ACZ  
1 
 
For the HV vs IGT task 91 features differed significantly, accuracy was 
100% with 5 features that made it to the top-3 in the SVM-RFE matrix (W KURT 
ΔΜcr post-ACZ (17), PCA TTP AIFSH post-ACZ (26), PCA HWL AIFSH post-ACZ 
(26), PCA HWL ΔΜncr post-ACZ (8) and ACA TTP ΔΜncr post-ACZ (1)). For the 
IGT vs T2DM task 10 features differed, the accuracy of 80.7% (sensitivity = 
87.5%, specificity = 70%) was achieved with 7 features that were identified to 
the top-1 of the SVM-RFE matrix (GM CF baseline (10), CVR (9), ACA ABV 
baseline (2), PCA HWL ΔΜncr post-ACZ (2), W HWR ΔΜcr baseline (1), ACA 
KURT ΔΜncr post-ACZ (1) MCA KURT ΔΜncr post-ACZ (1)). 
 
Sixth feature combination 
Overall number of quantified features: 244. 
For the HV vs T2DM task 74 features were significantly different. The 
highest accuracy was 93.8% (sensitivity = 93.8%, specificity = 93.8%) achieved 
with three features that made it to the top-2 of the SVM-RFE matrix (WB HWL R 
post-ACZ (31), WB TTP R post-ACZ (26) and CVR (7)). For the HV vs 
IGT&T2DM task, 92 features differed significantly, the maximum accuracy was 
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83.3% (sensitivity = 88.5%, specificity = 75%) achieved with 23 features (table 
6.10) that made it to the top-13 (SVM-RFE matrix). 
 
Table 6.10: Model 6, HV vs IGT&T2DM task top-10 features identified with SVM-RFE 
giving optimal performance 
Feature Occurrence 
(times) 
Feature Occurrence 
(times) 
CVR  42 PCA HWR ΔΜcr post-ACZ 42 
WB HWL R post-ACZ  42 ACA SKEW ΔΜcr post-
ACZ  
42 
MCA SKEW ΔΜcr post-
ACZ  
42 MCA SKEW ΔΜcr post-
ACZ 
42 
  W KURT AIF baseline  40 
WB TTP R post-ACZ 42 W KURT  ΔΜcr baseline 38 
 
92 features were significantly different between the groups for the HV vs 
IGT task. 92.3% (sensitivity = 80%, specificity = 100%) was the maximum 
accuracy achieved with 6 features that made it to the top-3 in the SVM-RFE 
matrix; these were: PCA TTP R post-ACZ (26), PCA HWL R post-ACZ (26), 
PCA HWR AIF post-ACZ (14), PCA FW AIF post-ACZ (10), PCA HWL AIF post-
ACZ (1) and W KURT ΔΜcr post-ACZ (1). For the IGT vs T2DM task 14 features 
differed significantly. Maximum achieved accuracy was 65.4% (sensitivity = 
75%, specificity = 50%) with 11 features that made it to the top-5 of the SVM-
RFE matrix. 
 
Seventh feature combination 
Overall number of quantified features: 384. 
For the HV vs T2DM task, the number of significantly different features 
identified with t-tests was 119. Following SVM-RFE implementation the 
maximum achieved accuracy was 84.4% (sensitivity = 93.8%, specificity = 75%) 
achieved with a minimum of 3 features, these features made it to the top-1 in 
the SVM-RFE matrix and were as follows: WB HWL R post-ACZ (29), WM TTP 
R post-ACZ (2) and ACA TTP AIFSH post-ACZ (1). 
For the HV vs IGT&T2DM task, the significantly different features 
identified with t-tests were 160. The maximum achieved accuracy was 88.1% 
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(sensitivity = 88.5%, specificity = 87.5%) achieved with a minimum of 22 
features that made it at least once to the top-7 in the SVM-RFE matrix. The 
identified top-10 features can be found in table 6.11.  
 
Table 6.11: Model 7, HV vs IGT&T2DM task top-10 features identified with SVM-RFE 
giving optimal performance along with their occurrence in the top-M. 
Feature Occ. (times) Feature Occ. (times) 
WB HWL R post-ACZ  42 ACA TTP ΔΜncr post-ACZ  24 
CVR 35 PCA HWL R post-ACZ 21 
ACA HWL ΔΜncr post-
ACZ 
34 PCA HWR ΔΜcr post-
ACZ  
13 
WB TTP R post-ACZ  32 W KURT AIF baseline 11 
W KURT ΔΜcr baseline 31 PCA TTP R post-ACZ 11 
 
For the HV vs IGT task, the significantly different features identified with 
t-tests were 154. The maximum accuracy was 92.3% (sensitivity 70%; 
specificity 100%) achieved with 2 features (PCA TTPR post-ACZ (5) and PCA 
HWL AIFSH post-ACZ (21)) that made it to the top-1 of the SVM-RFE matrix. For 
the IGT vs T2DM task, the significantly different features identified with t-tests 
were 19. The maximum recorded accuracy was 80.7% (sensitivity = 81.3%, 
specificity = 80%) for 6 features (MCA HWL R baseline (1), W HWR ΔΜcr 
baseline (1), PCA HWL ΔΜncr post-ACZ (2), GM CBF baseline (17), CVR (4), 
ACA aBV baseline (1)), all made it to the top-1 (SVM-RFE matrix) at least once. 
A summary of the model performance, the identified number of features 
and the number of significant features per task, can be found in the Appendix1 
in table A6.1. In table A6.2, the accuracy, sensitivity, specificity, NF and the top-
5 features are shown for the best two performing models per task. Finally, in 
figure 6.6 the classification accuracy as a function of the number of features 
incorporated in the task is plotted for models 1,2,4,5 and 6. 
 
Overall models 1 and 5 had the optimal performance for the HV vs T2DM, HV 
vs IGT&T2DM and HV vs IGT tasks. For the IGT vs T2DM task, models 5 and 7 
were the optimal. Perfect classification (100%) was achieved for the HV vs IGT 
task. Classification was also very high for the HV vs T2DM task (96.9%). The 
performance for IGT and T2DM separation was lower compared to other tasks.  
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Figure 6.6: Model accuracy for every classification task obtained using LOOCV as a 
function of the number of features for models 1,2,4,5 and 6. 
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6.3.3 Classification based just on the baseline scan 
 
Model 1 
106 features were identified, for the HV vs T2DM task, 11 differed 
significantly, the calculated 75% accuracy (sensitivity = 62.5%, specificity = 
68.8%) was achieved with one feature: ACA SKEW AIFSH. For the HV vs 
IGT&T2DM task, 23 features were different; the achieved accuracy was 81.0% 
(sensitivity = 92.3%, specificity = 62.5%), achieved with 6 features (PCA KURT 
ΔΜcr (4), W KURT ΔΜcr (12), ACA SKEW AIFSH (31), W KURT AIFSH (26), ACA 
KURT ΔΜncr (9) and W KURT ΔΜncr (2)) that made it to the top-2 in the SVM-
RFE matrix. For the HV vs IGT task, 24 features were different, the achieved 
accuracy was 61.5% (sensitivity = 40%, specificity = 62.5%) achieved with 10 
features (top-5: W HWR ΔΜcr (16), WB TTP ΔΜncr (14), WB HWL ΔΜncr (6), W 
FW ΔΜcr (5) and MCA TTP ΔΜncr (4)) that made it to the top-2 in the SVM-RFE 
matrix. For the IGT vs T2DM task, 3 features differed significantly and the 
maximum accuracy with all 3 (W HWR ΔΜcr, MCA TTP AIFSH, MCA HWL AIFSH, 
all with an occurrence of 26) was 69.2% (sensitivity = 81.3%, specificity = 50%). 
 
Model 4 
17 features were identified. For the HV vs T2DM task, 2 features differed 
significantly, 71.9% was the maximum accuracy (sensitivity = 62.5%, specificity 
= 62.5%) achieved with minimum 1 feature (GM CBF). For the HV vs 
IGT&T2DM task 1 features differed, maximum accuracy was 64.3% (sensitivity 
= 88.5%, specificity = 18.8%) with 1 feature (GM CBF). For the HV vs IGT task, 
no features differed significantly between the groups. For the IGT vs T2DM 
task, 3 features were significantly different; maximum accuracy was 76.9% 
(sensitivity = 75%, specificity = 80%) with all three features (GM CBF, W CBF, 
ACA aBV). 
 
Model 5 
122 features were identified. For the HV vs T2DM task 13 features 
differed; maximum performance was 75% (sensitivity = 75%, specificity = 75%) 
with 2 features (ACA SKEW AIFSH (29), GM CBF (3)) that made it to the top-1. 
For the HV vs IGT&T2DM task 24 features differed significantly, maximum 
	 155	
accuracy of 78.6% (sensitivity = 88.5%, specificity = 62.5%) was achieved with 
7 features (top-5: W KURT AIFSH (15), ACA SKEW AIFSH (32), ACA KURT 
ΔΜncr (18), W KURT ΔΜcr (9), PCA KURT ΔΜcr (6)) that made it to the top-2 in 
the SVM-RFE matrix. For the HV vs IGT task 24 features differed, maximum 
accuracy was 61.5% (sensitivity = 70%, specificity = 86.4%) with 10 features; 
the same as for model 1. For the IGT vs T2DM task 24 features differed 
significantly, maximum accuracy was 61.5% (sensitivity = 40%, specificity = 
62.5%) achieved with 4 features (top-1) these were W HWR ΔΜcr (6), GM CBF 
(18), W CBF (1), ACA aBV (1). In table 6.12 a summary can be found facilitating 
comparisons between the performance based on features derived from the 
baseline scans and for both baseline and post-ACZ for all 4 tasks and the 3 
models. 
 
Table 6.12: Comparison between the performance of models based solely on the baseline 
scan and models based on both pre and post-ACZ scans. NF1 refers to the initial number of 
significantly different features following t-tests. NF2 refers to the number of features contributing 
towards optimal class-differentiation following SVM-RFE and training of the SVM classifier. Acc. 
Is the recorded classification accuracy. 
Model NF1  Acc. (%) NF2  NF1  Acc. (%) NF2 
 Only baseline Baseline & post-ACZ 
Healthy volunteers vs type-2 diabetes 
1 11 75 1 59 96.9 27 
4 2 71.9 1 3 81.3 1 
5 13 75 2 62 90.6 6 
Healthy volunteers vs type-2 diabetes & impaired glucose tolerance 
1 23 81 6 85 92.9 14 
4 1 64.3 1 7 81.0 4 
5 24 78.6 7 92 92.9 11 
Healthy volunteers vs impaired glucose tolerance 
1 24 61.5 10 85 100 5 
4 0 N/A 0 6 73.1 6 
5 24 61.5 10 91 100 5 
Impaired glucose tolerance vs type-2 diabetes 
1 3 69.2 3 6 65.4 4 
4 3 76.9 3 4 73.1 4 
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5 6 76.9 4 10 80.7 7 
 
For every task the performance was increased when using both baseline and 
post-ACZ features. This is particularly noticeable for the HV vs IGT task. The 
results indicate that an additional perfusion acquisition following induced 
vasodilation can provide invaluable information on hemodynamic alterations 
and contribute towards optimal class-separation. 
Optimal features emerged from all vascular territories and mainly captured the 
pattern of delayed and dispersed bolus delivery (e.g. HWL, TTP, KURT). From 
the typically quantified QUASAR metrics, CVR was the one identified most 
often as part of the optimal patterns. The majority of important features 
emerged from the post-ACZ acquisition. 
 
 
 
6.4 Discussion  	
Increased GM CBF and reduced CVR were detected in hyperglycemia 
Our findings suggest that baseline CBF is increased in T2DM compared 
to HV, and IGT demonstrates a similar pattern to T2DM. This has been found in 
only a few studies and could suggest the existence of a potential compensatory 
mechanism to account for impaired oxygen delivery to the tissue. Vasodilation 
as a response to tissue hypoxia has been found in diabetes (302). Glycated 
hemoglobin (HbA1c), which is higher than normal in both IGT and T2DM has an 
increased heme-oxygen affinity. The oxygen dissociation curve of this 
hemoglobin species is shifted compared to normal and this underlies tissue 
hypoxia (303). Insufficient oxygen and glucose retention by the tissue due to 
insulin resistance could result in the observed compensatory mechanism 
causing dilation with increased amounts of blood flowing to the tissue. Following 
vasodilation a big increase in the GM CBF value was observed for healthy 
individuals. This change captured by CVR was lower in IGT and even lower in 
T2DM compared to HV. 
Increased baseline CBF and reduced CVR in T2DM suggest that 
maximum vasodilation has been reached at baseline since pharmacologically 
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induced vasodilation, which is supposed to mimic the physiological one, does 
not lead to the anticipated blood flow increase. Our findings, regarding the 
response to a vasodilating stimulus, are in line with transcranial Doppler, 
internal carotid blood flow and BOLD studies reporting reduced responses (15, 
42, 53). These techniques are substantially different from ASL since the first 
two are focused on the velocity of red blood cells and the second does not 
quantify baseline and post-stimulus values but rather the observed change. 
There is no published study currently examining cerebral perfusion in T2DM 
using a multi-TI/PLD ASL approach. The single-PLD approaches have detected 
a lower or similar baseline CBF value in T2DM compared to HV and a lower 
CVR (15, 36).  
The increased baseline CBF finding could also be connected with the 
findings of van Bussel et al. (304); in their study examining the default mode 
network they found a better more efficient organization of the network in T2DM 
and pre-diabetes. This finding, similarly to the increased baseline perfusion 
observed here, might indicate an early compensatory mechanism, in a 
cognitively asymptomatic population, preceding cognitive decline. In their study, 
as in ours, the population was neurologically normal. 
Brain perfusion in T2DM is hypothesised to be impaired as a result of 
endothelial dysfunction and BBB disruption (10, 51). The inconsistency of 
perfusion imaging findings in diabetes could be attributed both to cohort 
idiosyncrasies (usually the studies involve small cohorts) and to the utilised 
imaging techniques. When considering the adopted perfusion imaging 
approaches, both sequence parameters and post-processing approaches can 
vary and have the potential to impact the observed perfusion values and affect 
the resulting conclusion.  
One of the factors that can vary, especially in single-PLD ASL MRI 
studies is the PLD value per se. In Moya-Moya patients it has been shown that 
a single-PLD approach underestimates perfusion compared to multi-PLD 
implementations, which also demonstrate a better agreement with PET 
measurements (305). Increased ATT does not necessarily lead to perfusion 
underestimation (the perfusion peak is missed) as it can lead to overestimation 
due to slower magnetization relaxation inside the blood (125). A technique 
insensitive to transit time changes such as the one used in this study is unlikely 
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to miss the perfusion peak and could potentially shed light upon the underlying 
perfusion pattern. In addition to this, time-resolved ASL and in particular 
QUASAR ASL has the potential to provide rich information that can be used to 
unravel abnormal cerebral perfusion patterns. Its competitive advantage is the 
retention of hemodynamic signals allowing for a detailed hemodynamic 
analysis. 
 It is important to emphasise that our results are corrected for potential 
atrophy due to the use of a partial volume correction method, thus reflecting the 
actual perfusion value in the existing cortical GM.  
 Usually in brain perfusion studies, CBF and CVR are quantified and in 
more rare cases arterial or mean transit time are also determined. A more 
detailed hemodynamic analysis is not typically conducted. 
 
Extended hemodynamic analysis of ASL signals provides additional 
insight into hemodynamic impairment. 	
Per model analysis 
It was shown that the hemodynamic curves representing the pattern of 
delivery of water to the tissue are different between healthy individuals and 
subjects with diabetes and pre-diabetes. By carefully examining figure 6.5 it can 
be seen that baseline T2DM curves have a higher peak and are wider than the 
HV ones. Following ACZ injection, the anticipated increase is observed in the 
peak value in all curves for HV, a lower increase in IGT and an even lower 
increase in T2DM for all examined ROIs. IGT curves at baseline are more 
similar to HV curves and the post-ACZ curves are more similar to the diabetes 
curves. This observation could suggest that a compensatory mechanism has 
not yet been established for IGT. This pattern, which can be characterised in a 
qualitative manner by observing figure 6.5, has also been captured by our more 
detailed hemodynamic analysis. The evaluated models combined 
hemodynamic features extracted from processed and unprocessed QUASAR 
data.  
 It should be noted that the AIFSH, ΔΜcr and ΔΜncr signals are based on 
originally acquired signals and not on any subsequent processing, which can 
have an impact on the observed differences. These signals comprised model 1 
for which a very high accuracy in the examined classification tasks was 
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achieved. This finding is of great importance, since, if a significant pattern was 
not captured by the original unprocessed ASL signals, a potential high 
performance after processing could imply that this was the effect of modelling.  
 The second evaluated model comprised metrics extracted solely from the 
three hemodynamic curves comprising the linear perfusion model (AIF -> 
residue -> ΔΜcr). The third examined model comprised features from all 5 
hemodynamic curves. Along with the detailed hemodynamic features extracted 
for the first time from the QUASAR signals, typically quantified QUASAR 
metrics were also determined. ATT, aBV and CBF are also extracted from the 
hemodynamic curves. CBF is quantified as the peak of the residue function, 
ATT is the difference in the rising times of the AIF and ΔΜcr signals and aBV is 
the area under the arterial signal curve scaled by several parameters related to 
the theoretical bolus area. These typically quantified QUASAR features 
constituted the fourth evaluated model. When model 4 was used, the 
performance for all tasks was reduced with only one exception, task 4, where it 
was one of the three best models. In models 5, 6 and 7, model 4 was combined 
with different combinations of hemodynamic curves.  
 
Per task analysis 
For the HV vs T2DM task, we observed that the best models were model 
1 and model 6. Model 1 had a very high performance achieved with a large 
number of features. Models 3, 5 and 6 also achieved a high performance 
though with a smaller number of features. Interestingly enough, model 6 had a 
high performance with only 3 features. When only the QUASAR-derived 
features were used, the model’s accuracy (model 4) was 81.3%, lower than the 
accuracy of models 1, 5 and 6 indicating that the consideration of additional 
hemodynamic features is beneficial for accurate class-differentiation. Most 
importantly, the features leading to optimal separation between HV and T2DM 
based on the top-performing models emerged mainly from the ACA and PCA 
territories, the whole brain and from GM.  
For the HV vs IGT & T2DM task, high accuracy (lower than the HV vs 
T2DM task) was achieved with model 1 and model 5. This task investigated 
whether the IGT and T2DM groups, if put together, could be accurately 
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separated from HV. The high performance suggests that IGT and T2DM could 
be potentially considered as one distinct group.  
For the HV vs IGT task, when the QUASAR-derived features alone were 
considered, the accuracy was 73.1%. When models 1 and 5 were used, the 
classification accuracy was perfect (100%) and more importantly, achieved with 
a low number of features indicating that the considered extended analysis 
captures better the difference between HV and IGT than a conventional 
QUASAR analysis. These features were the same for both models. They stem 
from the PCA and ACA territories and watershed areas and were all extracted 
from the post-ACZ curves indicating that the main difference between the 
groups was not at baseline but following the vasodilating stimulus. They are all 
capturing the time it takes for the tracer to reach the peak in the PCA and ACA 
territories and the pattern of dispersion in watershed areas.   
The classification accuracy when conducting analysis of the baseline 
scan for the HV vs IGT task was far lower (61.5%) compared to the recorded 
100% when features from both pre- and post-ACZ acquisitions were used. This 
observation is of great importance, since it suggests that at baseline the 
perfusion differences between IGT and HV are less prominent compared to the 
post-ACZ ones. Based on hemodynamic features examining the response to a 
vasodilating stimulus, classification of HV vs IGT was perfect, suggesting that a 
distinct hemodynamic pattern for IGT is absent at rest but has already 
developed for tasks requiring increased blood flow. Hence, when investigating 
early hemodynamic impairment, recording the response to a stimulus could be 
of additional prognostic or diagnostic benefit. 
For the IGT vs T2DM task, all models had a relatively lower performance 
compared to the previous tasks. Model 1, which was optimal for the other tasks, 
provided a low accuracy of 65.4%.  Models 7 and 5 had a higher accuracy 
(80.7%), based mainly on typically quantified QUASAR features. The number of 
significantly different features between the groups also is of great interest since 
on its own it is indicative of an existing pattern. For the first three tasks when 
considering the top performing models examining normoglycemia vs 
hyperglycemia, the number of identified features ranged between 59 and 92 
depending on the task and model. For the fourth task this number ranged 
between 4 and 10. 
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Overall top-scoring features extracted from the hemodynamic curves for 
the first three tasks involved TTP, skewness and HWL, which are indicative of 
the delays in the delivery of the tracer to the tissue and kurtosis and HWR 
which capture the dispersion profile of the delivered bolus. 
 The performance of the model is not the only metric that one should 
focus on. We should not forget that the utilised sample size is small so a large 
number of features comparable to the sample size could imply that the 
classification performance is a result of overfitting. In tasks and models where 
the number of features giving high classification was small (i.e. models 3, 5, 6, 
HV vs T2DM task; models 1, 3, 5, HV vs IGT task) confidence can increase 
about the generalisability of the result. LOOCV, which was used as a safeguard 
for overfitting, is a robust method which is used to address such issues, 
however it is known to provide optimistic values with regards to the 
generalisability error (267).  
 It should be emphasised that the goal of this part of the study was not to 
build a robust classifier to be used as a ‘stand-alone’ model. Rather, based on 
our data and by acknowledging the limitations posed by our sample size, we 
attempted to capture a pattern describing the differences between our groups, 
using methods adept for small datasets. The generalisability of the model was 
assessed using cross-validation. We demonstrated a certain tendency captured 
by QUASAR ASL. This tendency was particularly strong for HV vs T2DM and 
HV vs IGT tasks, where the accuracy was high and the number of utilised 
features by the classifier very low.  
 A detailed hemodynamic analysis, as described in this chapter, is not 
typically conducted. The majority of ASL protocols do not actually allow for such 
an analysis, since they are single time-point or they do not utilise vascular 
crushers. However, this work has shown that considering multiple metrics, 
which can capture the whole shape of the hemodynamic curves, holds great 
potential to better characterise the underlying perfusion pattern and thus 
distinguish subtle differences between normal from abnormal. This 
hemodynamic analysis could be used in other diseases affecting brain 
perfusion, whether severe or subtle, in order to monitor hemodynamic 
alterations over time, or between groups.  
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It is important to note that this pipeline utilised a model-free post-
processing approach, whereby inferences about hemodynamic curves and 
curve-fitting are avoided. This makes the technique less robust to noise, but 
avoids using models based on assumptions that could be violated, particularly 
due to existing pathological alterations. Even in this implementation, not all 
priors could be avoided. A value of 91% inversion efficiency was assumed, 
based on published QUASAR measurements (154). Also, a single value for the 
relaxation time of the blood was used (T1b = 1.65s) for every subject. However, 
it is known that T1b varies with the value of the hematocrit (306), it is also 
known to be different between normoglycemia and hyperglycemia (307). At the 
time when the subjects were scanned, their hematocrit was not recorded. 
Another factor to be taken into account with regards to the acquisition is that for 
all subjects the velocity threshold when the crusher gradients were on, was 
4cm/s. For subjects with athelosclerosis and delayed perfusion, there is a 
chance that the intravascular signal will not be crushed properly due to its low 
velocity compared to healthy volunteers. 
 
6.5 Conclusions 
In this chapter, we investigated in depth cerebral hemodynamics in IGT 
and T2DM using a conventional and an extended hemodynamic analysis 
approach. Conventional perfusion analysis captured several differences of 
interest, such as increased baseline GM CBF, reduced CVR and differences in 
ATT between groups. As part of the applied extended hemodynamic analysis, 
hundreds of features capturing the underlying perfusion pattern were extracted 
from QUASAR data. 
We examined the performance of models comprising different 
hemodynamic feature combinations in the following classification tasks: HV vs 
T2DM, HV vs insulin resistance, HV vs IGT and IGT vs T2DM. Numerous 
metrics differed between the groups and we used t-tests to determine the 
significantly different features. Subsequently, we utilised a machine learning 
pipeline to determine optimally differentiating feature combinations by 
evaluating 7 possible models, each model containing a different feature 
combination. Due to the small dataset, overfitting was a major concern that was 
somewhat addressed by LOOCV. However, claims about model building and 
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biomarker identification cannot be made with a high degree of confidence. We 
determined feature combinations derived from hemodynamic curves that differ 
between our groups and have shown that, for the given dataset, these features 
can capture class-differences. Of particular interest are the features with high 
occurrence, especially in tasks where the optimal feature number leading to 
high accuracy was low.  
The best models were the ones involving the unprocessed QUASAR 
curves (initial crushed, non-crushed signal and their subtraction). This is an 
indication that there is indeed a difference captured by the technique and it is 
not the by-product of the processing pipeline. One of our models comprised the 
typically quantified QUASAR features. This model demonstrated a lower 
accuracy compared to models incorporating the newly quantified metrics. 
Additionally, we have shown that the features with the highest impact in the 
correct classification of the subjects were not the typically quantified QUASAR 
features, which were only occasionally top-ranked features, being outperformed 
by newly evaluated curve-descriptive metrics.  
 The significance of our findings extends in several directions. First and 
most importantly, we found a distinct hemodynamic pattern for both T2DM and 
IGT compared to HV. T2DM differed both pre- and post–ACZ from HV whereas, 
interestingly, IGT at baseline had a similar pattern to HV, while post-ACZ it was 
dissimilar to HV. Class-separation between HV and IGT was optimal, as 
opposed to IGT and T2DM separation, suggesting the existence of more 
hemodynamic similarities between IGT and T2DM rather than between IGT and 
HV. Secondly, we identified metrics that can capture better the hemodynamic 
pattern compared to the typically quantified QUASAR metrics. Thirdly, we have 
shown that there is an additive advantage of having a post-stimulus acquisition 
and combining the metrics of both acquisitions in a single model. Finally, we 
have shown that QUASAR ASL, which is currently under-used as an ASL 
modality given its advantage of acquiring multiple signals, can capture subtle 
hemodynamic patterns and could potentially provide us with hemodynamic 
disease biomarkers. 
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Chapter 7: 
Processing of multi-modal MR images in 
type-2 diabetes and impaired glucose 
tolerance 	
Abstract 
Retinopathy, neuropathy and nephropathy are some of the most 
common complications of T2DM. In addition, patients are at a higher risk of 
developing Alzheimer’s or having a stroke compared to the healthy population. 
The disease can influence both the macro and microvasculature. Studies have 
shown that the degree of mild cognitive impairment compared to aged-matched 
healthy volunteers is higher in diabetes. The disease’s impact on the 
vasculature, complications such as stroke and its connection with cognition, are 
some of the main drivers for examining the diabetic brain.  
MRI can provide an invaluable window into alterations occurring at both 
a functional and a structural level. In this chapter, we shift the focus from 
perfusion changes in the brain to structural and physiological changes, the latter 
ones connected with the velocity of the inflowing blood at the carotid level and 
the diffusivity of water molecules. Several techniques and pre-processing tools 
were evaluated and optimal suggestions are presented for brain extraction, bias 
field correction and segmentation; three of the most important pre-processing 
steps in brain MR image analysis. By using state-of-the-art techniques for 
structural MRI analysis we have quantified the volume of numerous structures 
of interest (e.g. amygdala, hippocampus), GM, WM, cerebrospinal fluid and 
cortical thickness. Using voxel-based morphometry, we sought to determine 
regions of difference between the groups without defining specific ROIs. FLAIR 
T2-scans were used to quantify the white matter hyper-intensity burden in our 
cohort using available software. PC-MRA images were used to quantify velocity 
of the inflowing blood at the level of the carotids. A detailed analysis of the 
blood velocity pattern was implemented in Matlab using an in-house developed 
semi-automated tool allowing for arterial vessel determination. The apparent 
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diffusion coefficient was quantified for structures of interest using DWI. Finally, 
using in-house software, the coronal maximum intensity projection of 3D TOF-
MRA scans was analysed and several vasculature-descriptive metrics such as 
the vessel length, density and number of branching points were quantified. 
The results for the T2DM patients relative to the healthy volunteers point 
towards: a) increased number of leukoaraiosis; b) lower carotid flow velocity at 
baseline and post-ACZ, c) lower number of branching points in the vasculature 
and d) GM differences in structures such as the thalamus, hippocampus and 
amygdala. The examined IGT subjects had similarities with the HV population 
structurally, however, they demonstrated a similar pattern to the T2DM group 
when carotid flow velocity was examined.  
The results point towards global and localised functional and structural 
differences between T2DM and HV, with the pre-diabetes group demonstrating 
structural characteristics similar to the HV group and functional ones similar to 
the T2DM group. 
 
7.1 Introduction 
The ability to learn and remember, along with the speed of information 
processing, are the main cognitive domains influenced during late-life in 
patients with T2DM (308). Global and local GM atrophy patterns, volume 
reduction in structures such as the hippocampus, white matter lesions, lacunes 
and silent brain infarcts are considered end-point changes, possibly preceded 
by functional alterations (34). Such changes have been thoroughly investigated 
using high resolution T1-weighted and T2-weighted MRI scans (mainly FLAIR) 
and are connected with small vessel disease and cognitive decline (309). 
Findings, based on a large study conducted to investigate structural changes in 
the diabetic brain as a result of the followed treatment protocol, ACCORD-MIND 
(310), suggest that global and local atrophies are connected with diabetes 
duration and that lower GM volume is connected with cognitive decline (311). It 
was found that intensive glucose control was connected with reduction in the 
loss of GM (312). MR imaging has also been used to examine structural 
alterations associated with the integrity of the WM tracts, and changes focused 
on diffusion-related parameters, blood velocity and perfusion (33, 34).  
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Being a multi-purpose imaging technique, MRI allows for the extraction 
of information capturing a variety of structural and functional aspects of the 
examined organ - in our case the brain. As briefly discussed in Chapter 2, 
numerous MRI modalities have been devised that enable the detection of 
abnormalities in the brain structure, diffusion, perfusion, blood velocity and 
vasculature. For some modalities, it might be sufficient to visually inspect the 
resulting image and detect obvious alterations. For instance, when examining a 
T2-FLAIR scan, a neuro-radiologist can spot relatively quickly and accurately 
the presence of white matter hyper-intensities. When examining cerebral 
angiograms, prominent collateral circulation, stenosis or occlusions can be 
detected by carefully examining the image.  
However, when the investigated changes are not eye-catching, a simple 
visual assessment of the scan might result in missing crucial information. For 
example, when a subtle global atrophy pattern exists, only an automated 
technique is capable of successfully capturing this information. A 3D high-
resolution structural image might consist of more than 200 slices; a radiologist 
will have to inspect them one-by-one to segment structures of interest and 
detect potential abnormalities. This laborious task usually requires going back 
and forth in the image to validate the manual selections and is typically 
conducted on MPRAGE and T2-FLAIR scans. In MR Angiography, utilisation of 
the maximum intensity projection is quite common for detection of potential 
abnormalities (313). 
Manual region definition is considered the gold standard for anatomical 
segmentation and is not confined to high resolution T1-weighted and FLAIR 
scans, but is also used for modalities such as PC-MRA. Numerous studies have 
reported high inter- and intra - observer variability when examining manual 
segmentations of T1 and T2-weighted scans (314, 315). Due to this variability 
and the time requirements for the task, significant scientific effort has been 
made over the last decades in developing algorithms to perform such tasks 
automatically. The development of automated tools for segmentation and ROI 
selection has the potential to facilitate, and greatly accelerate, image 
interpretation, while being at the same time easy to use. These tools can also 
boost reproducibility and potentially provide metrics that can be used for 
disease stage evaluation. 
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Processing of a high resolution anatomical scan might involve detailed 
cortical parcellation and ROI analysis usually centered on areas of interest such 
as the hippocampus (46) or other subcortical structures. Another popular 
approach is VBM, whereby comparison at a voxel-wise level between groups is 
conducted following image normalization to a common space (245). However, 
conventional VBM approaches are mass-univariate (248). Multivariate 
approaches, typically based on machine learning and regression models, are 
particularly popular in studies examining brain tumors and Alzheimer’s 
dementia (249, 250). In the field of T2DM, machine learning based MRI 
analysis methods have not yet been tested. The analysis of the structural scan 
in the present study was conducted using well-established methods.  
Along with the structural images used to assess atrophy patterns and 
cortical abnormalities, in this chapter we processed FLAIR, PC-MRA, DWI and 
TOF-MRA images. FLAIR images are usually analysed either manually or by 
using existing WM lesion segmentation tools. Here, we used one of the most 
popular tools for WMH segmentation, namely the lesion segmentation toolbox 
(238). Blood velocity was studied using PC-MRA. Findings based on the PC-
MRA technique are usually presented as flow values. In T2DM and IGT, it has 
been found that flow and velocity at the level of the carotids is decreased. This 
finding is corroborated by PC-MRA and TCD studies (36, 42, 44, 53). In the 
present study, we conducted a detailed velocity pattern analysis based on the 
PC-MRA data.  
Angiogram processing usually involves the construction of maximum 
intensity projections, which are visually inspected to detect obvious stenosis or 
occlusions. Automated tools for vessel segmentation are at an experimental 
stage (313, 316) and neuroimaging software tools have not yet incorporated 
angiogram analysis software. Only one study published recently has looked into 
angiogram-derived metrics in T2DM, which reported a lower number of 
branching points (192). 
Our aim in the present chapter was to process the following MR 
modalities: High resolution T1-weighted (MPRAGE), FLAIR, DWI, PC-MRA, 
TOF-MRA and extract useful metrics that could be evaluated as potential 
disease biomarkers. For processing of the DWI, PC-MRA and TOF-MRA scans, 
in-house Matlab scripts were developed. The MPRAGE images were analysed 
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using cortical parcellation, voxel-based morphometry and a machine-learning 
based technique.  
This chapter describes preliminary evaluation of every modality 
described above (as a series of sub-chapters) as an initial study of 
abnormalities occurring in IGT and T2DM. The goal is to gain an insight into 
changes of structural and physiological nature that could fuel future work 
especially when considered in tandem with the hemodynamic findings reported 
in the previous chapter.  
 
7.2 T1-weighted (MPRAGE) scan analysis 
 
7.2.1 Methods 
7.2.1.1 Brain extraction 
Two approaches were assessed for brain extraction. The first evaluated 
tool was FSL’s BET (213). Several values were tested for the intensity threshold 
(f), separating brain from non-brain tissue, starting from the values suggested 
by Popescu et al.  (317). The second approach used SPM’s tissue 
segmentation tool. The outputs of the segmentation are tissue specific maps. In 
order to construct a brain mask based on the segmentation results, the 
generated GM, WM and CSF masks were summed up to acquire the contour of 
the brain tissue. The masks generated with both approaches were visually 
evaluated for the presence of holes; the masked brains were subsequently 
checked for detection of areas where part of the cortex was masked out. In 
such cases, morphological operations were performed locally (dilation, erosion 
and image filling) to correct for imperfections in the generated mask.  
 
7.2.1.2 Bias field correction and brain segmentation 
Three tools were evaluated for bias field correction and brain tissue 
segmentation. The first tool was FSL’s FAST (318) and the second, SPM’s new 
segment algorithm (214). Both SPM and FSL segmentation routines have BFC 
strategies incorporated in their pipeline and rely on GMMs for tissue 
segmentation.  The main difference is that SPM incorporates spatial priors, 
whereas FSL uses Markov random fields theory to incorporate spatial 
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information. For the third approach, the ANT’s N4 algorithm (208) was utilised 
for the BFC step and SFCMC (232), was used for tissue segmentation.  
BFC can be applied on the masked or the non-masked images. To 
determine the optimal choice, the N4 algorithm was implemented using three 
different approaches. The algorithm was run having as an input: a) the whole 
image, b) a masked version of the image and c) the whole image along with the 
respective mask.  
As described in section 3.1.4, SFCM operates in a local window, which in 
the default implementation is a 5x5 isotropic window (232). To identify the 
optimal neighbourhood size for the spatial extent of the clustering, we tested a 
weighted 5x5 window, no window (equivalent to simple FCM without accounting 
for similarities in a local neighbourhood) and isotropic 3x3, 7x7 and 9x9 
windows. The MAPE was calculated for voxels within the brain mask and for 
voxels with ground truth GM value greater than zero. 
The tissue classification problem was defined as a three-class problem, 
the classes being: GM, WM and CSF. 
The efficacy of the aforementioned algorithms was evaluated by using 
simulated data from the McGill’s brainweb database 
(http://brainweb.bic.mni.mcgill.ca/brainweb/). For the downloaded simulated 
data (involving T1-weighted and segmented GM, WM, CSF maps), the specific 
chosen parameters of 1mm3 isotropic voxel and 25% bias field were based on 
brains of healthy subjects and on manual tissue segmentation. The brainweb 
digital phantom is typically used to evaluate segmentation techniques (319). 
Metrics used to determine the accuracy of the segmentation techniques were 
the MAPE at a voxel wise level for GM and WM maps.  
 
7.2.1.3 Voxel-based morphometry  
Voxel-based morphometry allows for detection of brain regions that differ 
between groups by avoiding specific ROI determination, since it proceeds to 
group-wise comparisons at a voxel level. The pipeline behind VBM in FSL and 
SPM is highly similar. Both these techniques are mass-univariate (comparisons 
are conducted at a single voxel level). 
In this study, FSL’s pipeline was used, since fewer prior assumptions 
compared to SPM are utilized in the analysis. We deviated slightly from the 
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pipeline instructions, so that we could use the brain extracted and BFC images 
generated during the previous steps. The first applied pre-processing step 
outside the VBM FSL pipeline was bias field correction using N4. Subsequently, 
the images were brain extracted as per method two described in the previous 
section (7.2.1.1).  
Following brain extraction, the FSL VBM (276) pipeline was 
implemented. FSL creates a GM study template using the same number of 
subjects from every group. This template is subsequently mirrored and a final 
mean GM template is created and used as a registration target. There are two 
transformation options for the generation of the template, linear or non-linear; in 
the present study the non-linear option was used and the results were visually 
inspected using FSLeyes. Subsequently, this template was used as a 
registration target for normalization of the individual GM PV maps to a common 
space (MNI). 
Group-wise comparisons were conducted for the registered GM partial 
volume maps. The registered maps are typically smoothed to render them more 
normally distributed so that statistical comparisons can take place without 
violation of the normality assumption. In the present study two Gaussian kernels 
were evaluated: a) σ=2 and b) σ=3.  The implementation of two kernels served 
as a means to evaluate whether the extent of the observed effects was larger 
with increasing smoothing. 
The constructed GLM model comprised analysis of variance (ANOVA) (3 
groups HV, IGT, T2DM) tests with age and sex as covariates. These covariates 
were mean centered, by subtracting the study population mean from every 
subject. Registration to the generated study-specific template involves a 
Jacobian modulation step, hence correction for global differences of the brain 
size is a redundant step. The generated model was as in figure 7.1 and was 
constructed using detailed published instructions, part of the FSL VBM (276) 
and FSL GLM (320) guides.  
The regions of difference were detected using the resulting thresholded 
p-value maps and the labeled Harvard-Oxford cortical and subcortical atlases 
with 2mm thickness and 25% threshold provided as part of the FSL software. 
Regions of difference were detected using a dedicated Matlab script.  
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Figure 7.1: GLM generated using FSL’s dedicated tools.  Two covariates were used for the 
three groups.  
 
VBM was run with the TFCE option on (321) and 5000 permutations 
accounting for multiple comparisons, a combination which has demonstrated 
optimal performance according to the FSL documentation (276). The analysis 
was run for 16 HV, 12 IGT subjects and 16 patients with T2DM (1 discarded 
due to poor image quality). New age mean for the T2DM group was 54.4 ± 11.8 
years. 
 
7.2.1.4 Freesurfer analysis 
Freesurfer operates in a conceptually different way compared to the rest 
of the popular neuroimaging software. The 3D brain volume is transformed to a 
2D cortical surface. This surface consists of triangles (described by vertices and 
edges), as opposed to the standard Cartesian image representation in 3D. This 
surface is subsequently inflated, turning into a sphere. The idea is that this 
sphere will be similar amongst subjects, so it can be used for registration to and 
from an atlas-sphere by aligning the gyri and sulci. Subsequently, this sphere is 
used for cortical parcellation based on an existing atlas (203, 322). The 
A)	3-group	comparisons	(F-tests) 	 	 				B)	2-group	comparisons	(t-tests)	
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execution time of “recon-all”, the command used for detailed structural analysis 
is, on average, 17 hours depending on the available processing power. The 
preprocessing steps implemented in this 17h window involve amongst others: 
motion correction, normalization to the MNI space, intensity normalization, neck 
and skull stripping, segmentation, tessellation and sphere inflation and cortical 
parcellation (323) and are described in detail in the Freesurfer online guide 
(https://surfer.nmr.mgh.harvard.edu/fswiki/recon-all). One of the most important 
outcomes of the analysis, unique to the Freesurfer pipeline, is the cortical 
thickness measure. Additionally, PV maps are generated and regional volumes 
of cortical and subcortical structures of interest are quantified. 
Here, we report the values for cortical thickness, GM, WM, CSF, total 
intracranial volume, normalized values for GM, WM and CSF, the volume of 
structures of interest and more specifically the thalamus (RL), amygdala (RL), 
hippocampus (RL), brainstem, caudate, putamen and pallidum. Values were 
extracted from the “aseg.stats” file, one of the main outputs of the Freesurfer 
analysis. Additionally, generated masks for every structure were used to 
calculate volume structures. To account for gross differences in the head and 
brain size between the subjects, GM, WM and ventricular volume were divided 
by the total intracranial volume, as calculated during the Freesurfer analysis. 
The same step was followed for all the subcortical structures.  
 
7.2.1.5 Machine learning approach 
Utilising machine learning-based approaches for detection of patterns of 
difference has the benefit of being multivariate compared to morphometric 
approaches (248). In this chapter, we used a pipeline similar to the one 
described in Chapter 6. Comparisons were conducted for GM PV maps. The T1 
MPRAGE scans were normalized to the MNI space using an affine 
transformation, implemented in ITK-SNAP. These images were first segmented 
to their native space using SFCM; the transformation matrix generated in the 
previous step was used for their registration to the MNI using for this 
registration the c3d software. The registered PV maps were smoothed using a 
Gaussian filter to render them more normally distributed (σ=1.5).  
The registered GM and WM maps were down-sampled giving rise to 
images comprising 23x28x23 voxels (250). T-tests were implemented to keep 
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only the significantly different voxels. Subsequently, SVM-RFE was 
implemented to evaluate the weight of every voxel in the correct classification of 
the subjects. This pipeline is a simplified version of (250). In their study, direct 
neighboring voxels to the voxels with the higher weights identified as part of the 
feature ranking step were also incorporated in the analysis (even if they did not 
differ significantly between the groups), addressing one of SVM’s 
disadvantages, which is that it does not incorporate spatial information in the 
classification task. 
 
7.2.1.6 Statistical comparisons 
The groups were compared initially using binary comparisons, either by t-
tests or using the non-parametric equivalent (Wilcoxon rank sum test) when 
normality assumptions were violated.  Binary comparisons were conducted in 
Matlab. For 3-group comparisons one-way ANOVA, or its non-parametric 
equivalent, the Kruskal Wallis test, was used when ANOVA assumptions were 
violated. These comparisons were conducted using SPSS. The Benjamini-
Hochberg false discovery rate (FDR) methodology (324) was used to correct for 
multiple comparisons using a dedicated Matlab function.  
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7.2.2 Results 
7.2.2.1 Brain extraction 
Brain extraction results using FSL’s BET tool were not consistent. The 
skull was removed along with portions of GM an effect that could impact the 
subsequent registration process and VBM analysis (figure 7.2). Different 
threshold values were tested but there was not a single value providing 
consistently good results. The results shown in figure 7.2 are for f = 0.1 which is 
a very low threshold (maximum: f = 0.5, minimum: f = 0) for the separation of 
brain and non-brain tissue.  
 
Figure 7.2: Example results for FSL's BET tool using bias field and neck cleanup mode 
with a value of f=0.1. The algorithm cuts part of GM in the frontal part, an issue which would 
influence the subsequent registration process and CBF calculation. 
 
The effects were worse when non-healthy individuals were evaluated. 
Especially for diabetic subjects with enlarged ventricles, part of the brain filled 
with CSF was masked out and classified as background. This could greatly 
impact subsequent analysis especially in a batch mode as is usually the case in 
VBM. In figure 7.3 a representative case is shown from one such individual for 
whom BET failed. The approach based on SPM’s segmentation tool was 
chosen for the subsequent analysis since it demonstrated more stable 
performance (figure 7.4; same individual as in figure 7.3).  
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Figure 7.3: Failure of BET in a single subject with enlarged ventricles. 
 
 
Figure 7.4: Successful brain extraction using SPM and minor dilation and filling. 
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7.2.2.2 Bias field correction and tissue segmentation 
N4 bias field correction was implemented in three different ways to 
identify the optimal implementation with regards to the input data in the 
algorithm. These were: unmasked brain, masked brain and unmasked brain 
along with the mask. The results were as in table 7.1. 
 
Table 7.1: GM and WM MAPEs for the three examined approached for N4 BFC. 
 N4 unmasked N4 masked N4 with mask 
MAPE GM  23.56% 26.00% 43.36% 
MAPE WM 13.37% 15.79% 19.70% 
 
Mean absolute percentage errors for the segmentation process were 
calculated for GM and WM. In table 7.2 the results are shown for SPM, FSL and 
N4 unmasked combined with 6 different SFCM windows. Lower errors were 
recorded for both GM and WM with the W2 (isotropic 3x3) and W3 (isotropic 
5x5) windows. With larger kernels (W5 - 7x7 and W6 – 9x9) the errors were 
increased (table 7.2). In figure 7.5 a representative GM slice is presented 
segmented with the evaluated techniques along with the associated error map 
based on the ground truth segmentations. 
 
Table 7.2: MAPEs (%) for GM and WM for voxels belonging in the brain mask (not 
necessarily in the ground truth GM cluster) and for voxels belonging in the GM cluster 
based on the ground truth for all examined segmentation techniques. 
MAPE SPM FSL W1 W2 W3 W4 W5 W6 
GM mask>0 46.49 41.62 26.96 23.31 23.56 23.54 24.12 24.57 
GM GTGM>0 72.85 65.30 42.53 36.85 37.24 37.20 38.11 38.80 
WM mask>0 18.26 16.12 16.07 13.43 13.37 13.51 13.48 13.54 
WM 
GTWM>0 
42.52 37.54 37.44 31.31 31.16 31.49 31.41 31.57 
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Figure 7.5: Segmentation results from a representative simulated slice. Generated GM 
maps along with their associated error maps are shown calculated based on the brainweb 
ground truth data. 
 
7.2.2.3 Voxel base morphometry  
Following F-tests (ANOVA) analysis the first contrast, designed to detect 
voxel-wise differences between HV and IGT did not reveal any significantly 
different clusters with both evaluated Gaussian smoothing kernels. The second 
contrast designed to detect changes between HV and T2DM patients with a p-
value threshold of 0.05 and smoothing level of σ = 3, revealed that 8673 voxels 
were significantly different. With a smoothing level of σ = 2, the number of 
significantly different voxels was 7663 (figure 7.6).  
T-test analysis unraveled that the differences are driven by higher values 
in the healthy volunteer group. The regions of difference as identified by using 
the labeled Harvard- Oxford cortical and subcortical atlases were:  
• subcortical regions identified with both σ = 2 and σ = 3: Left cortical 
WM, left cerebral cortex, left lateral ventricle (LV), left caudate, left 
putamen, brain-stem, left hippocampus, left amygdala, left accumbens, 
right cortical WM, right cerebral cortex, right LV, right caudate, right 
thalamus, right putamen, right hippocampus, right pallidum, right 
SPM	 FSL	 N4	SFCM	W1	 N4	SFCM		W2	
MAPE	GM	(%)	 46.49	 41.62	 23.56	 23.54	
MAPE	WM	(%)	 18.26	 16.12	 13.37	 13.51	
1	
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amygdala and right accumbens. Left pallidum was only identified with 
the σ=3 kernel. 
• cortical regions identified with both σ = 2 and σ = 3: Frontal Pole, 
Insular Cortex, Temporal Pole, Superior Temporal Gyrus – anterior 
division, Middle Temporal Gyrus – anterior division, Inferior Temporal 
Gyrus – posterior division, Inferior Temporal Gyrus – temporooccipital 
part, Lateral Occipital Cortex – inferior division, Intracalcarine Cortex, 
Subcallosal Cortex, Cingulate Gyrus - posterior division, Precuneous 
Cortex, Cuneal Cortex, Frontal Orbital Cortex, Parahippocampal Gyrus - 
anterior division, Lingual Gyrus, Temporal Fusiform Cortex - anterior 
division, Temporal Fusiform Cortex - posterior division, Temporal 
Occipital Fusiform Cortex, Occipital Fusiform Gyrus, Planum Polare. The 
Occipital Pole was detected as a region of difference only with the σ=3 
kernel. 
 
Figure 7.6: VBM representative results with 2mm smoothing kernel. The screenshot is 
taken from FSLeyes. 
 
The percentage of the volume for each of these structures differing between 
the groups was determined. Results are reported for structures for which more 
than 5% of their total volume differed between the groups: 
• σ = 2 kernel:, subcortical regions: Left caudate (28.3%), left putamen 
(40.55%), brain-stem (5.3%), left hippocampus (10.9%), left amygdala 
(79.4%), left accumbens (78.7%), right putamen (28.4%), right 
hippocampus (12.1%), right caudate (9.0%) and right amygdala (36.9%). 
• σ = 2 kernel, cortical regions: Insular cortex (5.6%), Temporal Pole 
(8.2%), Cingulate Gyrus-posterior division (5.9%), Frontal Orbital Cortex 
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(5.5%), Parahippocampal Gyrus - anterior division (37.1%), Lingual 
Gyrus (11.4%), Temporal Fusiform Cortex - posterior division (10.2%), 
Temporal Occipital Fusiform Cortex (11.8%) and Occipital Fusiform 
Gyrus (6.5%). 
• σ = 3 kernel, subcortical regions: Left caudate (28.1%), left putamen 
(46.4%), brain-stem (7.0%), left hippocampus (15.2%), left amygdala 
(86.6%), left accumbens (78.7%), right caudate (7.8%), right putamen 
(21.1%), right hippocampus (9.6%) and right amygdala (39.3%). 
• σ = 3 kernel, cortical regions: Insular Cortex (9.3%), Temporal Pole 
(11.3%), Superior Temporal Gyrus –anterior division (6.5%), Middle 
Temporal Gyrus –anterior division (7.6%), Inferior Temporal Gyrus - 
posterior division (6.1%), Cingulate Gyrus - posterior division (6.8%), 
Frontal Orbital Cortex (6.3%), Parahippocampal Gyrus - anterior division 
(41.1%), Lingual Gyrus (12.3%), Temporal Fusiform Cortex - posterior 
division (12.4%), Temporal Occipital Fusiform Cortex (11.2%), Occipital 
Fusiform Gyrus (6.3%) and Planum Polare (5.3%). 
Highlighted regions are the ones that appeared as significant only in one of 
the two examined kernels. 
 
7.2.2.4 Tissue volume quantification 
The reported results in this section are based on the N4 BFC and SFCM 
clustering combination for segmentation and are as in table 7.3, for our cohort. 
 
Table 7.3:  Tissue volume (normalized for total brain volume and non-normalized) for GM, 
WM and CSF calculated using N4 BFC and SFCM clustering. 
 HV IGT T2DM 
GM volume (cm
3
) 801.02±73.59 812.51±57.63 765.50±86.21 
WM volume (cm
3
) 647.27±71.34 686.95±65.05 630.90±119.15 
CSF volume (cm
3
) 280.10±84.01 295.18±56.4 300.84±97.11 
Normalized GM 0.46±0.02 0.45±0.02 0.45±0.03 
Normalized WM 0.37±0.03 0.38±0.03 0.37±0.04 
Normalized CSF 0.16±0.04 0.16±0.03 0.18±0.05 
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None of the calculated values differed significantly between the groups. 
 
7.2.2.5 Freesurfer analysis 
The Freesurfer analysis results are presented in 3 tables (tables 7.4-7.6). 
In the first table, means for GM, WM, CSF, total intracranial (IV) and brain 
volume are shown for every group. In the second table, the volume of important 
subcortical structures is presented (additional results are tabulated in the 
Appendix2 – table A7.1), and in the final table, the cortical thickness values for 
the right and left hemisphere are reported. 
 
Table 7.4: GM, WM, CSF, intracranial volume and total brain volumes calculated using 
Freesurfer. 
 HV (cm3) IGT (cm3) T2DM (cm3) 
Cortical GM 436.8±40.4 446.8±40.7 418.5±49.2 
Subcortical GM 57.5±5.4 59.5±4.3 55.7±6.9 
Cortical WM 448.1±52.1 471.6±52.7 428.9±84.2 
CSF 0.9±0.2  1.1±0.3 1.0±0.3  
IV volume 1344.8±178.3 1472.2±202.7 1380.3±280.4 
Brain volume 1085.4±93.9 1139.7±99.1 1053.4±139.8 
 
Table 7.5: Volume of subcortical structures of interest for the three groups under 
consideration. 
 HV  (cm3) IGT (cm3) T2DM (cm3) 
Brainstem 20.8±2.2 21.3±2.1 19.5±2.7 
Left hippocampus 4.1±0.5 4.0±0.3 3.9±0.4 
Left lateral ventricles 7.9±4.1 13.0±7.2 14.1±10.6 
Left pallidum 1.4±3.2 1.5±0.2 1.2±0.3 
Left thalamus 7.4±1.0 7.4±0.8 7.4±1.2 
Right hippocampus 4.2±0.4 4.3±0.4 4.0±0.5 
Right lateral ventricles 7.3±3.2 10.5±4.1 12.7±7.9 
Right pallidum 1.6±0.2 1.7±0.2 1.5±0.3 
Right thalamus 6.4±0.8 6.7±0.6 6.2±1 
    
 
The cortical thickness for the left and the right hemispheres for the 
considered groups, as calculated during the Freesurfer analysis was as follows: 
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Table 7.6: Cortical thickness for the left and the right hemisphere as calculated using 
Freesurfer 
 HV IGT T2DM 
Left hemisphere 2.37±0.08 2.33±0.08 2.33±0.13 
Right hemisphere 2.37±0.09 2.34±0.08 2.32±0.12 
 
When performing ANOVA analysis, the differences were significant for: 
right LV (χ2(2) = 7.386, p = 0.03), normalized right LV (χ2(2) = 6.862, p = 0.03) 
and left pallidum (χ2(2) = 6.17, p = 0.05). Following multiple comparison 
correction using FDR none of the differences remained significant.  
 
7.2.2.6 Machine learning approach 
The scans for every subject were registered to the MNI space using ITK-
SNAP. Subsequently a universal brain mask was generated and applied to all 
scans. For every classification task, the voxels contributing towards optimal 
class differentiation were plotted using the following color coding: pink - voxels 
providing optimal classification performance, yellow – second best 
performance, green – third best performance and dark red all the different 
voxels – up to 500. 
 
HV- T2DM comparison 
The number of significantly different voxels for the high-resolution 
smoothed GM maps between the two groups was 39060 (total 265500 voxels). 
Following downsampling, the mean number of non-zero voxels was 4268 and 
the number of significantly different voxels was 851. Maximum classification 
accuracy was 90.6%, obtained with a minimum of 44 and a maximum of 75 
voxels. Classification accuracy was consistently higher than 74% with an 
increasing number of voxels. Accuracy as a function of the number of voxels 
along with the voxels contributing towards optimal class differentiation is plotted 
in figure 7.7. 
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Figure 7.7:  Classification accuracy for the HV vs T2DM task with an increasing number of 
features/ voxels accompanied with a figure showing the voxels contributing towards 
optimal class separation.   	
HV vs IGT 
In the high-resolution scenario, 23271 voxels were significantly different. 
Following downsampling, 541 voxels differed. Maximum accuracy of 100% was 
achieved, with minimum 18 and maximum of 60 voxels. Results for the task are 
plotted in figure 7.8. 
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Figure 7.8:  Classification accuracy for the HV vs IGT task with an increasing number of 
features/ voxels accompanied with a figure showing the voxels contributing towards 
optimal class separation.   
 
IGT vs T2DM 
In the high-resolution scenario, 11970 voxels were significantly different. 
Following downsampling, 184 voxels differed. Maximum performance of 100% 
was achieved with minimum 17 and maximum 50 voxels. Accuracy and voxels 
contributing towards optimal class differentiation are shown on figure 7.9. 
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Figure 7.9:  Classification accuracy for the T2DM vs IGT task with an increasing number 
of features/ voxels accompanied with a figure showing the voxels contributing towards 
optimal class separation.  
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7.2.3 Discussion 
 
Optimal brain extraction, bias field correction and segmentation 
techniques were identified. 
In this sub-chapter, processing of the acquired high-resolution T1-
weighted scan included in this study was discussed. Initially, we investigated 
three of the most important pre-processing approaches; brain extraction, bias 
field correction and segmentation. It was shown that brain extraction using an 
automated tool, such as the evaluated BET algorithm, can fail when major 
abnormalities are present in the brain, for example very intense atrophy or 
extensive enlargement of the ventricles. The brain extraction result needs to be 
visually inspected every time to reassure that this pre-processing step 
succeeded before proceeding to further processing. Residual skull, or loss of 
tissue, can greatly distort the results when proceeding with further processing. 
Following extraction, the masked brain can subsequently be used for 
segmentation, bias field correction and potentially for partial volume correction. 
Failure at an early pre-processing step can propagate through the whole 
analysis and remain undetectable if it is not captured right after the brain 
extraction task. The scenario of an undetected brain extraction failure can be 
particularly troublesome when VBM or machine learning approaches performing 
voxel-wise comparisons are implemented, since the erroneous masked brains 
will be averaged and compared with error-free images. 
The evaluated segmentation tools were those included in FSL and SPM 
and a method based on a combination of N4 BFC and SFCM clustering. The 
calculated MAPEs indicate that the combination introduced in this work 
outperformed every other. By examining the error maps, we can see that 
especially for the pixels at the edges of different tissue types SFCM 
outperforms the other methods. This finding is of particular importance since 
FSL and SPM are two of the most commonly used neuroimaging processing 
software tools. The comparison between them revealed that FSL has a better 
performance compared to SPM and both of them have an inferior performance 
compared to the introduced segmentation approach. The optimal weighting 
windows for the SFCM algorithm were the 3x3 and 5x5 isotropic ones leading to 
lower errors in both GM and WM. No weighting (simple FCM) resulted in higher 
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errors, whereas a higher degree of weighting (7x7 and 9x9 windows) was also 
connected with an increase in the MAPEs potentially due to the increased 
smoothing effect.  
The segmentation methods were evaluated using a commonly used 
digital phantom (Brainweb) and the ground truth segmentation maps provided 
along with it. This phantom was based on healthy individuals and not on a 
disease population. In the future, these segmentation tools could be evaluated 
using disease phantoms as well. In the past, SFCM clustering has been 
compared with other clustering methods and FCM variants (325), however, 
there is no published study to our knowledge comparing it to typically used 
neuroimaging software segmentation algorithms. Its recorded performance 
combined with N4 BFC, especially when considering the fact that it is 
assumption-free, proves that the technique holds great potential and could be 
the method of choice for tissue segmentation. 
 
Voxel-wise comparisons detected differences between HV and T2DM 
subjects. 
Global and localized gray matter atrophies, a consistent finding in 
neuroimaging studies focused on type-2 diabetes (33, 38, 40) were not 
identified in this study when examining Freesurfer-derived volumes of structures 
of interest. The same finding was observed when tissue volume quantification 
was conducted with the optimal segmentation protocol described previously. 
Our findings are in line with (43, 54), as in these studies, no significant 
differences were found in WM, GM or subcortical structure volumes between 
T2DM and HV. Our findings agree partially with a study by Dale et al. (326), 
where when comparing cognitively normal T2DM patients with HV, no 
differences were found for the hippocampal volume, however lower cortical 
thickness was detected. 
To investigate patterns of difference at a voxel-wise level without defining 
explicit ROIs, the FSL VBM analysis was utilised. The results indicate that 
significant differences exist only between the HV and T2DM groups. The 
analysis was run with two Gaussian smoothing kernels to investigate the effect 
of additional smoothing on the observed results. The applied kernels of σ = 2 
and σ = 3 are typically used in Neuroimaging studies and recommended in the 
	 188	
FSL VBM guidelines. F-tests were used for the 3-group comparison and 
subsequent t-tests indicated that the identified differences between HV and 
T2DM were driven by lower values in the T2DM group pixel-wise intensities. To 
identify changes in structures of interest, the areas for which the percentage of 
the voxels differing between the groups was more than 5% were reported. 
Interestingly, a larger smoothing kernel identified an additional 2 structures as 
areas of difference between the groups, as opposed to a smaller kernel. Areas 
of difference identified with both kernels included the caudate (L-R), putamen 
(L-R), hippocampus (L-R), amygdala (L-R) and the left accumbens. When 
considering cortical regions, the temporal gyrus was identified as an area of 
difference only with the σ=3 kernel. This result is of particular importance, since 
it suggests that additional smoothing can imply that structures not differing are 
brought up as different due to additional smoothing. On the other hand, it could 
mean that a smaller kernel masks out differences since individual variations 
might prevail. Lack of standardization for these procedures is likely to yield 
these kind of results. 
Studies using VBM in T2DM have found differences in numerous 
regions. Our results agreed partially (fusiform and cingulate gyri) with a study by 
Zhang et al. (38) where VBM with a larger smoothing kernel (8mm FWHM 
equivalent to a σ = 3.5) was used. The results are in agreement with (199), who 
found using SPM VBM differences in the caudate (L-R), putamen (L-R), left 
amygdala and left thalamus. A study by Moran et al. (40), with a big study 
population (350 T2DM patients, 363 HV), has shown reductions in GM, WM, 
hippocampal volume and GM loss in numerous areas of interest. The 
population though was not cognitively asymptomatic. In this latter study, SPM 
VBM and a cluster approach was used, as opposed to the utilised FSL VBM 
combined with TFCE analysis in the present study. Regions of agreement 
between our study and the Moran et al. study were the parahippocampal gyrus, 
left putamen, left caudate, cingulate gyrus and inferior temporal gyrus. Since 
our cohort was neurologically asymptomatic, these could be early changes 
occurring in diabetes, preceding cognitive decline. 
For the machine learning approach, low-resolution maps were used in a 
machine learning context and demonstrated a good performance for every 
examined classification task. Optimal classification was achieved with only a 
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few voxels. When more voxels were used, the identified areas of difference 
between normoglycemic and hyperglycemic groups were at the periphery of the 
brain and around the ventricles; the pattern was similar for both the IGT and 
T2DM groups when compared with the HV cohort. A higher ventricular volume 
in the IGT and T2DM groups can explain why voxels around the ventricles are 
brought up as optimal. However, identification of voxels at the periphery of the 
cortex could imply two things; either group-differences are driven by changes at 
the edges of the cortex, or mis-registration of the scans led to identification of 
these particular voxels. To resolve this, a larger cohort needs to be examined 
with the available method and more robust non-linear registration methods 
should be applied. Only a few voxels differed between the IGT and T2DM 
groups, however, they were sufficient to provide good classification. The 
classification accuracy was 100% for the HV vs IGT task and 91% for the HV vs 
T2DM task.  
The utilized sample-size in the present study is small but could provide 
useful insight on changes occurring in the examined groups if interpreted with 
caution. The observed results and areas of difference could be attributed to the 
sample idiosyncrasies or to other factors (e.g. age) and existing co-morbidities 
which were not accounted for. Several of our findings are in line with existing 
literature. Other findings will have to be validated using a larger study 
population. Especially the machine learning approach, as despite the utilization 
of a technique optimal for small datasets, there could still be overfitting. 
Processing of this small cohort unveiled several structural differences between 
the groups which is a promising observation. However, we will refrain from 
drawing conclusions about structural alteration occurring in IGT and T2DM and 
suggest that these initial findings can serve as a basis for further exploration. 
Overall, in this sub-chapter, optimal techniques for brain extraction, bias 
field correction and segmentation were described. When analysing the 
structural scans of the available cohort using an ROI-based volumetric analysis, 
no regions emerged as differing significantly between the groups. However, 
detailed voxel-wise comparisons not confined to specific ROIs revealed 
differences between the HV and T2DM cohorts (VBM, machine learning 
approach) and the HV- IGT groups (machine learning approach). 
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These observations are potentially of great importance and the described 
approaches and analysis methods can form the basis for a detailed analysis in 
larger cohorts. 
 
7.3 T2-weighted (FLAIR) processing 
 
7.3.1 Methods 
7.3.1.1 White matter hyper-intensity detection 
Non-physiological hyper-intense regions in WM described as white 
matter hyper-intensities (WMH) or leukoaraiosis are a common finding in elderly 
subjects and subjects with cardiovascular risk factors and are connected with 
an increased risk of stroke and dementia (327). In T2DM, findings have been 
inconsistent since not every study has found a direct correlation between WMH 
and diabetes (33). The hyper-intense regions in WM are connected with 
increased water content in the tissue and myelin destruction and are thought to 
result from prolonged hypo-perfusion (237). Evaluation of the WMH burden can 
be conducted either by using visual assessment, based on scales such as the 
Fazekas scale (328), or by using automated tools to quantify the hyper-intensity 
volume. WMH segmentation is a challenging task since the performance of the 
existing algorithms greatly varies, depending on the examined disease, the 
utilised scanner type and the applied sequence variants (237).  
Tested techniques for automated WMH segmentation were: a) the 
Wisconsin White Matter Hyperintensities Segmentation toolbox (329); b) a 
technique based on FCM clustering (232), similar to the one described 
previously for tissue segmentation in the MPRAGE image; and c) the Lesion 
segmentation toolbox in both its implementations (238). 
The first two approaches had a suboptimal performance, resulting in 
extensive regions being selected as hyper-intense, so we proceeded with our 
analysis using the lesion segmentation toolbox. The toolbox by Schmidt et al 
(238) has two implementations; one based solely on the FLAIR scan (lesion 
prediction algorithm - LPA) and one based on a combination of FLAIR and a 
T1-weighted scan (lesion growth algorithm – LGA). The LPA relies on a binary 
classifier based on logistic regression, which has been trained on 53 MS 
patients and is applied at a voxel-wise level. The LPA was found to perform 
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better than the LGA for our dataset, so for the analysis of our cohort LPA was 
used. 
 
7.3.1.2 FLAIR textural analysis 
Due to the high in-plane resolution and sensitivity to WMHs, FLAIR 
images have the potential to provide rich textural information. This information 
can be extracted from ROIs and the whole brain. For the present analysis, the 
image was divided into sub-regions, having as a central point the centre of 
every slice. The ROIs were as in figure 7.10. 
 
Figure 7.10: Definition of the ROIs used for textural analysis. 
 
From these 6 ROIs, Gabor textural features (330) and features derived 
from the gray-level co-occurrence matrix (253) were determined, these were: 
energy, homogeneity, correlation and contrast. Additionally, the mean, standard 
deviation, kurtosis and skewness from the defined ROIs were quantified. 
Overall 70 rotationally invariant Gabor features were built (255, 269) in 7 
wavelengths (2√2, 4, 4√2, 6, 6√2, 8, 8√2) and 7 orientations (0,30, 60, 90, 120, 
150, 180) with a spatial aspect ratio of 0.5. Each FLAIR image was 
subsequently filtered with every unique Gabor filter (49 overall) separately and 
the magnitude and phase images were derived.  
Gabor features can be made shift and rotationally invariant, which are 
both desirable properties when conducting textural analysis. To achieve this, we 
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followed the steps suggested by Riaz et al. (331). Mean and standard deviation 
of the magnitude images were calculated and subsequently the mean and 
standard deviation vectors were reshaped to 7x7 matrices reflecting the 7 
orientations and 7 wavelengths. A new 14x7 matrix was formed having at the 
top the means and at the bottom the standard deviations. The FFT of every row 
of the matrix was calculated and the 5 first coefficients were retained (330). The 
maximum number of unique frequency coefficients following FFT is given by the 
formula: orientations / 2 + 1, so in our case the number was 5. These features 
are shift and rotation invariant due to the properties of the discrete Fourier 
transform (331). 
For all extracted statistical and textural features, comparisons between 
pairs of groups were conducted using t-tests. Due to the large number of 
comparisons, multiple comparison correction was implemented by estimating 
the FDR methodology. Finally, we evaluated these features in a machine 
learning context, similar to the one described in Chapter 6. The maximum 
accuracy of the classifier, along with the number of features contributing to this 
performance were recorded. 
This procedure was investigated for 12 HV (4 scans not acquired), 11 
IGT (1 discarded due to poor image quality) and 17 T2DM patients. 
 
7.3.2 Results 
 Results for the examined cohort are shown in table 7.7. 
 
Table 7.7: Number and volume of leukoaraiosis in the examined cohort.  
HV IGT T2DM 
Age (years) 55.0±7.5 54.5±5.7 55.6±12.5 
number 9.5±4.4 11.1±4.9 19.5±11.3 
Volume (ml) 1.0±1.2 1.2±1.1 7.9±12.3 
Hypertension 
(number of 
subjects) 
4 9 8 
 
	 193	
The number of WMH was normally distributed, but the equal variance 
assumption was violated, so to compare the number and volume of WMH the 
non-parametric equivalent of one-way ANOVA, the Kruskal-Wallis test was 
used. Both the number of WMH and their volume differed between the groups 
(χ2(2) = 8.3, p = 0.016 and χ2(2) = 7.8, p = 0.02 respectively). Comparisons 
were also conducted for the number and volume of WMH using, as a grouping 
variable, the hypertensive status. The differences were not significant. 
 
 
T2 FLAIR textural analysis 
An overall of 474 textural features were calculated from 6 ROIs, these 
comprised: 70 Gabor textural features, 5 features from the gray level co-
occurrence matrix and 4 statistical features. Following t-tests, 57 features were 
significantly different for the HV vs T2DM comparison, 12 for the HV vs IGT and 
21 for IGT vs T2DM. Following correction for multiple comparisons, no feature 
was significantly different between the groups based on the adjusted p-values. 
However, we proceeded to machine-learning based analysis. For HV vs T2DM, 
maximum accuracy was achieved by one feature and it was 68.97%. Maximum 
accuracy for HV vs IGT was 65.2%, achieved with 3 features. For the IGT vs 
T2DM comparison maximum accuracy was 71.4% achieved with 6 features. 
Overall, the performance for every task was low based on the extracted textural 
features. 
 
7.3.3 Discussion 
A higher WMH burden was observed in T2DM compared to the healthy 
participants. WMHs were also detected in the HV and IGT groups; however, 
their volume was significantly lower compared to the T2DM participants. An 
increased WMH burden has been found in the past in several neuroimaging 
studies (35, 332), however, it is not a consistent finding (33).  Hypertension is a 
condition connected with increased leukoaraiosis extent, hence we conducted 
additional statistical tests to investigate if the number and volume of WMH 
differed significantly between subjects with and without hypertension. The 
analysis identified non-significant differences, implying that the observed effect 
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is not attributed to hypertension, but more likely, to diabetes or other existing 
comorbidities in our cohort, which were not accounted for in this study. 
The FLAIR image was also analysed using textural features to unravel 
potential textural differences between the examined groups. This modality was 
chosen for textural analysis due to the increased contrast between WMH and 
other tissues with a view to detecting potential subtle patterns of difference. 
Some features differed between the groups; however, multiple comparison 
correction left no significant differences. Correction for false positives is known 
to give rise to true negatives, so we proceeded to a machine learning-based 
analysis to examine whether the significantly different features between the 
groups provided good class differentiation. The accuracy of the classifier was 
low for all classification tasks indicating that textural analysis of the FLAIR 
image alone is not sufficient for optimal class differentiation. 
 
7.4 Phase Contrast – Magnetic Resonance Angiography (PC-MRA) 
analysis 	
7.4.1 Methods 
When carotid flow measurements are acquired, their typical processing 
involves using built-in scanner tools (in our case, tools provided as part of the 
Philips workstation) for manual segmentation of the carotids, or any other 
vessel of interest, and velocity, vessel area and flow quantification. This 
procedure can be time-consuming, user-dependent and potentially non-
reproducible. The requirement from the user is to manually select the area of 
interest in the available image. For this to be done optimally, the user might 
have to adjust the contrast for accurate delineation of the vessel limits. In this 
procedure, it is rather common to miss small parts, or include parts outside the 
vasculature, in an effort to select manually the optimal region. Another obstacle 
when using the Philips workstation (as was the case in this study) is that it 
requires direct access to the scanner, which might not be available.  Hence, a 
software tool based on Matlab was built to address these limitations and to 
quantify flow and velocity in an automated and reproducible way.  
The developed algorithm works as follows: The .REC folder is separated 
into three parts, a magnitude image, a phase difference image and a complex 
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difference image from where velocity measurements are extracted. For each of 
these parts, 40 acquisitions reflecting 40 time-points were recorded. For every 
part, the mean is calculated. Subsequently, the mean phase and complex 
difference images are multiplied. Only the positive values are kept to retain the 
signal arising from the arterial supply. The resulting image is normalised by 
dividing by the maximum intensity value. Subsequently, a threshold is used 
(tested values: 0.2, 0.3, 0.4, 0.5, 0.6). The threshold reflects the intensity of the 
voxels that were left out in the thresholding step. Hence, a threshold of 0.2, 
means that voxels with intensity less than 20% of the image’s maximum were 
thresholded out. As a result, voxels without any information from the 
vasculature are excluded.  
The optimal threshold was found to be 0.3, which was adopted for the 
subsequent analysis. Following this step, the retained voxels are overlaid onto 
the magnitude image to manually select an area surrounding the vessel of 
interest. The area of the manually picked ROI does not influence the final result, 
since the manual selection is introduced as a means of choosing an already 
segmented vessel of interest, rendering this approach user-independent. The 
only control the user has is to choose the optimal threshold and to select the 
vessel of interest. The followed steps and the images resulting from every stage 
are depicted in figure 7.11. 
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Figure 7.11: PC-MRA processing steps. A) mean magnitude image, B) mean phase image, C) 
mean velocity image, D) phase multiplied with velocity image (information from the veins is 
zeroed), E) arterial input overlaid on the magnitude image, F) hand drawn ROI, G) selected 
vessel overlaid on the velocity image. 
 
The mean, maximum and minimum velocities were calculated from each 
vessel of interest at each time point and the final reported value was the mean 
of each of them within the vessel. Flow was calculated as the product of the 
mean velocity and the area of the vessel.  
The areas of the vessel varied slightly for every individual and this could 
result in flow, min velocity and mean velocity differences due to the size of the 
vessel area. To account for that, the 10 voxels having maximum intensity inside 
the vessel of interest were retained, in order for the velocities to be compared 
with the same reference vessel area. This approach was run for the whole 
brain, the left and the right hemispheres separately. The retained voxels were 
the ones reflecting laminar flow, since they were situated at the center of the 
vessel. Additionally, to get a clearer picture of the inflowing blood flow pattern, 
results for all arterial input voxels exceeding the defined threshold were 
recorded. 
Of primary interest in the analysis of the PC-MRA data was the inflowing 
velocity pattern, the area of the supplying voxels and the overall inflowing flow. 
A)	
G)	F)	E)	
B)	 C)	 D)	
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During the acquisition, every possible effort was made for the same region to be 
selected for every individual, however that was not always the case. Small 
deviations were noticed. For this reason, we focused more on the velocity 
pattern. 
Two PC-MRA scans were acquired for every individual proximal to the 
right carotid, one at baseline and one following ACZ injection. The acquisition 
was optimized for the right carotid; however, measurements were also 
extracted from the left carotid and from all vessels surviving the thresholding 
procedure. CVR was evaluated as the percentage change in the flow values 
following administration of the vasodilating stimulus. 
Mean and standard deviations for all subjects were calculated and initial 
comparisons took place with t-tests when data were normally distributed and 
with Wilcoxon rank sum test when they were not normally distributed. To 
compare the values between the three groups one-way ANOVA was used and 
when its assumptions were violated, the Kruskal-Wallis test was applied to 
detect potential differences. FDR was used to correct for multiple comparisons. 
The analysis was run for 15 HV (1 discarded due to poor image quality), 12 IGT 
subjects and 16 T2DM patients (1 discarded due to poor localization of the 
carotid).  
 
7.4.2 Results  
Overall, 46 variables were calculated from the PC-MRA scans. The 
mean area covered by feeding vessels for every group when a threshold = 0.3 
was used is reported in number of voxels in table 7.8. 
 
Table 7.8: Mean vessel area (mean ± standard deviation) measured in number of voxels 
for the examined groups.  
 HV IGT T2DM 
Age (years) 48.4±13.6 54.8±5.3 54.4±11.9 
All pre-ACZ 55.73±13.51 63.75±19.58 61.63±23.91 
All post-ACZ 65.80±13.98 69.42±23.10 61.31±19.25 
Right pre-ACZ 18.13±2.29 20.33±4.03 22.69±8.01 
Right post-ACZ 23.20±6.05 24.00±4.86 25.38±10.27 
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Left pre-ACZ 19.60±3.36 19.42±5.47 21.13±8.86 
Left post-ACZ 25.07±6.30 23.83±8.24 21.94±7.67 
 
Differences between the areas covered by the examined vessels were 
not significant when examined using t-tests. Changes in the vessel diameter 
were significant only for the HV group for the right (z = 2.877, p < 0.01), left (z = 
2.749, p = 0.01) and all identified arterial input (z = 2.700, p = 0.01). Age was 
not significantly different between the groups after the exclusion of the 3 noisy 
scans. 
 
7.4.2.1 Flow evaluation 
Flow was calculated for the whole area of the chosen vessel (left and 
right carotids), for the 10 more intense voxels within this vessel (left10, right10) 
and for all the arterial vessels exceeding the selected threshold. Results for the 
baseline and post-ACZ flow are shown in figure 7.12 and for CVR in table. 7.9 
(CVR). 
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Figure 7.12: Baseline and post-ACZ flow for the different ROIs. Shown are the mean values 
per group accompanied with the standard deviation. 
Differences were significant at baseline between HV-T2DM for the 
following: right10 (z = -3.042, p = 0.01), left10 (t(26) = -2.691, p = 0.01). Post-
HV       IGT     T2DM
baseline
baseline
baseline
baseline
baseline
Post-ACZ
Post-ACZ
Post-ACZ
Post-ACZ
Post-ACZ
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ACZ fifferences were significant between HV-T2DM for the following: right (z = -
2.115, p = 0.03), right10 (z = -2.233, p = 0.03), left (t(26) = -3.066, p < 0.01), 
left10 (t(26) = -2.393, p = 0.02) and all (t(26) = -3.879, p < 0.01).  
 
Table 7.9: CVR for the 3 groups and examined areas evaluated as the % change between 
pre and post ACZ flow measurements. 
 right (ml/s) left(ml/s) right10(ml/s) left10(ml/s) All (ml/s) 
HV 54.24±20.47 55.85±26.73 29.49±23.19 29.65±23.91 51.50±11.87 
IGT 49.94±36.54 49.68±37.42 31.5±18.91 27.53±13.71 30.74±19.5 
T2DM 45.43±28.77 38.38±38.48 30.7±18.31 27.84±20.16 34.76±40.00 
 
Differences in CVR were significant between HV and T2DM for: all 
vessels (z = -2.273, p = 0.02), and between HV and IGT for: right (z = -1.976, p 
= 0.05) and all (z = -2.659, p = 0.01). 
 
7.4.2.2 Velocity measurements 
Baseline and post-ACZ velocity values are analysed for the following 
velocities: mean  maximum and minimum. Results are shown in figure 7.13 for 
the left and right carotid and the whole arterial input. Additional results for the 
10-voxel area can be found in the appendix2 (tables A7.2-A7.7). 
	 201	
	
Figure 7.13: Mean, maximum and minimum velocities for the left and right carotids and all 
arterial input for the three considered group 
Significant differences between the groups when using t-tests were identified for 
the following metrics: 
 
• Mean baseline velocity  
HV       IGT     T2DM
Baseline           Post-ACZ
Baseline           Post-ACZ
Baseline           Post-ACZ
Baseline           Post-ACZ
Baseline           Post-ACZBaseline           Post-ACZ
Baseline           Post-ACZ Baseline           Post-ACZ
Baseline           Post-ACZ
	 202	
Ø HV - T2DM: right (t(26) = -3.161, p < 0.01), right10 (t(26) = 
-3.409, p < 0.01), left (t(26) = -3.008, p = 0.01), left10 (t(26) 
= -3.257, p < 0.01) and all (t(26) = -2.895, p = 0.01).  
Ø HV and IGT: right (t(26) = -2.557, p = 0.02) and right10 
(t(26) = -2.240, p = 0.03). 
 
• Maximum baseline velocity  
Ø HV - T2DM: right (t(26) = -3.523, p < 0.01), right10 (t(26) = 
-3.529, p < 0.01), left (t(26) = -3.332, p < 0.01), left10 (t(26) 
= -3.333, p < 0.01) and all (t(26) = -3,097, p < 0.01). 
Ø HV – IGT: right (t(26) = -2.215, p = 0.04) and right10 (t(26) 
= -2.215, p = 0.04).  
Ø IGT - T2DM: all arterial input (t(26) = -3.420, p < 0.01).  
• Minimum baseline velocity  
Ø HV - T2DM: right (t(26) = -2.565, p = 0.02), right10 (t(26) = 
-3.169, p < 0.01), left (t(26) = -2.097, p = 0.04) and left10 
(t(26) = -3.088, p < 0.01) and all (t(26) = -3.420, p < 0.01).  
Ø IGT - T2DM: right (t(26) = -2.215, p = 0.04) and right10 
(t(26) = -2.318, p = 0.03). 
 
• Mean post-ACZ velocity  
Ø HV-T2DM: right (z = -2.154, p = 0.03), right10 (z = -2.431, p 
= 0.02), left (t(26) = -2.757, p = 0.01), left10 (t(26) = -3.125, 
p < 0.01) and all (z = -2.194, p = 0.03). 
Ø HV-IGT: right (z = -2.22, p = 0.03),  right10 (z = -2.318, p = 
0.02) and all (z = 2.611, p = 0.01). 
 
• Maximum post-ACZ velocity  
Ø HV-T2DM: right (z = -2.471, p = 0.01), right10 (z = -2.471, p 
= 0.01), left (t(26) = -3.029, p = 0.01), left10 (t(26) = -3.027, 
p = 0.01) and all (z = -2.866, p < 0.01). 
Ø HV-IGT: right (z = -2.123, p = 0.03), right10 (z = -2.123, p = 
0.03) all (z = -2.757, p = 0.01). 
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• Minimum post-ACZ velocity  
Ø HV-T2DM: right10 (z = -2.471, p = 0.01), left10 (z = -3.407, 
p < 0.01) and all (t(26) = -2.620, p = 0.01). 
Ø HV-IGT: right10 (z = -2.123, p = 0.03) and all (z = -2.542, p 
= 0.02) c) IGT-T2: left10 (z = -2.288, p = 0.03). 
 
Result summary 
Overall the differences between the three groups were significant for the 
following metrics:  
Baseline: 
• Right carotid: mean velocity (χ2(2) = 9.5, p = 0.01), max velocity (χ2(2) = 
8.433, p = 0.02), min velocity (χ2(2) = 6.935, p = 0.03), 10-voxel flow 
(χ2(2) = 8.726, p = 0.01), 10-voxel mean velocity (χ2(2) = 8.726, p = 
0.01), 10-voxel  max velocity (χ2(2) = 8.433, p = 0.02), 10-voxel min 
velocity (χ2(2) = 6.911, p = 0.03). 
• Left carotid: max velocity (F(2,40) = 6.042, p = 0.01), 10-voxel flow 
(F(2,40) = 6.875, p < 0.01), 10-voxel mean velocity (F(2,40) = 5.792, p = 
0.01), 10-voxel max velocity (F(2,40) = 6.046, p = 0.01), 10-voxel min 
velocity (F(2,40) = 5.45, p = 0.01),  
• All: mean baseline velocity (χ2(2) = 7.088, p = 0.03), max baseline 
velocity (χ2(2) = 8.668, p = 0.01). 
Post-ACZ: 
• Right carotid: mean velocity (F(2,40) = 3.795, p = 0.03), max velocity 
(χ2(2) = 8.373, p = 0.02), 10-voxel flow (χ2(2) = 9.065, p = 0.01), 10-voxel 
mean velocity (χ2(2) = 9.065, p = 0.01), 10-voxel  min velocity (χ2(2) = 
9.214, p = 0.01),  10-voxel  max velocity (χ2(2) = 8.433, p = 0.02). 
• Left carotid: flow (F(2,40) = 5.749, p = 0.01), mean velocity (F(2,40) = 
4.222, p = 0.02), max velocity (F(2,40) = 5.262, p = 0.01), 10-voxel flow 
(F(2,40) = 5.788, p = 0.01), 10-voxel mean velocity (F(2,40) = 5.671, p = 
0.01), 10-voxel  max velocity (F(2,40) = 5.257, p = 0.01), 10-voxel  min 
velocity (F(2,40) = 6.921, p = 0.01). 
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• All: flow (χ2(2) = 9.217, p = 0.01), mean velocity (χ2(2) = 7.918, p = 0.02), 
max velocity (χ2(2) = 11.298, p < 0.01), min velocity (F(2,40) = 4.412, p = 
0.02). 
CVR as calculated using the PC-MRA data differed significantly between the 
groups for all arterial input (χ2(2) = 8.23, p = 0.02). All the identified metrics 
remained significant following correction for multiple comparisons using FDR. 
 
7.4.3 Discussion 
Typical processing of a PC-MRA scan involves manual selection of the 
vessel of interest and quantification of several metrics from the chosen region. 
Commonly the flow values are reported. A new Matlab-based tool for carotid 
velocity and flow quantification was presented in this chapter. The method for 
arterial selection is user-independent and highly reproducible (unless users 
disagree on which vessel is the carotid). The tool’s novelty relies on a shift in 
the focus from carotid flow to the actual acquired velocity pattern, which can be 
examined in its entirety.  
When processing the PC-MRA scans, focus was put on the vessel for 
which the acquisition was optimised (right carotid) but also on the left part by 
keeping in mind that the acquisition might not have been perpendicular to the 
left side. The whole vessel was chosen in a user-independent manner. 
Additionally, a fixed area of 10 voxels inside the vessel of interest was selected 
to detect differences in the laminar velocity pattern, by considering a region of 
the same size for every subject. The analysis identified that the blood velocity 
was significantly different between the groups for both a set area of 10 voxels 
and the whole vessel region. Three velocities were evaluated, the maximum, 
minimum and mean. The flow value (multiplication between mean velocity and 
the area of the vessel) was also calculated and was found to differ between the 
groups.  
A finding of interest is that the area of the arterial supply was higher at 
baseline (not significantly) in the T2DM group and following ACZ injection there 
was no big increase indicating that the vessel did not dilate in response to the 
stimulus. This finding was not significant; however, it shows a tendency for the 
hyperglycemic groups to have more dilated carotids at baseline. Both the IGT 
and T2DM groups showed a stabilisation of the vessel diameter pre- and post-
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ACZ with only minor changes. On the contrary, the increase in the vessel 
diameter for the HV groups was significant for both left and right carotid and for 
all identified arterial supply. This finding could point towards a maximum 
vasodilation at baseline in the IGT and T2DM groups, associated with the 
presence of a potential compensatory mechanism due to impaired oxygen and 
nutrient delivery to the brain tissue.  
In terms of the evaluated velocities, the HV group demonstrated higher 
mean, min and max velocities compared to the IGT and T2DM groups. IGT 
subjects had values in between HV and T2DM subjects. Flow differed between 
HV and T2DM in the 10-voxel areas for the right and left carotids at baseline. 
For the same groups post-ACZ flow differed for all examined ROIs. CVR at the 
level of the carotids was decreased for the T2DM group in all the examined 
arterial input; in IGT the difference when compared to HV was significant for the 
right carotid and all arterial input. In terms of differences in the velocity pattern, 
for the 10-voxel regions, all examined velocities differed between the three 
groups pre- and post-ACZ, implying a distinct laminar flow pattern. When 
examining the whole vessel areas, differences were recorded at baseline for the 
mean (R, all), min (R) and max (L, R, all) velocities. Post-ACZ the patterns of 
difference were identified for: mean (L, R, all), min (all) and max (L, R, all) 
velocities. These findings were mainly driven by differences between HV and 
T2DM, with differences between HV and IGT mainly detected for the right 
carotid for which the acquisition was optimised. 
These findings ought to be discussed in light of the existing literature 
whereby a detailed velocity pattern analysis is not usually conducted. Only a 
few studies have looked into the carotid flow pattern using either TCD or PC-
MRA in diabetes. Typically, the reported metrics are flow, velocity and metrics 
such as pulsatility index (53). A study using PC-MRA and ACZ as a vasodilator 
found no differences in baseline flow and a decrease in CVR in T2DM; the 
findings were non-significant (333). A study using TCD has reported reduced 
mean flow velocity in T2DM (42), a finding in line with our velocity findings. In 
the same study, CVR was assessed using CO2 inhalation and was found to be 
significantly reduced in the diabetic cohort. Tiehuis et al. (44) did not find 
significant differences after correcting for brain volume. In their study, despite 
using PC-MRA, they focused on the calculation of CBF based on the velocity 
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information after correcting for the total brain volume. A study by Brundel et al. 
(193) showed that CBF, calculated by PC-MRA, was reduced in patients with 
T2DM. In the aforementioned study, CVR was assessed using TCD and was 
found to be increased; the significance of the findings though was not reported.  
To summarise the findings reported in the literature, CVR, when using 
velocity-based quantification strategies, has generally been found to be 
decreased in diabetes. Baseline flow tends to be similar between the groups, 
whereas baseline velocity is decreased.  
The present analysis is the first one of its kind focusing on a detailed 
analysis of the velocity pattern between the groups and findings suggest the 
existence of significant differences. We proposed that a detailed velocity and 
area analysis along with carotid flow calculation can have an additive diagnostic 
value since the observed flow pattern can be attributed either to a large vessel 
area or to a high blood velocity. Such an analysis can disentangle the cause of 
the observed flow differences and shed light on the inflowing velocity pattern. 
Based on the described findings, we suggest that the velocity of the inflowing 
blood is decreased in both IGT and T2DM and there is a non-significant 
increase in the area of the vessels, pointing towards dilation at baseline. 
Following pharmacologically induced vasodilation, we see a lower response 
with regards to vessel dilation, flow and velocity changes in the IGT and T2DM 
groups. 
 
7.5 Time-of-flight – Magnetic Resonance Angiography (TOF-MRA) analysis 
 
7.5.1 Methods  
Three methods were tested for angiogram segmentation. Methods 1 and 
3 were applied directly to the 2D coronal maximum intensity projection (MIP). 
Method 2 applied angiogram segmentation in two stages; an initial 
segmentation was performed in the 3D stack of axial slices of the angiogram. 
Subsequently the initial segmentation was projected (MIP) and a second 
segmentation was applied in the 2D projection. For method assessment two, 
subjects were used, one HV with a normal looking scan and one T2DM patient 
with high degree of collateral circulation.  
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Method 1 
The first method involved using an adaptive threshold calculated locally 
in areas of NxN pixels. The evaluated window sizes (N) were: 15x15, 25x25, 
45x45, 65x65, 85x85 and sensitivity levels of 0.2, 0.3, 0.4, 0.5. The utilised 
algorithm was Matlab’s adaptthresh (334), which calculates a threshold based 
on the calculated mean inside a sliding window. A higher sensitivity level allows 
more pixels to be included in the generated mask. 
 
Method 2 
The second evaluated approach was as follows: the image was initially 
filtered with a wiener filter (5x5) (335). K-means clustering was used to classify 
the voxels into three separate clusters and remove background along with 
voxels with intensity values close to background. A square mask in the area 
(150:350, 150:350) was created to separate each 2D slice into two regions, a 
central and a peripheral. The peripheral region incorporated mainly background 
and branches emerging from the external carotid. Furthermore, the 222 slices 
were separated into three groups. The first group involved the region from the 
base of the neck until the point where the main carotids start converging, the 
second region was defined from the point where the convergence of carotids 
starts until the upper part of the circle of Willis and the third involved the slices 
from that point to the upper slice. These six groupings gave rise to distinct 
groups, each having its own threshold (the values were normalized). Multiple 
thresholds were tested for every individual and every region. 
 
Method 3 
One of the most popular algorithms for vessel segmentation especially 
for retinal images is Frangi’s vesselness filter (336). The method enhances the 
vascular structures by filtering the image to improve vasculature segmentation. 
The filter detects tubular structures by exploiting the eigenvalues of the image’s 
Hessian (336). The Hessian matrix of an image comprises the second order 
partial derivatives. Second order derivatives of a continuous function can be 
used to detect local maxima and minima in a signal/image. These are the points 
where the derivative has a value of zero and the nature of maxima/minima can 
be determined by whether the second order derivative is negative (maximum) 
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or positive (minimum). Hence, the idea behind the Frangi filter is that, following 
smoothing by convolution with a Gaussian, the eigenvalues of the Hessian 
matrix are determined and a high ‘vessel response’ is said to exist when the 
eigenvalues fulfill set criteria (thresholding). For more details on the operating 
principles of the filter, the reader is referred to the original publication (336). The 
evaluated Frangi filters had standard deviation values of σ = 1, 3 and 5. A 
Matlab function built by D.-J. Kroon (282) was used for the implementation of 
the Frangi filter. 
 
Performance evaluation and calculated metrics 
The MIP of the coronal plane was used to visually evaluate the success 
of the segmentation methods. Metrics were extracted to evaluate potential 
differences in the area covered by vessels (indicative of vascular deficits) or the 
number of different branches (indicative of the presence of collateral circulation 
or loss of vasculature) for every individual. To proceed to vasculature-
descriptive metric extraction, the number of non-zero pixels was counted in the 
designated area of interest. Subsequently, the resulting vasculature 
segmentation was ‘skeletonized” using the bwmorph Matlab function with “thin” 
as an argument and 10 iterations and the resulting length of the vascular tree 
was calculated (MATLAB and Image Processing Toolbox 2016a, The 
MathWorks Inc., Natick, Massachusetts, USA). The number of branching points 
was also recorded, again using bwmorph.  
Metrics regarding the vessel density, centerlines (vessel length without 
density information) and number of branching points were recorded for vessels 
arising from the MCA territory. The image region including the MCA was 
manually chosen. To achieve optimal segmentation we used both the 
developed 2nd method and also segmentation based on simple Otsu 
thresholding (287).  
 
7.5.2 Results 
In figures 7.14 & 7.15, results for the 1st developed method are depicted 
with varying values for the adaptive window and threshold level. Visual 
assessment of the segmentation results suggests that optimal segmentation 
was obtained with a window of 45x45 and a sensitivity level of 0.3. These 
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values were used for subsequent comparison of the segmentation result using 
methods 2 and 3.  
 
Figure 7.14: 1st method for angiogram segmentation for one HV.  Every row corresponds to 
a different window size (15x15, 25x25, 45x45, 65x65, 85x85) and every column to a different 
threshold (0.2, 0.3, 0.4, 0.5). 
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Figure 7.15: Segmented MIP for one T2DM subject using the first method. Every row 
corresponds to a different window size (15x15, 25x25, 45x45, 65x65, 85x85) and every column 
to a different threshold (0.2, 0.3, 0.4, 0.5). 
 
For the second method, with 6 distinct ROIs each having a tailor-made 
threshold, angiographic segmentation results are shown in figure 7.16. 
 
Figure 7.16: Segmentation with the 2nd method for one HV (top) and one T2DM patient 
(bottom) 
 
Segmentation results for method 3 (Frangi’s vesselness filter) are shown 
in figures 7.17 & 7.18. 
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Figure 7.17: MIP segmentation using Frangi filter with 3 different standard deviations 
(from left to right, σ = 1, 3 and 5) for one healthy subject. 
 
Figure 7.18: MIP segmentation using Frangi filter with 3 standard deviations (from left to 
right, σ = 1, 3 and 5) for one T2DM patient. 
 
The implemented Frangi vessel segmentation resulted in missing some 
of the smaller vessels at the anterior part of the brain, which were successfully 
identified with the developed methodology due to the various thresholds chosen 
carefully for every individual. This came at the expense of allowing several 
noisy pixels inside the segmented angiogram. For this particular study the 
region encompassing the MCA and ACA territories is of particular interest, since 
it is the region on which the perfusion ASL measurements were conducted, 
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hence it is important to identify the underlying vascular structure. A comparison 
of all three methods side by side for two subjects is shown in figure 7.19. 
 
Figure 7.19: Comparison of the MIP segmentation obtained with the 3 evaluated methods. 
From left to right: MIP, angiogram segmentation with the 1st, 2nd and 3rd method. 
 
Angiographic segmentation is a challenging task, and even after the 
introduced development, noisy regions were not efficiently masked out in 
several scans. As mentioned earlier, segmentation of the MCA territory is of 
particular interest, so results were evaluated for the MCA separately for the best 
performing methods (1 & 2). Results are shown in figure 7.20. 
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Figure 7.20: MCA territory segmentation. From left to right: Segmentation based on Otsu, MIP 
and segmentation with the 2nd angiogram segmentation method. 
 
Optimal segmentation results were obtained for the second method, as 
assessed by visual evaluation of the resulting maps, so it was used for the 
subsequent analysis of the segmented MCA vasculature. Results for the 
evaluated vasculature-descriptive metrics are shown in table 7.10. 
 
Table 7.10: Vasculature-descriptive metrics extracted from the MCA territory for the 3 
groups. 
 HV IGT T2DM 
Vessel density 4385.5±804.8 4146.7±894.7 3712.5±1134.0 
Vessel length 1396.9±209.3 1363.5±251.7 1208.5±336.3 
Branch points 149.9±28.5 138.0±31.6 110.7±40.9 
 
The differences were significant between HV and T2DM for the number 
of branching points (z = -3.103, p < 0.01). The number of branching points also 
differed between IGT and T2DM patients (z = -2.237, p = 0.03). Vessel length 
(p = 0.058) and density (p = 0.054) did not differ between HV and T2DM; an 
underlying tendency was noticed though for a lower vessel length and density in 
the T2DM group. 
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7.5.3 Discussion 
Angiogram segmentation is a cumbersome task and constitutes a vivid 
research area where neural networks have come into play to assist (316). 
Currently, there is no gold standard for this procedure; several tools have been 
developed but are at an experimental stage (337, 338). Here, we presented a 
semi-automated method, which requires the user to evaluate different 
thresholds in six regions in order to achieve optimal segmentation. The 
algorithm initially partitions the scan into two regions, a peripheral and a central 
one and subsequently to three additional sub-regions in the head-foot axis.  
The results for the developed approach were promising and 
demonstrated a good performance compared to alternative techniques 
evaluated for vascular segmentation. Our goal was not to successfully segment 
only the large vessels, but to extract accurately the anatomy and vasculature of 
the smaller arterioles. When the popular Frangi filter was used, even with the 
least degree of smoothing, detail (especially small vessels) was lost. A second 
evaluated approach based on a local adaptive threshold resulted in accurate 
vascular segmentation, although several noisy background voxels were 
included in the segmented mask. However, when this approach was used, the 
vascular anatomy was preserved in greater detail (especially small arterioles) 
and was better separated from the background. Hence, the subsequent 
quantitative analysis was facilitated.  
The main drawback of the introduced technique is that it is semi-
automated, requiring the user to test multiple thresholds. Additionally, it requires 
a subjective visual evaluation of the segmentation result based on the MIP.  
The angiogram analysis revealed significant group differences, although 
large variability existed within the groups. There was no distinct pattern that all 
diabetic patients followed, for some of them an increased collateral blood 
supply was noticed, whereas for others the collateral circulation was totally 
missing. When focusing on the MCA territory, following vasculature analysis, 
the number of branching points was significantly lower in the T2DM cohort 
compared to HV and a tendency for reduced vessel length and density was 
noticed, indicating that the overall tendency was for a reduction in the number 
of vessels. Another possible explanation is that due to slower flow in the 
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diabetes group the moving spins inside smaller vessels were saturated along 
with stationary spins resulting in signal loss.  
Regardless of the cause for this reduced number of vessels, these 
findings are of great importance, since they highlight that the vasculature of the 
examined T2DM cohort is influenced even in the absence of neurological 
complications. A decrease in the number of blood vessels or a slower blood 
flow could result from the build-up of atherosclerotic plaques and especially in 
the case of a slower flow, it could be connected with the increased ATT times 
observed in the cohort in the previous chapter. These findings are not surprising 
based on the diabetic symptomatology since diabetic subjects are in a higher 
risk of ischemic stroke and are likely to develop small vessel disease. Another 
interesting observation is that the IGT cohort was highly similar to the HV cohort 
suggesting that alterations in the vascular anatomy have not yet occurred in this 
pre-diabetic group.  
However, quantification of vasculature-descriptive metrics from the MCA 
angiograms which could lead to useful disease biomarkers is not typically 
conducted. A PubMed search with the terms “MRA”, “diabetes” and “brain” 
conducted in October 2018, returned 44 articles from which only one was 
relevant. This study by Yashiro et al. (192) reported findings similar to ours with 
regards to the number of branches / branching points. In their study, they 
focused on the same area (MCA) as we did in the present study. Their analysis 
involved additional metrics such as stems and vessel tortuosity, which were all 
extracted based on line tracing in the final MIP. 
Quantitative angiogram analysis, typically not conducted due to the 
complex processing and the requirement for vessel segmentation, holds great 
promise for detecting subtle disease patterns. Our study along with the study by 
Yashiro et al. (192) are the only ones to our knowledge that have looked into 
analysing TOF-MRA images from a T2DM cohort in a quantitative way and 
resulted in similar findings. Angiograms hold great potential for extraction of 
vasculature-descriptive metrics and in the long run a detailed fully-automated 
analysis could provide important biomarkers. Being currently a field attracting 
increasing interest due to the segmentation challenges, TOF-MRA images 
could be used in the future for quantification of multiple metrics when their 
	 216	
processing is more standardised and the obstacles created by imperfect 
segmentation are surpassed.  
 
7.6. Diffusion Weighted Image analysis 
 
7.6.1 Methods 
DWI scans were acquired at 2 b-values (b = 0 and 1000 s / mm2) and in 
three orthogonal gradient directions. This DWI acquisition allows solely for the 
quantification of the ADC map, which is useful in order to identify how isotropic 
the diffusion pattern is. The higher b-value sensitizes the water molecules to 
motion and the three applied directions determine the directionality of this 
sensitization, whereas b=0 gives a T2-weighted image which allows for 
quantification. The ADC was calculated for every individual for b = 1000 using 
the following equation: ADC = log(S / S0) / b, whereby S0 is the signal for b = 0 
and S the signal for b = 1000. The signals were calculated for every b as the 
geometrical mean from signals emerging from all the directions. A further 
interesting extension to this study would be to apply more b-values and utilize a 
larger number of directions (e.g. 64) to sensitize the acquisition to more 
directions and hence determine other quantities of interest such as fractional 
anisotropy and radial diffusivity. A more detailed DTI acquisition would also 
allow for analysis of the white matter tracts and structural connectivity which 
was not possible in the present study. 
Images were normalized to the MNI space using ANTs registration to 
generate an affine transformation. ADC values were extracted for structures of 
interest using the cortical and subcortical Harvard-Oxford maps from the 
following regions (left and right): amygdala, thalamus, hippocampus, caudate, 
putamen, pallidum, WM, CC, lateral ventricles, brainstem and accumbens. 
Additionally, ADC values were compared for the temporal, parietal, occipital and 
frontal lobes, the insula and thalamus. Overall data from 11 HV (aged 55.9 ± 
7.1), 12 IGT (aged 54.8 ± 5.3) and 16 T2DM (aged 54.5 ± 11.8) patients were 
available. 
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7.6.2 Results 
The ADC values for the different lobes and structures of interest are 
shown in tables 7.11 & 7.12. Example images for one subject are as in figure 
7.21. 
	
Figure 7.21: Example images for one subject for b=0, b=1000 s/mm2 and the associated 
ADC map. 
 
Table 7.11: ADC values for the main lobes, insula and thalamus for the examined groups. 
 HV (*10-3) mm2/s IGT(*10-3) mm2/s T2DM(*10-3)mm2/s 
Frontal lobes 0.99±0.14 0.98±0.10 1.02±0.16 
Temporal lobes 0.82±0.08 0.83±0.06 0.85±0.10 
Parietal lobes 0.98±0.14 0.95±0.11 0.99±0.12 
Occipital lobes 0.84±0.09 0.84±0.06 0.85±0.09 
Insula 0.94±0.12 0.94±0.08 1.03±0.20 
Thalamus 0.93±0.11 0.94±0.16 1.12±0.35 
 
Table 7.12: ADC values in structures of interest for the examined groups. 
 HV(*10-3)mm2/s IGT(*10-3)mm2/s T2DM(*10-3)mm2/s 
Brainstem 1.10±0.15 1.15±0.16 1.27±0.21 
Left accumbens 0.69±0.05 0.73±0.11 0.81±0.32 
Left amygdala 0.84±0.13 0.97±0.09 0.99±0.18 
Left caudate 1.06±0.23 1.15±0.47 1.44±0.65 
Left CC 1.00±.0.12 0.99±0.09 1.02±0.13 
Left 
hippocampus 
0.99±0.09 1.04±0.09 1.15±0.19 
Left LV 2.23±0.38 2.41±0.45 2.44±0.46 
Left pallidum 0.75±0.12 0.69±0.13 0.69±0.14 
Left putamen 0.71±0.07 0.69±0.05 0.71±0.06 
Left thalamus 1.07±0.15 1.07±0.20 1.26±0.41 
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Left WM 0.80±0.05 0.83±0.06 0.90±0.20 
Right 
accumbens 
0.71±0.06 0.70±0.07 0.88±0.27 
Right amugdala 0.87±0.11 0.98±0.06 0.99±0.15 
Right caudate 1.15±0.29 1.29±0.40 1.59±0.59 
Right CC 1.02±0.14 1.01±0.09 1.04±0.13 
Right 
hippocampus 
1.01±0.08 1.05±0.13 1.10±0.19 
Right LV 2.15±0.44 2.28±0.39 2.38±0.40 
Right pallidum 0.61±0.11 0.57±0.19 0.62±0.16 
Right putamen 0.66±0.07 0.64±0.11 0.67±0.10 
Right thalamus 1.03±0.21 1.06±0.20 1.21±0.38 
Right WM 0.79±0.05 0.81±0.04 0.89±0.17 
 
Differences between the HV and the T2DM group were recorded for the 
following structures: brainstem (t(26) = 2.309, p = 0.03), left amygdala (t(26) = 
2.339, p = 0.03), left hippocampus (t(26) = 2.506, p = 0.02), right accumbens (z 
= 2.097, p = 0.04), right amygdala (t(26) = 2.146, p = 0.04) and right caudate 
(t(26) = 2.352, p = 0.03). HV and IGT differed in the following regions: left and 
right amygdala (t(26) = 2.953, p = 0.02 and t(26) = 2.898, p=0.01),  and for IGT-
T2DM for the right accumbens (z = 2.344, p = 0.02). Following FDR correction 
for multiple comparisons, none of the differences remained significant. However 
a tendency was noticed for the ADC values in the regions of difference 
identified prior to FDR correction to be higher in T2DM and IGT compared to 
HV indicating that the molecular diffusion is higher.  
For the 3-group comparisons and the structures identified as significantly 
different in the binary comparisons the results were as follows: brainstem 
(F(2,36) = 6.293, p = 0.04), left amygdala (χ2(2) = 8.467, p = 0.01), left 
hippocampus (χ2(2) = 7.146, p = 0.03), right accumbens (χ2(2) = 7.311, p = 
0.03) and right amygdala (χ2(2) = 6.284, p = 0.04). Following multiple 
comparison correction with FDR none of the differences remained significant 
between the groups. 
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7.6.3 Discussion 
The diffusion pattern in the available cohort was investigated using DWI. 
The acquisition with three directions and two b-values allowed only for the 
calculation of ADC maps and not for a detailed diffusion analysis as would be 
the case with a DTI acquisition. Several significant differences were initially 
identified using statistical comparisons, however, significance was lost following 
multiple comparison correction. The ADC values in T2DM demonstrated a 
tendency to be higher in the amygdala, caudate, hippocampus, accumbens and 
the brainstem; in IGT the ADC was higher in the amygdala. These findings 
might indicate that there is a trend of increased water diffusivity, potentially 
connected to the endothelial dysfunction and BBB disruption observed in T2DM 
(10). Hence, the amygdala could potentially be one of the first areas with 
impaired (increased) water diffusivity in hyperglycemia, since it is the single 
structure brought up in the binary comparisons between hyperglycemia and 
normoglycemia.  
Studies of diffusion patterns in T2DM have found global and local 
increases in ADC values (mean diffusivity) in line with our findings (339, 340). 
The majority of studies have used more advanced multi-directional techniques, 
such as DTI, to examine microstructural changes in WM, so more focus is put 
on non-isotropic/directional metrics such as fractional anisotropy (199). A more 
detailed analysis of the diffusion pattern would be of interest for the present 
cohort; however, the DWI acquisition means that this isn’t possible. In the 
future, DTI or diffusion kurtosis imaging sequences could be incorporated into 
protocols investigating WM changes in T2DM and IGT. 
 
7.7 Summary 
In this chapter a multitude of MRI modalities were processed and 
processing solutions were discussed. These modalities involved high-resolution 
T1-weighted, T2 FLAIR, PC-MRA, DWI and MRA scans. The MPRAGE (T1 
scan) was processed using multiple methods that have been extensively 
validated previously for group-wise comparisons. The burden of WMH was 
quantified from the FLAIR scan using existing software. The PC-MRA scan was 
analysed using a newly developed Matlab-based approach. DWI images were 
processed by implementing in Matlab the theoretical equations for quantification 
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of the ADC. Finally, the angiograms were also segmented using a newly 
developed method and vasculature specific metrics were derived. After proving 
the efficiency of the developed approaches, they were implemented to the 
available dataset.  
For the MPRAGE processing: the brain was extracted based on SPM 
and minor dilation, erosion and filling operations were implemented when the 
results were suboptimal. Segmentation using SFCM with a 5x5 window was 
implemented following BFC with N4. Additionally, MPRAGE images were 
processed using VBM with FSL, Freesurfer, for cortical parcellation and 
structure volume determination and a machine learning-based approach based 
on feature reduction and classification. Key findings from this modality 
regarding the T2DM group (when compared to HV) involved differences in 
areas such as the hippocampi, amygdala and thalami identified using VBM. 
Interestingly there were no differences between HV and IGT subjects. The 
machine learning approach unraveled that high classification performance was 
achieved when considering voxels in the periphery of the cortex and around the 
ventricles. 
For the T2-FLAIR scan, the brain lesion segmentation toolbox was used. 
A significantly higher number and volume of WMH in T2DM was recorded. 
Results for the IGT groups were similar to the HV group. When using textural 
analysis to identify potential subtle textural changes, the achieved classification 
performance was poor for all examined binary tasks. 
The PC-MRA scan was processed using a developed Matlab tool, 
quantifying the velocity pattern at the level of the carotids. The average min, 
mean and max velocities were calculated for the whole arterial input, the left 
and right carotid. These velocities were quantified for the whole vessel area and 
for fixed regions of 10-voxels demonstrating the highest intensity. Key findings 
involved larger vessel area at baseline (non-significant) in the IGT and T2DM 
groups and lower velocity patterns at baseline and following ACZ injection 
compared to the HV group for both hyperglycemic groups. 
The acquired TOF-MRA images were analysed using a developed semi-
automated method. Results indicate that the diabetic group had a lower number 
of branching points. 
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Finally, for the analysis of the DWI a developed Matlab script was 
utilised. Findings following multiple comparison correction were not significant, 
however a tendency was noticed for increased ADC locally in IGT (amygdala) 
and T2DM (hippocampus, amygdala, accumbens, brainstem and caudate). 
Five MRI modalities were processed after having presented a proof of 
concept for the adopted processing approaches. The purpose was to present a 
preliminary analysis of functional and structural changes occurring in the 
examined groups that can be considered along with the extended 
hemodynamic analysis presented in Chapter 6. Further processing optimization 
of the examined techniques could be evaluated in the future. 
An optimal segmentation approach for the acquired MPRAGE scan was 
suggested and implemented. PC-MRA and TOF-MRA data were processed 
with newly developed a semi-automated methods and multiple metrics were 
extracted. These metrics, not typically quantified in neuroimaging studies 
differed significantly between the groups. Voxel-wise comparison for the 
structural scan using machine learning was implemented and high accuracy 
was achieved in the classification tasks. Image analysis unraveled structural 
and functional differences between HV and T2DM. A lower number of 
differences was recorded for IGT compared to both HV and T2DM. Regional 
differences in cortical and subcortical structures of interest (VBM), increased 
WMH burden (FLAIR), lower carotid flow velocity, non-significant carotid dilation 
at baseline (PC-MRA) and a reduction in the number of branching points in the 
MCA vascular territory (TOF-MRA) were the main findings for the T2DM group. 
Interestingly, IGT or else pre-diabetes was structurally similar to the HV group 
(MPRAGE, FLAIR, TOF-MRA). Functionally, differences were identified in the 
velocity pattern at the level of the carotids for IGT. Hence, IGT demonstrates a 
similar structural profile to HV, however, functionally the IGT profile bears 
similarities to the T2DM group. 
The identified differences are of great importance; some of them were 
identified for the first time (velocity pattern, vasculature characteristics) and a 
larger cohort will be needed to assess reproducibility and provide further 
validation. 	  
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CHAPTER 8: 
MRI-derived biomarkers for hyperglycemia 
unraveled 
In the previous three chapters, findings emerging from every examined 
MRI modality were presented and discussed separately, without drawing any 
connections. In Chapter 6 hemodynamic metrics were extracted from the 
QUASAR ASL sequence and were subsequently processed using a developed 
pipeline described in Chapter 5. The data were analysed using two approaches. 
The first was based on conventional QUASAR processing whereby CBF, ATT 
and aBV metrics were of primary interest. The second approach was based on 
the implementation of an extended hemodynamic analysis whereby numerous 
perfusion-related metrics were extracted from the acquired hemodynamic 
signals. In Chapter 7, T1- and T2-weighted structural, ΤOF-MRA, PC-MRA and 
DWI scans were processed and metrics of interest were quantified. Thus, the 
aim of this final chapter is to combine metrics extracted from all modalities 
under one umbrella, to unravel potential structural, functional and physiological 
interactions.  
Before examining such interactions, it is worth coming back to figure 4.1, 
introduced in chapter 4 and reproduced as figure 8.1 below, demonstrating the 
approximate spatial coverage of the utilised MRI techniques.  
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Figure 8.1: Spatial coverage of the utilised MR protocol. 
 
In particular, the PC-MRA scan was acquired at the level of the carotids, 
with every effort being made by the radiographers to perform the scan at the 
same anatomical position for every subject. The metrics obtained from PC-MRA 
related to blood velocity and carotid diameter, and these were combined to 
provide flow measurements. The acquisition was optimized for the right carotid; 
however, velocity and flow measurements were also extracted from the left 
carotid and additional smaller arterial input sources. 
 
Connections between QUASAR and PC-MRA 
Considering the QUASAR ASL acquisition in tandem with the PC-MRA, 
we expect that, for the temporal length of the bolus (τ = 0.65s), the underlying 
carotid flow pattern (both influenced by velocity and vessel cross-sectional 
area) will impact on the number of protons inverted by the ASL labeling pulses. 
As a result, the effect of both the velocity pattern and the number of labeled 
protons will be reflected in the calculated CBF values. Due to the utilisation of 
saturation pulses before and after the control and the labeled phases, the 
temporal length of the bolus is expected to be a well-defined 0.65s for all 
groups (155). If the labeling was continuous, the amount of labeled spins would 
QUASAR	coverage	
	
MPRAGE,	FLAIR,	
DWI	coverage	
	
TOF-MRA	coverage	
	
PC-MRA	coverage	
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be proportional to the velocity of the inflowing spins and to the area covered by 
the feeding vessel. Utilisation of a pulsed labeling scheme with pre- and post-
saturation pulses is nearly instantaneous which means that the amount of 
labeled spins at a given time in the labeling slab depends on the number of 
spins present at the time (connected to the area). Conversely, the amount of 
labeled spins surviving the post-saturation Q2-TIPS scheme (157) will depend 
on the velocity of the spins. These remarks are useful to consider when 
examining the flow pattern at the carotids and relating it to the perfusion 
parameters at the level of the cerebrum. 
Processing of the PC-MRA data established that carotid flow at baseline 
was lower for T2DM subjects compared to IGT and HV. The post-ACZ carotid 
flow was higher in HV, lower in IGT and even lower for the T2DM subjects. The 
mean velocities for the left and right carotids were higher for the HV group both 
at baseline and post-ACZ compared to the other groups, whereas the feeding 
vessel cross-sectional area was larger for the T2DM group at baseline (not 
significant); this pattern was reversed post-ACZ. 
 
Increased baseline CBF could be explained by increased carotid dilation. 
Perfusion-related metrics were extracted from the QUASAR ASL arterial, 
residual and tissue signals at a voxel-wise level along with CBF, aBV and ATT 
measurements. Normally, a finding indicative of increased velocity and carotid 
flow would be expected to co-exist with increased CBF (as is the case for the 
HV group) and a similar connection (decreased carotid flow – decreased CBF) 
would be anticipated for the T2DM group. However, the recorded results at 
baseline point towards an increased CBF for the T2DM group.  
The ASL signal is based on hydrogen protons in water molecules. Thus, 
tissue perfusion, as measured with ASL, relates to the amount of water being 
exchanged at the time of imaging. Even when considering this, a finding of 
increased baseline CBF would normally be connected to a finding of increased 
flow at the level of the carotids. However, as already mentioned, our findings in 
T2DM point towards increased baseline CBF at the cerebrum co-existing with 
reduced carotid blood velocity and increased carotid diameter. This increased 
vessel diameter might explain partially the increased baseline CBF finding in 
T2DM, especially when considering the applied pre- and post- saturation 
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pulses, implemented for a clear bolus definition. The idea behind Q2-TIPS is 
that the saturation pulses are applied at a time-point where the trailing edge of 
the labeled bolus leaves the labeling area. The amount of label that is saturated 
by the pulse depends on the velocity of the label and is therefore non-
quantifiable. If the blood velocity was sufficient for the trailing edge of the bolus 
to leave the labeling region in time, then this finding could be explained by 
increased vessel dilation.  
 
Increased carotid dilation and CBF at baseline in T2DM might suggest the 
existence of a compensatory mechanism. 
Following ACZ injection, an increase was noticed for all parameters in 
the HV group. The increase was lower for the IGT and T2DM groups for metrics 
emerging from both the QUASAR and PC-MRA scans. High flow-related 
baseline values and lower than expected increases in parameters following 
ACZ injection in the hyperglycemic groups might indicate the presence of a 
compensatory mechanism for impaired oxygen retention at rest, leading to 
vasodilation, especially in the T2DM group. In T2DM studies, it has been 
suggested that due to the shift in the oxygen dissociation curve of glycated 
hemoglobin, tissue hypoxia occurs and an increased baseline flow can be 
observed as a compensatory mechanism (302). This interpretation could 
potentially explain our results as well.  
The overall tendency for T2DM subjects, when examining their cerebral 
vasculature using TOF-MRA, was a reduction in the number of branching 
points. A tendency towards reduced vessel length and density was also noticed 
for the MCA (not significant). This finding could also result from the slower 
velocity of the moving blood inside the vasculature of T2DM patients, which can 
influence the depicted vasculature if the velocity is slow enough for the spins 
inside the vessels to be saturated. 
In chapters 6 and 7, it was found that type-2 diabetes is associated with 
lower CVR, increased baseline CBF, prolonged TTP, HWL and FW values for 
hemodynamic signals, lower velocity at the level of the carotids and increased 
number of WMH. A trend towards increased ADC values, lower cortical 
thickness and increased CSF volume was uncovered. Based on VBM analysis, 
we have identified areas of differences between the groups mainly centered in 
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the caudate, putamen, amygdala, brainstem, hippocampus and thalamus. The 
IGT groups demonstrated a distinct functional pattern, with similarities at 
baseline to the HV groups and post-ACZ to the T2DM group when considering 
the QUASAR scan. Structurally, IGT demonstrated more similarities with the HV 
group.  A slightly larger carotid diameter was discovered at baseline for IGT and 
T2DM. Baseline CBF was higher in T2DM compared to HV for the examined 
vascular territories, a pattern which was not present post-ACZ. The T2DM 
group also demonstrated a higher number of WMH and a smaller number of 
branching points compared to HV. A pictorial summary for quantified measures 
of interest is presented for the three groups in figure 8.2. The mean value is 
shown for the baseline and post-ACZ scans for the following metrics quantified 
in chapters 6 and 7: carotid diameter, carotid velocity (mean, min, max left and 
right), ACA, MCA, PCA, GM and WM CBF, number and volume of white matter 
hyperintensities (shown for convenience in the post-ACZ scan) and density, 
length and number of branching points. 
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Figure 8.2: Summary figure for the three examined groups and metrics of interest. Values 
for carotid velocity, CBF in the examined vascular territories, carotid diameter, number of WMH 
and GM and WM CBF are shown. 
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8.1 Determination of the feature combination leading to optimal class-
differentiation 
The idea, in this sub-chapter, is to detect the feature combination that 
leads to optimal group-differentiation, by taking into account features derived 
from every considered modality using a multi-variate processing approach. To 
achieve this, measures from each MRI technique, based on findings from 
chapters 6 and 7, were chosen in a supervised manner and were incorporated 
into the feature vector under consideration. The resulting vector was analysed 
using a machine learning approach to identify the optimal feature combination 
based on all techniques (figure 8.3). Two models were considered, the first one 
comprised all modalities and the second comprised MPRAGE, TOF-MRA, PC-
MRA and QUASAR scans. This choice was made since FLAIR and DWI scans 
were not acquired for all HV.  
The selected features from the QUASAR acquisition were the ones 
comprising model 5 which demonstrated one of the highest performances when 
examined in Chapter 6 (243 features). The included MPRAGE features were 
cortical and subcortical GM volumes, WM volume, ventricular volume 
(normalised), the volume of the hippocampi, brainstem, thalami, amygdala, 
putamen, accumbens and the left and right cortical thickness (18 features). The 
ADC values from the same structures along with the ADC from the occipital and 
temporal lobes were included only in the first model from the DWI scan (19 
features). 
The number and volume of WMH was included only in the first model. 
Mean, max and min velocities from the 10-voxel regions in the left and right 
carotids examined in Chapter 7 and all the arterial input were included from the 
PC-MRA scan (24 features). The number of branching points, vessel density 
and length were included from the TOF-MRA scan. Additionally, age and sex 
were added into the feature vector. 
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Figure 8.3: A pictorial representation of the machine learning analysis, combining metrics 
from all modalities. 
 
For the first model, 34 subjects were analysed (11 HV, 8 IGT, 15 T2DM). 
These numbers per group were formed due to the absence of 5 scans from the 
HV group: 3 FLAIR/DWI were not acquired, subjects with one noisy MPRAGE 
and 1 noisy PC-MRA scan were excluded, subjects with 2 noisy QUASAR and 
2 noisy FLAIR scans were omitted from the IGT group and subjects with 1 noisy 
QUASAR and 1 noisy MPRAGE scan from the T2DM group. Overall, the 
considered features numbered 311. Results for every task can be found in table 
8.1. 
 
Table 8.1: Accuracy (Acc) sensitivity (Sens) specificity (Spec) features and number of 
features (Nf) for every task and the first model.  The number in brackets accompanying the 
number of features indicates that they were identified in the top-M features. With BOLD the non-
QUASAR features are underlined. 
Task Acc(%) Sens(%) Spec(%) Features Nf 
HV vs T2DM 96.2 93.3 100 CVR (26), ACA HWL AIFSH 
post-ACZ (25), ACA TTP AIFSH 
post-ACZ (25), number of 
branching points (23), W 
SKEW AIFSH post-ACZ (15), W 
KURT AIFSH baseline (6), PCA 
HWR TIS post-ACZ (6), WB 
HWL AIFSH post-ACZ (2), ACA 
10 (5) 
QUASAR	MPRAGE	FLAIR	
PC-MRA	TOF-MRA	DWI	 Machine	
learning	
MACHINE	
LEARNING	
Op7mally	diﬀeren7a7ng	
features	
SUPERVISED	
ACHINE	
LEARNING	
LABELS:			HV 	IGT			T2DM	
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SKEW AIFSH post-ACZ  (1), 
ACA TTP TIS post-ACZ  (1) 
HV vs IGT& 
T2DM 
85.3 87.0 81.8 Not shown 68 (49) 
HV vs IGT 
 
89.5 75.0 100 PCA HLW AIFSH post-ACZ (18) 
PCA TTP COMB post-ACZ (1) 
2 (1) 
IGT vs T2DM 87.0 93.3 75.0 ACA HWL AIFSH post-ACZ 
(10), CVR (9), ACA TTP COMB 
post-ACZ (3), MCA SKEW 
COMB post-ACZ (1) 
4 (1) 
 
For the second model, data from 14 HV, 10 IGT patients and 15 patients 
with T2DM were retained and overall 289 features comprised the considered 
feature vector. These numbers resulted from exclusion of subjects with 1 noisy 
MPRAGE and one noisy PC-MRA scan for the HV group, 2 noisy QUASAR 
scans for the IGT group and one noisy QUASAR and one noisy MPRAGE from 
the T2DM group. Results for every task can be found in table 8.2. 
 
Table 8.2: Accuracy (Acc) sensitivity (Sens) specificity (Spec) features and number of 
features (Nf) for every task and the second model.  The number in brackets accompanying 
the number of features indicates that they were identified in the top-M features. Bold is used for 
the non-QUASAR features. 
Task Acc(%) Sens(%) Spec(%) Features Nf 
HV vs T2DM 96.6 93.3 100 CVR (19), ACA HWL AIFSH post-
ACZ (15), ACA TTP AIFSH post-
ACZ (11), PCA HWR ΔΜcr post-
ACZ (7), number of branching 
points (3), GM CBF baseline (2), 
ACA SKEW AIFSH baseline (1) 
7 (2) 
HV vs IGT& 
T2DM 
87.2 92.0 78.6 CVR (26), ACA HWL AIFSH post-
ACZ (5), PCA HWR ΔΜcr post-
ACZ (3), W KURT ΔΜncr baseline 
(3), W KURT AIFSH baseline (2) 
5 (1) 
HV vs IGT 
 
100 100 100 PCA HWL AIFSH post-ACZ (24), 
PCA TTP AIFSH post-ACZ (21), 
PCA HWL ΔΜncr post-ACZ (2), W 
KURT ΔΜcr post-ACZ (1) 
4 (2) 
IGT vs T2DM 68.0 80.0 50.0 CVR (9), GM CBF baseline (9), W 5 (1) 
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HWR ΔΜcr baseline (3), ACA 
KURT ΔΜncr post-ACZ (3), MCA 
HWL AIFSH baseline (1) 
  
The combined analysis of all modalities indicated that QUASAR ASL is 
the main modality contributing information leading towards optimal class-
separation. The only feature not derived from the QUASAR sequence brought 
up as optimal with a high occurrence for the HV vs T2DM task was the number 
of branching points, a feature extracted from the TOF-MRA image. The 
considered analysis, based on features from all modalities combined into a 
single model, emphasizes the importance of incorporating into a study protocol 
a perfusion imaging modality such as QUASAR for pathology detection. The 
number of branching points, which was part of the optimally-differentiating 
pattern for HV versus T2DM, was quantified based on processing of the TOF-
MRA scan, which is not typically conducted, since angiogram evaluation mainly 
involves visual assessment and is aimed at detecting gross changes.  
The dominance of QUASAR features in the final pattern could also be 
attributed to the fact that the number of features from every technique was not 
balanced (249). The approach of concatenating all features into a single vector 
is very common; however, other feature fusion strategies have been suggested. 
An approach, for creating a balanced feature vector, is based on applying 
classification approaches in every technique separately to reduce the features 
emerging from each one and subsequently combining the resulting optimal 
features into a single model (341). Such an approach was adopted to provide 
reassurance that the optimal pattern is not dominated by QUASAR features due 
to their very high number. 
 
Model 1 – balanced number of features 
A balanced number of features was considered for the two models and 
the HV vs T2DM and HV vs IGT tasks. 
For the HV vs T2DM task classification solely with the QUASAR features 
was run and the optimal performance was achieved with 44 features (88.5%). 
	 233	
The second highest performance was recorded for 14 features and was 84.6%1. 
These 14 features were retained. Subsequently, classification was run for all 
non-QUASAR features separately and the maximum achieved performance 
was recorded with three features: the number of branching points (occurrence 
of 23 in the top-1 of the SVM-RFE matrix), maximum velocity in the left carotid 
pre (occurrence of 2 in the top-1) and post-ACZ (occurrence of 1) and was 
65.4%. When the 11 significantly different features from all non-QUASAR 
modalities were combined with the 14 QUASAR features, maximum 
performance was 92.3% achieved with 5 features (top-2): number of branching 
points (occurrence of 2 in the top-M of the SVM-RFE matrix), ACA TTP AIFSH 
post-ACZ (occurrence of 3), W SKEW AIFSH post-ACZ  (occurrence of 2), ACA 
HWL AIFSH post-ACZ  (occurrence of 24) and CVR (occurrence of 21). Hence, 
even when using a balanced feature vector, the dominating features emerged 
from QUASAR ASL and were based on the time delays in the delivery of the 
bolus to the tissue post-ACZ and CVR. The only non-QUASAR feature part of 
the optimal pattern, which also dominated the non-QUASAR classification task, 
was the number of branching points. 
For the HV vs IGT task, when only QUASAR features were used, 
maximum performance of 89.5% was achieved with 2 features: PCA HWL 
AIFSH post-ACZ (18), PCA TTP ΔΜncr post-ACZ (1). When non-QUASAR 
features were used, 2 features differed significantly and maximum performance 
was 63.2% achieved with a single feature the ADC of the right amygdala. When 
all features were combined, maximum performance of 89.5% was achieved with 
the QUASAR features. These QUASAR features were both extracted from post-
ACZ curves and in particular from the PCA vascular territory.  
 
Model 2 – balanced number of features 
When examining the HV vs T2DM task and the QUASAR derived 
features, 56 differed significantly and a maximum performance of 86.2% was 
achieved with 29 features. Second best performance was 82.8% with 10 
features, which were kept for the subsequent analysis. When examining the 	1	Please note that differences in performance compared to chapter 6 are explained by the 
different subjects used for analysis in this section due to absence of DWI and FLAIR 
acquisitions for several subjects	
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non-QUASAR features, 14 differed (out of the 45) and a maximum performance 
of 79.3% was achieved with 9 features. When combined, maximum 
performance of 96.6% was achieved with 10 features identified to the top-5 of 
the SVM-RFE matrix. These included the number of branching points (29) from 
non-QUASAR features and the other 9 were all derived from QUASAR: PCA 
HWR ΔΜcr post-ACZ  (occurrence in the top-M: 22), W KURT ΔΜcr baseline (2), 
ACA TTP AIFSH post-ACZ (26), ACA SKEW AIFSH baseline (1), W KURT AIFSH 
baseline (1), MCA PEAK AIFSH baseline (1), ACA HWL AIFSH post-ACZ  (27), 
GM CBF baseline (7) and CVR (29). 
 For the HV vs IGT task, 93 features derived from the QUASAR sequence 
were significantly different. Maximum performance of 100% was achieved with 
4 features. When the non-QUASAR features were examined, only one differed 
significantly between the groups and maximum performance was 66.7%; this 
feature was the volume of cortical GM. When combined, maximum performance 
of 100% was achieved solely with the QUASAR features identified in the top-2 
of the SVM-RFE matrix, which were: W KURT ΔΜcr post-ACZ (occurrence of 1), 
PCA TTP AIFSH post-ACZ (21), PCA HWL AIFSH post-ACZ (24), PCA HWL 
ΔΜncr post-ACZ (2). 
Hence, feature fusion to create balanced vectors changed the observed 
results and performance for the first model and the HV vs T2DM task for which 
a lower performance was achieved. The QUASAR feature dominance in the 
optimally differentiating feature pattern is not attributed to the fact that the 
technique contributes the majority of features, but rather to their high 
discriminatory power. For the HV vs T2DM task, an equally strong feature was 
the number of branching points. Similarities in performance, with and without a 
balanced feature vector, could also be attributed to the usage of a 
dimensionality reduction technique retaining only significantly different features, 
which greatly reduces the number of utilised features.  
The reader is reminded that accuracy of 96.9% was achieved with 27 
features (Chapter 6.3.2) for the HV vs T2DM task. Model 2 in the present 
chapter achieved a performance of 96.6% with only 7 features emerging mainly 
from the ACA, PCA territories and from GM. The achieved accuracy was the 
same as in chapter 6.3.2 for the HV vs IGT task with features emerging from 
the post-ACZ curves and the PCA territory and watershed areas. 
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Overall in this subchapter features from all examined modalities were combined 
into a single model. It was shown that optimal feature combinations for the 
examined tasks emerge mainly from the QUASAR sequence. The only non-
QUASAR feature contributing to optimal separation between HV and T2DM 
emerged from the cerebral angiogram. Accuracy for this task was the same 
when solely QUASAR and features from all techniques were considered. 
However, inclusion of the number of branching points (TOF-MRA) led to a 
smaller optimal pattern, which is desirable.   
 
8.2 Overall thesis discussion 
The goal of the work presented in this thesis was to gain a deep insight 
into the brain of subjects with impaired glucose tolerance and type-2 diabetes, 
being particularly focused in cerebral perfusion. To achieve this, MRI modalities 
capturing different aspects of structure and function were analysed using state-
of-the-art processing techniques to capture group-differences and detect 
cerebral areas and MR-derived metrics contributing towards optimal group-
separation. 
 The detailed analysis and described methodologies established that the 
volumetric changes were subtle between the groups especially when focusing 
on specific ROIs; more differences were detected when the image was 
analysed at a voxel-wise level. The number and volume of white matter hyper-
intensities was significantly higher in the T2DM groups compared to HV. 
Processing of the cerebral vasculature was focused on the MCA territory and 
identified that the number of branching points differed. Carotid flow velocity 
analysis unraveled several differences in the velocity pattern between T2DM 
patients and HV, both at baseline and following ACZ injection. Both laminar and 
whole vessel velocity was decreased in both T2DM and IGT. At the level of the 
cerebrum, perfusion analysis conducted using QUASAR ASL and newly 
developed processing tools, identified a multitude of hemodynamic metrics 
differing between all considered groups, suggesting the existence of a distinct 
hemodynamic pattern. 
 
	 236	
Structural alterations were focused on several cortical and subcortical 
regions, WM and cerebral vasculature. 
Global and localized atrophies have been consistently reported in 
diabetic cohorts (33). When analysing the available cohort though, only the 
ventricular volume differed between the groups; a finding which did not remain 
significant following multiple comparison correction. This finding is of great 
importance, since it could potentially mean that the considered diabetic group 
was captured at a disease stage where prominent structural abnormalities 
associated with volume reduction have not yet occurred. Significant structural 
alterations involved WMH and changes in the vasculature. The number of WMH 
was higher in T2DM, a finding not consistently reported in T2DM studies. The 
IGT group had a similar volume and number of WMH to the HV group. The 
number of branching points in the MCA territory was significantly reduced in 
T2DM. The results from the DWI analysis uncovered several areas where the 
water diffusivity was impaired, such as the amygdala, hippocampi, brainstem 
and caudate. The amygdala (left and right) was the only region differing 
between HV and IGT, suggesting that early changes in the diffusivity of water 
molecules might occur there. However, it needs to be emphasised that the DWI 
findings were not significant following multiple comparison correction, hence 
they are suggestive of the existence of a certain pattern regarding water 
diffusivity which warrants further investigation.  
VBM analysis identified several regions of difference between the 
groups. VBM differs from ROI specific approaches, since it focuses on the GM 
PV maps at a voxel-wise level. Hence, it is capable of detecting more dispersed 
patterns of difference between the groups. Structures that differed between IGT 
and T2DM involved the amygdala, thalami, hippocampi and accumbens. The 
IGT group did not differ from the HV group.  
The fact that the cohort was cognitively asymptomatic and without 
prominent atrophy patterns, highlights the importance of conducting a detailed 
functional (in our case hemodynamic) analysis to shed light on potential 
functional alterations that could lead, if prolonged, to structural changes 
observed consistently in T2DM patients.  
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Functional analysis identified the existence of a potential compensatory 
mechanism  
Functional characteristics were explored using PC-MRA, capturing the 
blood velocity pattern at the level of the carotids and QUASAR ASL, capturing 
the CBF pattern at the level of the cerebrum. Starting from the carotid level, the 
velocity of the blood was reduced and vessels appeared more dilated in T2DM 
and IGT (not a significant finding). Following ACZ injection, the increase in the 
carotid diameter was significant only for the HV group indicating the ability for 
vasodilation. The carotid diameter was relatively static in both IGT and T2DM 
following induced vasodilation. These findings, together, point towards 
increased dilation at baseline for the hyperglycemic groups with reduced ability 
to respond to increased needs for oxygen and nutrients, when presented with a 
task requiring dilation to meet energy demands.  
A detailed hemodynamic analysis, conducted using ASL at the level of 
the cerebrum, focused on the vascular territories of the internal carotid and 
watershed areas, identified a delayed, more dispersed, delivery of the labeling 
bolus in the T2DM groups. Interestingly, the results for IGT at baseline were 
more similar to the HV groups and post-ACZ to the T2DM group, indicating that 
functional alterations are also occurring in pre-diabetes. More importantly, 
classification of HV and IGT was perfect and driven by features capturing 
delayed and dispersed bolus delivery post-ACZ, while no structural differences 
were observed between the HV and IGT groups. This finding indicates that a 
potential analysis targeted at unraveling early biomarkers for diabetes, focused 
on subjects with pre-diabetes, might miss early functional changes if it 
investigates only structural changes or functional alterations occurring at rest. 
 The finding of increased baseline CBF was an unexpected finding for the 
cohort. We were expecting decreased CBF both at baseline and post-ACZ and 
a decreased CVR based on previous reports for the T2DM group (33). The two 
latter findings were verified, the former one was not. These findings are of 
particular interest, since increased CBF has only been reported in a few studies 
(46, 47). It might be connected with early stages of tissue hypoxia, whereby the 
oxygen is not sufficiently retained due to hyperglycemia and a compensatory 
mechanism leading to baseline hyper-perfusion is established to meet the 
tissue energy demands (302).  
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This mechanism has also been observed in the early stages of 
Alzheimer’s, when mild cognitive impairment has been detected (342). 
However, this compensatory mechanism fails after a certain point leading to 
structural alterations, hypo-perfusion and cognitive changes. The cohort under 
consideration was neurologically asymptomatic; hence, we might have captured 
this cohort at a stage where the compensatory mechanism built to account for 
tissue hypoxia, has not yet failed. This would potentially explain both the finding 
of increased baseline CBF, increased vessel dilation and reduced CVR. For this 
to be validated, a follow-up scan and detailed cognitive evaluation should take 
place. Potential cognitive changes and failure of the detected compensatory 
mechanism leading to hypo-perfusion would provide a clearer picture of how 
the cascade of alterations occurs in diabetes. 
 
Features that could be evaluated as potential disease biomarkers were 
identified using a machine learning framework 
Currently, there are no MR-derived features connected exclusively with 
T2DM. Global and local atrophy patterns, typically detected in diabetic subjects, 
are also present in other conditions such as Alzheimer’s (343). WMHs, 
occasionally present in T2DM, are also connected with all major cardiovascular 
risk factors, such as hypertension, and are not a consistent finding (327). 
Altered patterns in mean diffusivity, carotid flow, velocity and cerebral blood 
flow are not exclusively connected with diabetes and also occur in other 
diseases such as Alzheimer’s (343, 344). Hence, using a framework examining 
feature combinations and identifying the optimal-ones for the classification task 
in question might have the potential to capture disease-specific patterns of 
pathophysiology. 
The results, especially those based on arterial spin labeling, are 
extremely promising regarding the ability of the technique to capture subtle 
hemodynamic patterns. Optimal classification was achieved with only a few 
QUASAR-derived features that could be evaluated as disease biomarkers 
(Chapter 6). The achieved classification accuracy for the HV versus T2DM task 
reached 96.6% and for the HV versus IGT task 100%, when considering solely 
QUASAR hemodynamic features. These findings suggest that inclusion of a 
perfusion imaging acquisition in clinical protocols, especially in its dynamic 
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form, could be beneficial and of clinical value. Features that were identified as 
highly discriminant for both the HV vs T2DM and HV vs IGT tasks could be 
evaluated as potential biomarkers for hyperglycemia and diabetes. Such 
features capture the pattern of delivery of the labeled bolus to the tissue (how 
delayed and dispersed the pattern is) and were extracted from all acquired 
hemodynamic curves. Also, the majority of optimal features were extracted from 
the post-ACZ scan, emphasizing the importance of incorporating into the 
protocol a vasodilating stimulus to evaluate the ability of the neurovascular unit 
to adapt to higher energy demands. 
In this final chapter, all the techniques were brought together and 
analysed using a machine-learning framework to identify optimally 
differentiating feature combinations. Two methods were applied to detect the 
feature combination leading to high classification performance. The first method 
utilised all QUASAR features and a selection of features from all the other MRI 
modalities, which were significantly different or were expected to differ between 
healthy individuals and diabetic patients. In the second model, a small number 
of highly discriminant features from QUASAR was used along with the same 
selection of features from the other MRI modalities to create a balanced pattern. 
The QUASAR features for both methods, dominated the classification tasks 
leading to optimal class separation, suggesting that the QUASAR-extracted 
hemodynamic metrics are particularly strong features in accurately classifying 
normoglycemia versus hyperglycemia. The only feature emerging from another 
technique was the number of branching points, calculated based on the TOF-
MRA scan, which was one of the top features for HV vs T2DM classification. 
The accuracy was 96.6%, achieved with only 7 features, as opposed to 96.9% 
with 27 features, when utilising only QUASAR features. This suggests that the 
number of branching points is a strong feature leading to a smaller optimal 
pattern of features. Overall, the QUASAR metric dominance when the multi-
modal features were combined into one single model, emphasized even more 
the strength of the considered QUASAR-derived features and their sensitivity in 
separating the groups under consideration. 
The protocol utilised in this study was extensive, capturing different 
aspects of function and structure. However, further information could be 
acquired. Of interest would be, instead of using DWI, to acquire DTI images. 
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DTI images can shed light on the complex diffusion patterns in the brain and 
are not confined to the calculation of a single parameter (ADC). Diffusion 
tractography could be applied, along with graph analysis, to examine structural 
connectivity (345). Additionally, MRS data could be acquired and information 
regarding the concentration of different metabolites quantified (346). Finally, 
resting-state fMRI could shed light into changes in functional connectivity of 
areas of interest (347). This would allow the identification of optimally 
discriminative features based on an even larger collection of MRI features, 
using an approach similar to the one used earlier on this chapter, where 
features from different modalities were combined in a supervised manner. 
In this study, only a small cohort was available and this poses limitations 
for the generalisability of the observations, since we could be modeling cohort 
idiosyncrasies. A larger cohort needs to be recruited, in order to examine if the 
findings of this thesis can be replicated. An interesting extension would be to 
compare QUASAR ASL with time-encoded ASL, which offers high SNR and 
examine them in the same study to see if the same pattern can be captured 
using alternative multi time-point ASL techniques.  
The extracted optimal features from the classification tasks hold great 
potential to be examined as disease biomarkers and are directly connected to 
underlying physiological processes, coupled with the mechanism of water 
delivery to the tissue. Hence, it would be of interest to examine, in a future 
study with a larger cohort, the associated hemodynamic curves. Another 
interesting extension to this study would be to recruit a cohort comprised of 
healthy volunteers, IGT and T2DM subjects with and without cognitive 
impairment to evaluate whether the detected compensatory mechanism fails 
when cognitive decline emerges. 
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Appendix 
Appendix1 
 
Chapter 6 
 
Table A6.1: Summary of classification accuracy and number of features for every task 
and model. Models in bold are the ones for which optimal performance was achieved. 
Model Number of 
features 
Significant 
features 
Accuracy (%) Top-M 
features (M) 
Healthy volunteers vs type-2 diabetes 
1 211 59 96.9 27 (12) 
2 211 71 84.4 7(3) 
3 351 116 93.8 9(3) 
4 34 3 81.3 1(1) 
5 244 62 90.6 6(3) 
6 244 74 93.8 3(2) 
7 384 119 84.4 3(1) 
Healthy volunteers vs type-2 diabetes & impaired glucose tolerance 
1 211 85 92.9 14(4) 
2 211 85 83.3 5(1) 
3 351 153 88.1 42(19) 
4 34 7 81 4(3) 
5 244 92 92.9 11(3) 
6 244 92 83.3 23(13) 
7 384 160 88.1 22(7) 
Healthy volunteers vs impaired glucose tolerance 
1 211 85 100 5(3) 
2 211 86 92.3 7(3) 
3 351 148 92.3 2(1) 
4 34 6 73.1 6(3) 
5 244 91 100 5(3) 
6 244 92 92.3 6(3) 
7 384 154 92.3 2(1) 
Impaired glucose tolerance vs type-2 diabetes 
1 211 6 65.4 4(1) 
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2 211 10 69 5(1) 
3 351 15 69.2 11(4) 
4 34 4 73.1 4(1) 
5 244 10 80.7 7(1) 
6 244 14 65.4 11(5) 
7 384 19 80.7 6(1) 
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Table A6.2: Details for the two best performing models for every task. The accuracy (Acc), 
sensitivity (Sens) and specificity (Spec) for every model are shown. Along with these the 
number of significantly different features (NF1) and the number of features providing optimal 
class differentiation (NF2) are provided. Finally, in the last column, the top scoring features 
(maximum 5) are shown accompanied by a number indicating their occurrence. The maximum 
possible number in the brackets would be for task 1: 32, task 2: 42, task 3: 26 and task 4: 26. 
Task 
 
Model 
 
NF1 Acc. 
(%) 
Sens. 
(%) 
Spec. 
(%) 
NF2 Feature combination 
providing optimal 
accuracy (max 5 shown) 
HV vs 
T2DM 
1 59 96.9 100 93.8 27 PCA HWR ΔΜcr post-ACZ 
(32), PCA FW ΔΜcr post-ACZ 
(32), ACA TTP AIFSH post-
ACZ (32), ACA SKEW AIFSH 
baseline (32), ACA HWL 
AIFSH post-ACZ (32) 
HV vs 
T2DM 
6 74 93.8 93.8 93.8 3 WB HWL Res post-ACZ (31), 
WB TTP Res post-ACZ (26), 
CVR (7) 
HV vs 
IGT&T2DM 
1 85 92.9 96.2 87.5 14 PCA HWR ΔΜcr post-ACZ 
(40), MCA SKEW ΔΜcr post-
ACZ (35), ACA SKEW ΔΜcr 
post-ACZ (18), W KURT ΔΜcr 
baseline (18), ACA KURT 
AIFSH baseline (17) 
HV vs 
IGT&T2DM  
5 92 92.9 96.2 87.5 11 CVR (36), MCA SKEW ΔΜcr 
post-ACZ (31), ACA HWL 
AIFSH post-ACZ (23), PCA 
HWR ΔΜcr post-ACZ (21), 
ACA SKEW AIFSH baseline 
(7) 
HV vs IGT 1 85 100 100 100 5 PCA HWL AIFSH post-ACZ 
(26), PCA TTP AIFSH post-
ACZ (26), W KURT ΔΜcr 
post-ACZ (17), PCA HWL 
ΔΜncr post-ACZ (8), ACA 
TTP ΔΜncr post-ACZ (1) 
HV vs IGT 5 91 100 100 100 5 
IGT vs 
T2DM 
5 10 80.7 87.5 70 7 GM CBF baseline (10), CVR 
(9), ACA aBV baseline (2), 
PCA HWL ΔΜncr post-ACZ 
(2), MCA KURT ΔΜncr post-
ACZ (1) 
IGT vs 
T2DM 
7 19 80.7 81.3 80 6 MCA HWL R baseline (1), 
PCA HWL ΔΜncr post-ACZ 
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(2), GM CBF baseline (17), 
CVR (4), ACA aBV baselne 
(4) 
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A7.1 
 HV  (cm3) IGT (cm3) T2DM (cm3) 
Left accumbens 0.6±0.2 0.7±0.2 0.6±0.1 
Left amygdala 1.7±0.3 1.7±0.2 1.6±0.2 
Left caudate 3.4±0.4 3.7±0.4 3.7±0.9 
Left putamen 5.6±0.7 5.9±0.7 5.5±1.0 
Right accumbens 0.6±0.2 0.7±0.2 0.6±0.1 
Right amugdala 2.2±0.4 2.2±0.3 2.0±0.3 
Right caudate 3.6±0.5 3.7±0.6 3.7±0.8 
Right putamen 5.7±0.6 5.9±0.6 5.3±0.7 
 
Chapter 7.4 
Qflow tables with the mean and standard deviation for the calculated velocities 
 
 
Table A7.2: Baseline mean velocity for the 3 groups and areas of interest. 
 right (ml/s) left(ml/s) right10(ml/s) left10(ml/s) All (ml/s) 
HV 26.36±2.77 24.28±3.78 30.19±2.68 28.09±4.99 22.59±2.77 
IGT 23.54±2.94 22.53±3.78 27.30±4.03 25.31±4.46 20.97±2.22 
T2DM 21.41±5.44 19.32±5.23 24.86±5.45 21.80±5.35 18.89±4.16 
 
 
Table A7.3: Baseline max velocity for the 3 groups and areas of interest. 
 right (ml/s) left(ml/s) right10(ml/s) left10(ml/s) All (ml/s) 
HV 35.38±3.42 32.69±5.97 35.38±3.42 32.69±5.97 36.22±3.77 
IGT 31.96±4.61 29.30±5.22 31.96±4.62 29.30±5.22 34.48±2.78 
T2DM 28.96±6.24 25.31±6.34 28.93±6.25 25.30±6.24 30.18±5.78 
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Table A7.4: Baseline min velocity for the 3 groups and 5 areas of interest. 
 right (ml/s) left(ml/s) right10(ml/s) left10(ml/s) All (ml/s) 
HV 16.89±3.02 15.67±2.99 24.23±2.32 22.77±4.29 11.47±1.88 
IGT 14.54±2.32 14.66±2.93 21.70±3.37 20.23±3.36 10.21±1.90 
T2DM 13.15±4.83 12.78±4.48 19.96±4.72 17.72±4.78 9.82±3.35 
 
 
Table A7.5: Post-ACZ mean velocity for the examined cohort and the areas of interest. 
 right (ml/s) left(ml/s) right10(ml/s) left10(ml/s) All (ml/s) 
HV 32.10±6.33 28.50±6.61 38.32±6.45 34.45±8.26 27.96±4.65 
IGT 29.17±2.93 27.37±4.81 35.39±3.93 32.02±5.07 25.02±3.15 
T2DM 27.11±6.40 23.92±6.20 32.14±6.98 27.82±7.36 23.97±5.62 
 
 
Table A7.6: Post-ACZ max velocity for the examined cohort and the areas of interest. 
 right (ml/s) left(ml/s) right10(ml/s) left10(ml/s) All (ml/s) 
HV 44.43±6.89 39.84±9.36 44.42±6.92 39.82±9.38 46.22±6.13 
IGT 40.85±5.14 33.38±5.56 40.85±5.14 36.53±6.16 41.05±4.90 
T2DM 37.16±7.97 30.77±7.95 37.11±8.00 32.16±8.71 38.60±7.83 
 
Table A7.7: Post-ACZ min velocity for the examined cohort and the areas of interest 
 right (ml/s) left(ml/s) right10(ml/s) left10(ml/s) All (ml/s) 
HV 19.25±6.26 16.71±5.47 30.89±6.50 28.29±7.41 14.10±3.24 
IGT 16.66±2.60 17.20±4.03 28.78±2.94 26.95±4.18 11.96±2.43 
T2DM 15.96±5.14 15.09±4.84 25.94±6.13 22.32±5.99 11.73±3.24 
 
 
